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ABSTRACT 
Understanding the role of the gut microbiota in the development of cardiometabolic 
conditions has important implications for both prevention and treatment.  Whilerecent research 
suggests that gut microbiota may play a key role in obesity and metabolic diseases, less is known 
about what role it plays in the development of these conditions in children.  In this study, we used two 
large epidemiologic cohorts to investigate the relationships between obesity and cardiometabolic 
conditions and the gut microbiota of mothers, infants and adolescents.  We explor d gut microbial 
characteristics as a potential mechanism to explain the association between maternal weight and the 
development of obesity in offspring in the NOMIC cohort.  We examined the associ tion between 
adolescent gut microbiota and hepatic fat in the EPOCH cohort.  For our analyses, we used random 
forests and regression methods.  We found differences in the maternal gut microbiota at the time of 
delivery with both pre-pregnancy overweight/obesity (OW/OB) and with excessive gestational weight 
gain (GWG).  The infant gut microbiota was predictive of BMI at age 12, and maternal OW/OB also 
showed associations with the infant gut microbiota features predictive of childhood BMI.  In the 
EPOCH cohort, we found that the gut microbiota diversity and taxa were associated with hepatic fat 
accumulation in adolescents.  The findings of this research could have implications for public health 
efforts to prevent and treat these problems because the gut microbiota of pregnant wome , children 
and adolescents are alterable through simple, non-invasive means, such as diet, prebiotics, and 
probiotics.  Furthermore, our results suggest that the gut microbiota may lso offer potential as early 
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CHAPTER I  
INTRODUCTION  
Background 
Obesity and diabetes prevalence among American children and adolescents has increased 
dramatically in recent years.1,2 In order to reverse these trends, it is imperative to understand the 
causes, some of which may relate to the gut microbiota. The maternal gut microbiome, the 
colonization process of the infant gut, and the established gut microbiota of the child may have 
lifelong consequences for obesity risk and cardiometabolic disease. The overall aim of this research is 
to explore microbial exposures as a mechanism to explain the development of obesity and related 
cardiometabolic outcomes in youth.    
There is increasing evidence that the gut microbiota plays a role in besity and 
cardiometabolic conditions. Low gut microbial diversity has been associated with increased 
inflammation, adiposity, insulin resistance and dyslipidemia.3,4 Transplantation of gut microbiota 
from obese humans to normal weight mice was shown to  increase adiposity.5 M crobial exposures 
during pregnancy and early life may influence immune and metabolic programming in the offpring.6 
Among the first of these microbial exposures is the transfer of microbiota from mother to child during 
delivery.7,8 Some studies have shown differences in maternal gut microbiota by obesity status and 
gestational weight gain.9,10 However, it is unknown exactly what role these prenatal and early life 
factors have on the development and establishment of the offspring gut microbiota, whether the 
development of the infant gut microbiota impacts obesity and metabolic disease risk later in life, and 
if the gut microbiota can serve as an early biomarker for cardiometabolic conditions.  This is an 
important area of research because it may offer opportunities for interventions that could prevent 
disease or curb its progression.   
 The research presented here capitalizes on data from two cohort studies. The first, the 
Norwegian Microflora (NOMIC) study, includes over 500 mothers and their children. A subset of the 
mothers provided one fecal sample after delivery, and the children provided numerous fecal samples 
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during the first 2 years of life. The large sample size and extensive microbial samples allowed us to 
explore the relationships between maternal weight / weight gain, maternal and infant gut microbiota, 
and childhood obesity. The second study, Exploring Perinatal Outcomes in Children (EPOCH), 
consists of 500 individuals exposed and not exposed to gestational diabetes mellitus (GDM) in utero 
with microbial data from a subset of 120 participants, between the ages of 12 and 9 years. These 
data enabled us to evaluate the relationships between hepatic fat and the gut microbiota, and to 
evaluate its potential as a biomarker for non-alcoholic fatty liver disease. 
Specific Aims & Hypotheses 
Aim 1 
To determine the characteristics of maternal gut microbiota at delivery, specifically the 
diversity and composition, that correlate with maternal pre-pregnancy overweight or obesity 
(OW/OB) and excessive gestational weight gain (GWG), using the NOMIC cohort. 
Hypothesis 1.1 
Compared to non-OW/OB, the gut microbiota at delivery of women with pre-pregnancy 
OW/OB will have lower gut microbial diversity.  Similar patterns will be seen with excessive GWG 
relative to non-excessive GWG. 
Hypothesis 1.2 
Compared to non-OW/OB, the gut microbiota at delivery of women with pre-pregnancy 
OW/OB will have differences in taxonomic omposition.  Similar patterns will be seen with excessive 
GWG relative to non-excessive GWG. 
Aim 2  
To explore the associations between maternal pre-pregnancy OW/OB, the development of 
infant gut microbiota and offspring BMI at age 12 in the NOMIC cohort. 
Hypothesis 2.1 
The infant gut microbiota over the first two years of life will be predictive of BMI-for-age z-




Infant gut microbiota characteristics predictive of BMI-for-age z-scores at age 12 will be 
associated with maternal OW/OB. 
Aim 3  
To evaluate the gut microbial diversity and composition of teenagers in the EPOCH cohort in 
relation to hepatic fat. 
Hypothesis 3.1 
Teenagers with igher hepatic fat fraction will have lower microbial diversity compared with 
teenagers with less hepatic fat.  
Hypothesis 3.2 
Gut microbiota taxonomic composition will be predictive of hepatic fat fraction. 
Overall Impact and Innovation 
One of the most exciting aspects of this research is that most of the early lif  microbial 
exposures are alterable and offer opportunities for disease prevention in the future. Once the process 
of infant gut colonization is understood, as well as the effects of that process on life- ong health, steps 
can be taken to influence that process, such as aiming to improve maternal di t during pregnancy, 
controlling gestational weight gain, increasing breastfeeding, and making choices about mode of 
delivery and antibiotic use that take into account both short and long-term health and safety.  
Furthermore, the gut microbiota of pregnant women, children and adolescents can be influenced by 
diet, prebiotics, and probiotics.6   
This project is the first study to investigate the effects of maternal characteristics, before and 
during pregnancy, on the gut microbiota of the mother at birth, as well as on the offspring over the 
first two years of life, and to examine how these factors relate to the development of childhood 
obesity. It is also among the first studies to examine the potential of gut microbiota as a biomarker for 




CHAPTER II  
LITERATURE REVIEW  
Conceptual Framework for this Study 
The conceptual model for this study is shown in Figure 1.  Broadly, we examined the 
relationship between the gut microbiota and obesity, as well as related conditions, i  pregnant 
women, infants, and teenagers.  While animal models and laboratory research have provided potential 
mechanisms through which gut microbiota could influence the development of obesity and related 
conditions, larger-scale population level studies, such as this one, are imperative in order to truly 
understand the role that gut microbiota play, and whether gut microbes are a feasible and impactful 
target for prevention or treatment efforts. 
Aim 1 of this study examined the relationship between maternal characteristics (pre-
pregnancy OW/OB and excessive gestational weight gain, GWG) and the gut microbiota at the time 
of delivery.  Since there is evidence to suggest that gut microbiota play a key role in obesity and 
weight gain, it is important to understand whether these factors in mothers are associated with 
differences in the types of gut microbiota transferred to the infant during delivery.  These early 
microbes could then set the trajectory of gut colonization in the infants, s well as play a role in 
immune and metabolic programming, together influencing their lifelong risk of developing obesity or 
other diseases.  Aim 2 focused on the infant gut microbiota predictive of childhood BMI, and its 
relationship with maternal OW/OB.  Understanding the relationships between maternal OW/OB, 
maternal and infant gut microbiota, and childhood BMI is important because the maternal and infant 
gut microbiota could be potential targets for obesity prevention efforts.    
The final aim of this study explored the relationship between the gut microbiota of 
adolescents and hepatic fat deposition.  We also considered the influence of diet, demographic and 
co-morbidities on hepatic fat.  The fatty liver measures examined in this aim of the study were taken 
at the same time as the gut microbial sample.  Thus, we were not able to make causal inferences, but 
we were able to evaluate the utility of the gut microbiota as a clinical biomarker of hepatic fat. 
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Childhood Obesity is a Major Risk Factor for Adult Obesity and Disease 
Obesity is a global epidemic, affecting younger and younger people.  Although recent years 
have seen a reversal in the increases in childhood overweight and obesity,11 the prevalence among 
American youth is still 31.8%; among adults, it is 69.0%.12 While excess weight has real and 
immediate social and psychological consequences for children,13 there are also concerning long-term 
consequences, uch as increased risk for early onset of type 2 diabetes.14 Children who are overweight 
or obese are substantially more likely to be overweight or obese as dults, compared to normal-weight 
children.11 Adult obesity increases the risk for type 2 diabetes, coronary heart disease, c rtain types of 
cancer, stroke, liver and gallbladder disease, sleep apnea, as well as other adverse conditions.15  
Gut Microbiota Play a Key, but not Fully Understood, Role in Obesity and Related Conditions 
Both human and animal studies involving fecal transfers between individuals suggest that gut 
microbiota play a key causal role in obesity and insulin sensitivity.  For example, a clinical trial by 
Vrieze et al.35 showed that transference of gut microbiota from lean donors to men with metabolic 
syndrome resulted in a significant increase in insulin sensitivity. Similarly, nimal studies have 
shown that gut microbiota transferred from obese mice into germ-fr e mice induces increased 
adiposity.36 Gut microbiota from twins discordant for obesity transferred into gnotobiotic mice (i.e. 
mice born and raised in an isolator devoid of all microbes except for those intentio ally added) 
showed similar results: microbiota from obese individuals led to increased adiposity compared to 
microbiota from lean individuals.  Furthermore, the increased adiposity could be reversed by 
exposure to microbiota from the lean mice, but that reversal only occurred when mice were fed a diet 
high in fruits and vegetables and low in saturated fat.5  Animal studies also suggest that theobese gut 
microbiota has increased capacity to harvest energy from food.36 Gut microbiota composition may 
also be instrumental in instigating a chronic low-grade inflammatory state and, subsequently, insulin 
resistance, particularly in those predisposed to obesity.37,38 
In human studies, low gut microbial diversity has been associated with increased 
inflammation, adiposity, insulin resistance and dyslipidemia.3 Certain types of common gut 
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microbiota have been associated with anti- and pro-inflammatory effects (e.g., Fecalibacterium and 
Proteobacteria, respectively),39,4 which could have adverse metabolic or obesogenic effects.  
However, studies of obesity in humans have had conflicting results, and there is not a clear 
understanding of whether specific microbial taxa or levels of overall diversity are consistently 
associated with obesity.40   
Closely linked to obesity and related metabolic diseases is nonalcoholic fatty liver disease 
(NAFLD).  This condition has likewise been linked to gut microbiota, both in its et ology and its 
progression, although, as with obesity, human studies have been contradictory.41 Animal studies have 
shown a link between bacterial overgrowth in the small intestine and NAFLD, as well as provided 
potential mechanisms to explain these associations, specifically related to gram-neg tive bacteria.  
This type of bacteria has a component in the cell walls called lipopolysaccharide that has a 
proinflammatory effect and seems to influence metabolism as well.  These lipopolysaccharides have 
been associated with increases in insulin resistance, endogenous ethanol production and choline 
deficiency, all of which are implicated in NAFLD.41  
There have been fewer studies of the role of gut microbiota in the developm nt of obesity and 
related conditions in children and adolescents.  At around age 2-3 years, the phylogenetic 
composition of gut microbes tends to stabilize into an adult-like configuration.  Thus, we would 
expect that patterns and associations seen in adults would potentially be similar for children over the 
age of 3. While this has not been confirmed by research, two recent studies have evaluated the impact 
of lifestyle interventions on gut microbiota in overweight and obese adol scents.42,43  These studies 
showed an association between weight loss and changes in specific gut microbes (such a decreases in 
types of Clostridium, and increases in Lactobacillus  and types of Bacteroides) as well as 
corresponding immune responses. Many of the phylogenetic shifts were comparable to what has been 
seen in similar studies of adults. The second and third aims of this study helps to fill this gap in the 
research about the role of gut microbes in obesity-related conditions in children.   
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Obesity Begins in utero: Evidence for the Fetal Programming Hypothesis 
The “fetal programming” hypothesis or the “developmental origins of adult disease” sets 
forth the notion that exposures in utero, at birth and in early life may have long-term effects on adult 
health and disease.16  Intrauterine exposure to maternal diabetes is associated with increased risk of 
obesity and metabolic syndrome in childhood.17,18 Similar results have been seen for both excessive 
pre-pregnancy weight and weight gain during pregnancy.19,20 Results from animal studies support that 
the maternal gut microbiota may have in utero programming effects on the immune and metabolic 
systems of the developing fetus.21   
Microbial Exposures During Prenatal and Early Life Influence Immune and Metabolic 
Programming  
Related to the fetal programming hypothesis is the “hygiene” or “old friend’s” hypothesis,22 
which proposes that a l ck of early life exposures to certain microorganisms, parasites, and viruses 
impacts the development of the immune system, particularly the programming of regulatory cells, and 
increases long-term disease risk. Exposure to these organisms generally does little damage to the host, 
and the hypothesis purports that through co-evolution, humans developed a dependence on them for 
proper immune function; however, they are uncommon in most contemporary westernized soc eties, 
contributing towards the explosion of chronic diseases, such asutoimmune disease, cardiovascular 
disease, diabetes and obesity.   
Evidence supports that pre- and post-na al microbial exposures impact immune and metabolic 
programming.6,23  For example, infants born to mothers regularly in contact with farm animals (which 
are thought to be a marker for a wide range of microbial exposures) during pregnancy, as well as 
those growing up on farms, have decreased risk of asthma and atopic disease, and they show up-
regulation of receptors of the innate immune system.24,25  There is growing evidence that these 
receptors also play a key role in the progression of obesity, insulin resistance, diabetes, nonalcoholic 
fatty liver disease and related metabolic diseases.26   
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One of the major sources of early infant exposures to microbes is through the gut.  Animal 
studies suggest that interactions between infant gut microbes and innate immune receptors are 
essential for building immune tolerance.23 Likewise, some bacteria have been shown to enhance the 
adaptive immune response by activating the differentiation of regulatory T cells.27  Aberrant 
development of the gut microbiota leading to dysfunctional immune activation and responsiveness is 
a potential explanation for the common environme tal risk factors shared by diverse diseases, 
including obesity, allergy, celiac disease, and inflammatory bowel disease.23 
Maternal Microbiota and Other Early Life E xposures Determine Initial Gut Microbial 
Colonization in Infants 
A 2006 study by Penders et al.28 of over 1000 infants concluded that the most important 
factors affecting early gut microbial composition are mode of delivery, type of infant feeding, infant 
antibiotic exposure, gestational age, and infant hospitalization.  According to the authors, the gut 
microbiota composition of term infants who were born at home via vaginal delivery and breastfed 
exclusively was the most “beneficial.” The initial gut microbiota of infants born vaginally has 
components of both maternal vaginal and gut microbiota,9,10 while initial gut microbiota in infants 
born via Cesarean section most closely resembles the parental skin microbiota.9 The gut microbial 
composition differs between children who are breastfed relative to those who are formula-fed, with 
those who are formula-fed having more similarities with adults.29 These disparities are due in part to 
microbial content of breast milk and formula, and in part to the fact that numerous human milk 
oligosaccharides can only be metabolized efficiently by certain types of gutmicrobes, thus 
encouraging proliferation of certain types of microbiota.29  Furthermore, there is some evidence for 
the translocation of maternal gut microbiota into the mammary gland, and hence into breastmilk.30 
Antibiotic use in the first month of life has been associated with decreases in microbial diversity and 
bacteria believed to be beneficial.28  
The process of infant gut colonization is highly variable, but it does tend to have 
characteristic phases.  The initial colonization is dominated by facultative bacteria, that is, bacteria 
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that can produce energy aerobically or anaerobically, such as Enterobacteriaceae, Enterococcus and 
Streptococcus.  They create a more anaerobic environment by consuming the oxygen, hence 
anaerobic genera, such as Bifidobacterium, Bacteroides and Clostridium, increase in numbers around 
the first week of life.  The infant gut microbiota stabilizes and is essentially “adult-like” around the 
age of 2, with the vast majority of gut microbes being strict anaerobes at that point. The colonization 
process in the intervening time seems to depend on the factors listed above – e.g. mode of delivery, 
breast-feeding, antibiotic use, and environment – as well as the introduction of solid foods. The 
maternal gut is the most important source of Escherichia coli, Bifidobacterium, and Bacteroides; the 
maternal vagina is a source of Lactobacillus and Streptococcus. 28  The maternal intestinal and 
vaginal microbes have a lower transfer rate in infants born via C-section, and Clostridium, 
Enterobacter and Klebsiella are more common. 28,31  Breast-feeding has been associated with less 
Clostridium, particularly C. difficile, Bacteroides, Enterobacteriaceae, Enterococcus, and more 
Bifidobacteria and certain types of Lactobacillus.32  
 
Long-term Effects of Maternal Characteristics on Child Gut Microbiota are Poorly Understood 
Given that maternal gut microbiota is a major determinant of early infant gut colonization, 
particularly for vaginally born and breastfed infants, it is important to understand the factors that 
influence the microbiota over the course of pregnancy and at birth.  Koren et al.33 saw that maternal 
gut microorganisms changed dramatically from the first to third trimester, with large increase in 
variability across mothers and a reduction in individual microbial diversity.  When transferred to 
germ-free mice, gut microbiota from third trimester women caused greater increases in adiposity and 
insulin resistance than that of women in the first trimester. This sample of women did not show 
differences in gut microbiota at either time point by pre-pregnancy obesity status or GDM.  However, 
other studies34,8 have shown differences in gut microbiota of pregnant women by pre-pregnancy 
weight, weight gain and metabolic biomarkers.  Similarly, infant gut microbiota at 1 month differed 
based on maternal pre-pregnancy weight and weight gain.7  However, most studies of maternal and 
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infant gut microbiota have had fewer than 100 people.  Since between-person variability of gut 
microbes is quite high, and even higher among pregnant women, it is important to h ve large studies 
that can distinguish patterns despite the wide variation.  The NOMIC cohort provided a large sample 
that enabled us to explore the relationship between maternal weight / weight gain and maternal gut 
microbiota at birth as well as to examine the association between these factors and the development 
of the infant gut microbiota over time.   
The Association Between the Gut Microbiota and the Development of Obesity and Other 
Disease Outcomes in Children Has Not Been Well Studied 
Very little is known about how gut microbes become established, and while we are beginning 
to understand some of the most influential factors that affect that process (mode of delivery, etc.), we 
do not understand the relationship between the colonization process and risk for metabolic disorders 
or diseases, like obesity. One small study by Kalliomaki et al.44 showed differences in the 
composition of the gut microbiota during the first year of life in between children who were normal 
weight relative to those who were overweight or obese at age 7, specifically more Bifidobacteria and 
fewer Staphylococcus aureus.  (Bifidobacterium are generally believed to be beneficial, while S. 
aureus may be pathogenic in large numbers.45)  Likewise, Luoto et al.46 saw a trend towards more 
Bifidobacteria in gut samples at 3 months of age in children who were normal weight at age 10 than 
in those from children who were overweight at that age.  
Other studies have provided indirect evidence that early gut microbiota may play a role in 
excessive weight later in life.  A large prospective Danish birth cohort saw an association between 
factors known to influence early gut microbes and later overweight.  Use of antibiotics in the first 6 
months of life were associated with increased risk of overweight at age 7 among children born to 
normal weight mothers, however, a protective effect was seen in children born to overweight 
mothers.47  Kalliomaki et al. also saw that more overweight children had received antibiotics in the 
first 6 months of life than normal weight children.44  In addition, birth via C-section may increase risk 
for the development of obesity.48 
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Further indirect evidence stems from the knowledge that the process of infant gut 
colonization has undoubtedly changed drastically in the past century with changes in hygiene, the 
birth process, the use of antibiotics and other societal shifts.  Studies have suggested that current 
colonization patterns differ substantially from those as recently as the 1970s  and 1980s, including 
less transference of maternal gut microbes, less and later exposure to E. coli, and higher prevalence of 
C. difficile.32,45    
If the gut microbiota play a key role in metabolic and immune programming during the first 
years of life, then it is important to understand whether various aspects of the early-life colonization 
process influence risk for later diseases.  Factors such as the diversity of microbes, the presence or 
absence of key microbes, or the timing of colonization of various microbes could infl ence life-long 
risk for obesity, metabolic diseases, or immune-mediated conditions.  Thus, in Aim 2 of this study, 
we explored how early life microbial diversity and taxonomic composition differ in children who 
become overweight or obese later in childhood, and examined the role of maternal pre-pregnancy 






Figure 1. Conceptual Model for this study, with green arrows indicating the main associations explored in Aims 
1 and 2, purple arrows indicating those explored in Aim 3, and blue arrows indicat g other potentially 
influential factors, some of which will be controlled for in statistical models. 
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CHAPTER III  
METHODS 
Overview 
This study used two prospective cohorts in order to examine the rol of gut microbiota in 
obesity and related cardiometabolic conditions, both in pregnant women and in youth. Figure 2 
summarizes the aims and hypotheses and the populations for each. The NOMIC population provided 
a sample of mothers and infants, and we evaluated the effects of maternal pre-pregnancy obesity and 
excessive gestational weight gain on the maternal gut microbiota at birth (Aim 1), as well as the 
effects of maternal pre-pregnancy obesity on the development of the infant gut microbiota during the 
first two years of life and its relationship to the development of childhood obesity (Aim 2). We 
assessed the association between gut microbiota and hepatic fat at a later time period in childhood, 
using the EPOCH cohort (Aim 3). 
NOMIC  Population (Aims 1 & 2) 
The NOMIC population is a birth-cohort that was established for the purpose of studying the 
development of the gut microbiota during infancy and its consequences for child health. It is a 
subcohort of a larger study, called HUMIS, that is focused on the effects of environmental toxins on 
human milk and health outcomes.49  NOMIC consists of 552 mother-child pairs, who were recruited 
by paediatricians at the Ostfold Hospital in Norway, after delivery, and were followed longitudinally 
starting in 2002 and continuing through 2016. The sample includes 68 twins and 3 non-twin sibling 
pairs. A subset of the mothers provided fecal samples within the first 4 days after delivery (n=175). 
Infants provided fecal samples at 4 and 10 days, as well as at 1, 4, 12 and 24 months. The fecal
samples were frozen by participants, kept frozen during transportation, and stored at -20o C at the 
Biobank of the Norwegian Institute of Public Health.50 The information collected is shown in Table 1. 
Data Collection 
The data from NOMIC is from numerous sources, including questionnaires given at 1, 6, 12, 
and 24 months after delivery, pregnancy journals, the Medical Birth Record (MBR), and the 
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Norwegian Mother and Child Cohort Study (MoBa).51,52  The pregnancy journal is the Norwegian 
medical record of prenatal clinic visits.  It includes all clinical notes, tests and measurements taken 
during routine prenatal visits.  In the NOMIC cohort, the median number of prenatal visits was 11, 
and the maximum number was 24.  The MBR has extensive information related to birth and delivery, 
and it is linked to all participants in NOMIC.  MoBa is a Norwegian birth cohort study of over 90,000 
pregnant women in Norway recruited between 1999 and 2008.  Some of these women participated in 
both MoBa and NOMIC and have given consent for the data to be linked.   
Maternal Data: Urine glucose tests, blood pressure, height, and weight pre-pregnancy and at 
all prenatal visits are from the pregnancy journal.  The difference in weight from the beginni g to the 
end of pregnancy is from the 1 month NOMIC questionnaire, as are maternal education, Norwegian 
ethnicity and use of antibiotics during pregnancy.  Women were asked about the timing, duration, 
reasons and types of antibiotics used during pregnancy.  Information on maternal smoking at the 
beginning and end of pregnancy, diabetes status, and parity are from the MBR.  Maternal ag  was 
calculated based on her personal social security number, which contains birth date.  Maternal age and 
height were truncated at extreme values in order to minimize patient identifiability; similarly, parity 
was categorized.  Missing information from each of the main information sources were completed 
with information from the other sources whenever feasible.     
Paternal data: Paternal height and weight are from a maternal questionnaire from MoBa 
during the second trimester of pregnancy. 
Infant data:  Gestational age and birth weight are from the MBR.  Mode of delivery, height 
and weight over time, as well as all information related to antibiotic usage, breastfeeding, use of 
formula, and the introduction of solid foods, are from the NOMIC questionnaires.  Gestational age 
was primarily calculated by the last menstrual period. Ultrasound estimates are routinely performed in 
the second trimester in Norway but this information was only used if the discrepan y between the two 
exceeded 14 days.  The information on perinatal use of antibiotics consisted of antibi tic usage at day 
of birth, day after birth, 3-7 days of life, 7-14 days of life, 14-28 days of life, and monthly atibiotic 
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usage thereafter in the first two years of life. In addition, mothers reported number of days since the 
child last had antibiotics when the one and two year fecal samples were taken.  Child sex is from the 
MBR.  Height and weight at age 11 are from follow-up of the NOMIC cohort, which includes linking 
to data from the routine school follow up of children.  
Processing of Microbial Samples from NOMIC  
DNA was extracted using the standard Power Soil Kit protocol (MoBio). The extracted DNA 
was amplified using polymerase chain reaction (PCR) with barcoded primers targeting the V4 region 
of 16S rRNA as detailed n Yatsunenko et al.53 Each PCR product was quantified using PicoGreen 
(Invitrogen) and equal amounts (ng) of DNA from each sample were pooled and cleed using the 
UltraClean® PCR Clean-Up Kit (MoBio). Sequences were generated on a MiSeq personal sequencer 
(Illumina, San Diego, CA). The samples were processed in two batches. Organizational tax omic 
units (OTUs) were assigned via a closed reference-bas d system using the Greengenes 13.5database 
(which is extensive and includes the vast majority of the organisms present in the human gut) and a 
97% threshold to define a match. OTUs correspond approximately to species and are used when 
microorganisms are identified based on gene sequences. A rarefied OTU table at 5000 sequences per 
samples served as input data for primary analyses.   
 
Aim 1 
To determine the characteristics of maternal gut microbiota at delivery, specifically the 
diversity and composition, that correlate with maternal pre-pregnancy overweight or obesity 
(OW/OB) and excessive gestational weight gain (GWG), using the NOMIC cohort. 
Study Design 
The full prospective cohort of mothers in NOMIC who provided fecal samples 4 days after 
delivery includes 177 samples from 175 women. (Two women provided samples during two distinct 
pregnancies.) For Aim 1, we excluded 6 women without pre-pregnancy BMI information, and the 
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second samples from the women with two non-twin children in the study. Thus, our analysis of 
pregnancy overweight / obesity ncluded 169 mothers.  
We utilized standard BMI cut-offs to define underweight, normal, overweight and obese 
(Table 2). For each category of pre-pregnancy weight, there is a recommended range of pregnancy 
weight gain issued by the IOM, also shown in Table 2.   The NOMIC cohort includes ome twin 
pregnancies and many pre-term pregnancies.  The guidelines for gestational weight gain are for full 
term singleton pregnancies. The recommendations for twin pregnancies are provisional.  Thus, our 
analysis of GWG used only full-term singleton births (N=108).  
The outcomes of interest were the alpha diversity and composition of maternal gut microbiota 
4 days after delivery. Alpha diversity is a measure of both the number (richness) and distribution 
(evenness) of taxa within a single sample. Higher alpha diversity has been associated with better 
health across numerous studies.3,54,55 Microbiota composition is complex, and we will use different 
methods to study composition in each aim. 
Statistical Approach 
Hypothesis 1.1 
Compared to non-OW/OB, the gut microbiota at delivery of women with pre-pregnancy 
OW/OB will have lower gut microbial diversity.  Similar patterns will be seen with excessive GWG 
relative to non-excessive GWG. 
We calculated alpha diversity index for each sample and used rank-based regression models 
with alpha diversity as the outcome and exposure status as the primary covariate of interest, while 
controlling for maternal characteristics.  
 
Hypothesis 1.2 
Compared to non-OW/OB, the gut microbiota at delivery of women with pre-pregnancy 
OW/OB will have differences in taxonomic omposition.  Similar patterns will be seen with excessive 
GWG relative to non-excessive GWG. 
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In order to identify whether specific groups of microorganisms varied with exposure status, 
while taking into account the interrelationships of the microbial taxa and maternal characteristics, we 
used supervised learning techniques. These methods are appropriate to analyze complex microbial 
data with large numbers of taxa and high prevalence of rare taxa because the assumptions underlying 
more traditional statistical techniques are often violated.56,57 Using a random forest classifier with 
supervised learning, we determined taxa and characteristics that play a key role in differentiating 
between samples of exposed and unexposed women. We then used this information in more 
traditional statistical regression models, controlling for other maternal characteristics, in order to gain 
an understanding of the direction of the associations between exposure and taxa. 
Throughout this aim and all of the aims in this study, QIIME, R and SAS were used for 
analyses.  Data checks were used to verify that the data remain unchanged when transferring back and 
forth between packages.   
Power and Sample Size 
In order to estimate the power for the outcome of alpha diversity, we approximated the 
modelling approach with an ANOVA test.  We obtained estimates of the standard deviation and 
number of operational taxonomic units (OTUs; an operational definition of a specie  based on DNA 
sequence data) from the Turnbaugh et al. study of obese and lean twins.55 Shannon diversity index 
has a maximum value that depends on the number species; it is the natural logarithm of the total 
number of species in the sample. Assuming the samples contain a total of 750 OTUs, the maximum 
Shannon index would be 6.6. We estimated the sample size for each exposure based on the 
distribution of pre-pregnancy BMI and actual GWG of the full-term women in the cohort.  In order to 
detect a mean difference in Shannon diversity of 0.1, we had a power of >97% to compare groups by 
exposure status.  This difference of 0.1 in alpha diversity was reasonable to expect given that 
Turnbaugh et al. saw alpha diversity differences by obesity status of around 0.2.  
Although we did not know how many factors of interest would be included in the models for 
differences in taxa for Hypothesis 1.1 in order to do a formal power analysis, many previous studies 
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had been able to determine taxonomic differences between groups with sample sizes smaller than 
150.44,55  
Aim 2  
To explore the association between maternal pre-pregnancy OW/OB, the development of 
infant gut microbiota and offspring BMI at age 12 in the NOMIC cohort. 
Study Design 
The full prospective cohort of infants in NOMIC includes 552 infants, for this study we had 
Illumina data from 2372 infant samples from 530 infants of 493 mothers available.  Mothers who 
were missing pre-pregnancy BMI information were excluded, leaving 2300 infant gut microbiota 
samples from 510 infants (including 31 sets of twins) of 478 mothers.  Among these infants, 165 had 
follow-up height and weight measurements in adolescence, with corresponding 781 gut microbiota 
samples.  This subset of the data was used for the analysis of BMI-for-age z-scores. 
Statistical Approach 
Hypothesis 2.1 
The infant gut microbiota over the first two years of life will be predictive of BMI-for-age z-
scores at age 12.   
We used random forests at each sampling time to predict BMI z-scores using infant gut 
microbiota characteristics, both measures of alpha diversity and taxonomic relat ve abundance.  We 
evaluated the accuracy of these random forests using R2.  We then investigated the nature of the 
relationship between the most predictive features and BMI using linear regression models, both 
unadjusted and adjusted for confounding factors. 
Hypothesis 2.2  
Infant gut microbiota characteristics predictive of BMI-for-age z-scores at age 12 will be 
associated with maternal OW/OB. 
In order to examine whether the infant gut microbiota taxa ssociated with BMI-for-age z-
scores at age 12 were also associated with maternal OW/OB, we used permutational ANOVA.  We 
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also used longitudinal beta-binomial regression models to further examine the direction of 
associations between maternal OW/OB and each gut microbiota taxon i the infant predictive of BMI. 
EPOCH Population (Aim 3) 
EPOCH is a historical prospective study of 500 mother / child pairs. Women were identified 
through the Kaiser Permanente of Colorado (KPCO) perinatal database based on presence or absence 
of gestational diabetes mellitus (GDM) during singleton pregnancies. In 2005-2010, one study visit 
was conducted, involving both these women and their children aged 6-12 years, who were exposed
and unexposed to DM in utero. A second data collection occurred from 2012 to 2016 while the 
children were 12-19 years, and a fecal sample was being requested from a randomly selected 
subsample of 240 participants with 1 exposed participant for every 2 unexposed, matched on gender 
and race/ethnicity (80 exposed and 160 unexposed). The final sample size for the gut microbiota data 
was N=120.  Of those, one sample failed to sequence, two had poor quality reads, four were missing 
dietary information, and six were missing the outcome measure of hepatic fat fraction, leaving a 
sample size of 107. 
Data Collection 
Maternal Data:  Maternal GDM is based on physician diagnosis and ascertained from the 
KPCO perinatal database.  The diagnosis was based on a two-stage test, with a result of ≥140 mg/dl 
for a 1-hour oral glucose tolerance test (OGTT) at 24-28 weeks of pregnancy, as well a follow-up 3 
hour 100-g fasting diagnostic OGTT.  Maternal pre-gnancy body mass index was calculated from 
the KPCO measured weight before the last menstrual cycle preceding pregnancy and height collected 
at the in-person research visit. Gestational weight gain was from the perinatal database. Race / 
ethnicity was self-reported using 2000 U.S. census definitions. Maternal level of education and tot l 
household income at the time of birth were self-reported, as was smoking during preg ancy. 
Offspring Data: Both of the data collections involved completion of the Block Kid’s Food 
Questionnaire,58 a semi-quantitative food frequency questionnaire (FFQ) developed for children aged 
8 years and older, which assesses 85 food items consumed in the last week, frequency and average 
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portion size. Height and weight were measured at both study visits.  Waist circumference measured 
was according to the National Health and Nutrition Examination Survey protocol.59  Visceral and 
subcutaneous fat mass were measured via Magnetic Resonance Imaging (MRI) scan with a 3T imager 
(General Electric, Waukashau, WI), as described in previous studies.60 Similar MRI scans were used 
to assess non-alcoholic fatty liver disease (NAFLD) at the second study visit.  Hepatic imaging was 
performed using multi-breath-hold double gradient echo sequences.  
Scan parameters were adjusted for use with the 3T and include: TR = 144 ms (in-phase and 
out-of-phase), echo time of TE = 3.2 ms (in-phase) and 4.3 ms (out-of-phase), flip angles of 10 and 
70 degrees on a GE 3T MRI scanner. Images were acquired at slice thickness = 5 mm, field of view 
to encompass the abdomen, matrix size = 256 × 179, and number of excitations (Nex) = 1. Fat 
fraction was calculated from the mean pixel signal intensity data, for each flip angle acquisition, using 
the formula: Hepatic fat fraction (HFF) = (SIin−phase – SIout−of−phase)/2 SIin−phase.  The true HFF is 
determined by the algorithm: If HFF(100) <HFF(700), then HFF = HFF(100), otherwise HFF = (1 - 
HFF(100) ). A diagnosis of fatty liver in children was established with HFF ≥ 5%.  Before the second 
study visit, a subsample (described above) of participants were asked for a microbiome stool sample.  
If they agree to provide a sample, they are sent instructions as well as a Fisher Scientific BBL™ 
CultureSwab™ kit, which is a dual swab system for the sterile col ction and transport of fecal 
microbiological samples. Participants were asked to take the sample as close as possible to the time 
of the in-person interview.  The samples were frozen at the time of the interview and stored at -800 F. 
DNA Extraction and Sequencing 
DNA was extracted using the standard Power Soil Kit protocol (MoBio). Extracted DNA was 
PCR amplified with barcoded primers targeting the V4 region of 16S rRNA as det iled in Yatsunenko 
et al.53 Control water samples that had undergone the same DNA extraction and PCR amplification 
procedures were also sequenced. Each PCR product was quantified using PicoGreen (Invitrogen), and 
equal amounts (ng) of DNA from each sample were pooled and cleaned using the UltraClean PCR 
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Clean-Up Kit (MoBio). Sequences were generated on a MiSeq personal sequencer (Illumina, San 
Diego, CA). 
Denoising and OTU Picking 
Reads were first quality filtered and trimmed to a uniform length based on average position of 
first low quality base pair among all samples. DADA220 was then run on default parameters to 
denoise the data and find exact sequence abundances across samples. These sequences were then used 
as input for open reference OTU picking using QIIME 1.921 with a 99% identity threshold to 
determine OTUs.  Greengenes 13.8 was used as a reference database of ne r-full length sequences,61 
and unassigned sequences were clustered into e novo OTUs using UCLUST.62 Analyses were 
standardized at the minimum sequence depth, 2537 sequences per sample, to avoid biases.  The OTUs 
were summarized at the most specific known level of taxonomy for all analyses of taxonomic 
composition. 
Preliminary Studies 
The association between adiposity measures and DM exposure in utero has been established 
in the EPOCH cohort. Children who were exposed had faster growth trajectories fr m 27 months 
through 13 years of age.63  Similarly, exposed children had higher BMI, waist circumference, visceral 
adipose tissue, and subcutaneous adipose tissue as well as more centralized fat distribution pattern in 
6-13 year olds.60 This study will assess the association between characteristics of gut microbiota and 
hepatic fat. 
Aim 3 
To evaluate the gut microbial diversity and composition of teenagers in the EPOCH cohort in 
relation to hepatic fat. 
Study Design 
The data for this aim was cross- ectional.  The gut microbiota sample, measures of hepatic 
fat, and the dietary survey were all part of the second study visit.  The exposures of interest were gut 
microbiota alpha diversity and composition.  We also considered dietary macronutrients as a percent 
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of total intake, as well as comorbidities, including sex-specific BMI-for-age z-scores, calculated using 
CDC reference standards.64   The outcome was hepatic fat fraction.  We also dichotomized this value 
into 1) NAFLD (>5% hepatic fat fraction) and 2) at-risk for NAFLD (>3% hepatic fat fraction). 
Statistical Approach 
Hypothesis 3.1 
Teenagers with igher hepatic fat fraction will have lower microbial diversity compared with 
teenagers with less hepatic fat.  
We used linear regression models to examine the association between alpha diversity of gut 
microbiota, using Shannon Diversity Index, and hepatic fat fraction (HFF).  We chose Shannon 
Diversity because it is a measure that gives equal weight to evenness and richness.  We controlled f r 
sex, age, race/ethnicity, parental education, exposure to gestational diabetes in utero a d delivery 
method at birth. We also considered the inclusion of parental income, but it was highly collinear with 
parental education and showed a weaker association with the outcome.   
Hypothesis 3.2  
Gut microbiota taxonomic composition will be predictive of hepatic fat fraction. 
We used random forests to predict hepatic fat based on 1) gut microbiota xa; 2) dietary total 
daily kilocalories and the following macronutrients as percent of total intake: total fat, saturated fat, 
polyunsaturated fat, monounsaturated fat, total protein, total carbohydrates, sugars, soluble fiber, and 
insoluble fiber; 3) demographic and comorbid conditions: sex, age, race/ethnicity, parental income, 
parental education, exposure to gestational diabetes in utero, delivery mode at birth and current BMI 
z-score; and 4) the combination all of the these, in order to gain understanding of the role of gut 
microbiota and diet in the generation of hepatic fat, as well as to evaluate whether gut microbiota taxa 





Table 1: Data available from NOMIC Study 
Parental characteristics Infant characteristics 
Paternal factors • Height and weight  
Maternal factors • Age  • Education • Norwegian ethnicity • Smoking & antibiotic use during pregnancy • Urine glucose tests & diabetes status • Blood pressure • Parity • Height  • Pre-pregnancy weight • Weight at all prenatal visits & at end of pregnancy  
Microbial Data • All microbial taxa levels in fecal samples 
• Gestational age at delivery  • Mode of delivery  • Sex • Antibiotic use • Duration of exclusive breastfeeding  • Use of formula  • Timing of solid food introduction • Weight & height at 1,6,12, and 24 months 














Weight Gain (lbs) 
<18.5: Underweight 28–40 
18.5-24.9: Normal  25–35 
25.0-29.9: Overweight 15–25 
≥30.0: Obese 11–20 
Maternal Data 
GDM, pre-pregnant weight, weight 
gain 
Demographic, race/ethnicity, SES, 
parity, self-reported smoking  
Offspring Data 
Birth weight, Gestational Age, 
Mode of delivery 
Food Frequency Questionnaires 
Weight, height, waist circumference, 
SAT, VAT, fatty liver  
Microbial Data  








Figure 2. Aims (A1-A3) and hypotheses (H1.1-H3.2) of this study and the source populations. Black arrows 
indicate associations explored in this study. 
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CHAPTER IV  
MATERNAL GUT MICROBI OTA AT THE TIME OF D ELIVERY DIFFERS BY PRE -
PREGNANCY WEIGHT STATUS 1 
Abstract 
Background: Recent evidence supports that the maternal gut microbiota impacts the initial 
infant gut microbiota. Since the gut microbiota may play a causal role in the development of obesity, 
it is important to understand how pre-pregnancy weight and gestational weight gain (GWG) impact 
maternal gut microbiota at the time of delivery. Objective: To investigate the association between 
maternal pre-pregnancy weight, GWG and maternal gut microbiota at the time of delivery. Mthods: 
We performed 16S rRNA sequencing on gut microbiota samples from 169 women 4 days after 
delivery and from infants of 159 of these women 10 days after birth. We categorized the women 
according to pre-pregnancy body mass index into overweight/obese (OW/OB, BMI>25, N=52) or 
non-overweight/obese (BMI<25, N=117).  Mothers of full-term singleton infants (N=116) were 
categorized into excessive and non-excessive GWG.  We compared alpha diversity and taxonomic 
composition of the samples by exposure groups, adjusting for potential confounders. We al o 
compared taxonomic similarity between maternal and infant gut microbiota. Results: Maternal pre-
pregnancy OW/OB was associated with lower alpha diversity, as well as differences in numerous 
operational taxonomic units (OTUs) and genus-level taxa. Excessive GWG was not associated with 
alpha diversity but was associated with differences in taxonomic composition.  Many of the 
compositional differences seen with OW/OB status and excessive GWG, such as the highly heritable 
family Christensenellaceae, the genus Lachnospira, and OTUs from Parabacteroides, 
Bifidobacterium and Blautia, have been previously associated with obesity / leanness or have been 
seen to play an important role in infant health.  Presence of OTUs from Parabacteroides and 
Bifidobacterium in the maternal gut was predictive of presence in their infants.  Conclusions: Our 
                                                     
1 This paper is under review at Microbiome. 
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results show differences in maternal gut microbiota composition at the time of delivery by pre-
pregnancy weight and GWG. However, differences in alpha diversity were only seen with pre-
pregnancy weight group.  Some of these taxa showing differences may be passed on to the infant. 
Introduction  
Obesity prevalence among children and adolescents has increased dramatically in recent 
years.1,65  While lifestyle factors play a large role in this epidemic, lifestyle changes have pro n to be 
a challenging avenue to prevent the rising rates of obesity.  Recent research suggests that the gut 
microbiota may contribute towards the development of obesity and may offer a feasible target for 
prevention or intervention.66 The maternal gut microbiota may influence infant obesity risk through in 
utero programming effects 21 or through vertical transfer of obesogenic gut microbiota from mother to 
child during birth 31 and in breastmilk.30 Thus, it has been suggested that the maternal gut microbiota 
may offer a unique opportunity to interrupt the cycle of obesity.67  
There is increasing evidence to support that the gut microbiota may play a caus l role in 
obesity.68,69 Some of the most compelling evidence involves transplantation of gut microbiota from 
obese humans to “germ free” mice (i.e. mice that have not been colonized by microorganisms), which 
has been shown to increase fat mass, whereas microbiota from lean humans does not.5,36 Additionally, 
in humans, gut microbiota (fecal) transplantation from lean donors to obese individuals has improved 
insulin sensitivity.35  Gut microbiota during infancy has also been associated with later overweight 
and obesity 44, and numerous exposures known to impact the early gut microbiota, such as birth via 
cesarean section and antibiotics, have also been associated with increased obesity risk.47,48 
Some studies have shown differences in maternal gut microbiota at different tim points 
during pregnancy by obesity status and gestational weight gain.9,10 Although studies of gut microbiota 
during pregnancy have been inconsistent,70 some evidence suggests it changes substantially over the 
course of pregnancy and varies widely across women, making it particularly challenging to 
characterize gut microbiota during this time.33  Even in non-pregnant adults, it has been challenging 
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to establish a clear picture of the gut microbial characteristics that are consistently associated with 
obesity.40  
 
In this study, we evaluate he maternal gut microbiota at the time of delivery and determine 
whether it differs by maternal pre-pregnancy overweight/obese (OW/OB) or excessive gestational 
weight gain (GWG).  We assess the association between maternal gut microbiota at the time of 
delivery and infant gut microbiota at day 10 of life.  This is a very important area of research because 
maternal gut microbiota isalterable – through diet, pre- and pro-biotics, and antibiotics usage during 
pregnancy.  If maternal gut microbes are transferred to the infant, and if they can influence obesity 
risk in their infants, then preserving or altering them is of particular importance. 
Methods & Materials 
Study Cohort 
NOMIC is a Norwegian birth cohort designed to study the establishment of gut microbiota 
during infancy and its consequences for child health. Two term babies were recruited for every 
preterm baby. Participating mothers were asked to fill out periodic questionnaires and to collect and 
freeze a fecal sample at postpartum day 4, as well as a sample from their infants at dy 10. Study 
personnel retrieved the fecal samples and kept them frozen during transport to the Biobank of the 
Norwegian Institute of Public Health, Oslo where they were stored at -20° C upon arrival. 
The study was approved by the Regional Ethics Committee for Medical Research in Norway 
(approval ref 2002, S-02216) and the Norwegian Data Inspectorate (ref 2002/1934-2). The approvals, 
as well as informed consent from the mothers, were obtained prior to collection of data and samples.   
Study Sample 
This study includes the subset of 169 mothers from NOMIC who provided a fecal sample, 
whose sample provided high quality Illumina data, and for whom both height and pre-pregnancy 
weight were available to calculate BMI (see Figure S1).  Two of these women had two children in 
NOMIC and provided samples after each delivery; their second samples were excluded.  
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Additionally, gut microbiota samples were available at day 10 for the infants of 159 of these women. 
 
Exposure Definitions 
Pre-pregnancy BMI was based on maternal self-r port of weight at the first clinic visit; the 
median time of the first visit was at 9weeks of gestation (IQR: 7.3-11.3 weeks). Height and weight 
were measured at that visit, and these values were compared to reported pre-pregnancy BMI in order 
to validate the values. Pre-pregnancy BMI was initially categorized as: underweight, normal weight, 
overweight and obese according to standard definitions.71 We then further combined these groups 
into: 1) non-OW/OB: underweight (N=7) and normal weight (N=110), BMI <25 (N=117); and 2) 
OW/OB: overweight (N=32) and obese (N=20), BMI>25 (N=52).   
When evaluating the impacts of excessive GWG on the gut microbiota, women who were 
missing GWG (N=1) and not full term (N=50) were excluded because there are not w ll-established 
weight gain recommendations for pre-term births.  Furthermore, we chose to exclude mothers of 
twins since there were only two, making this difficult to account for in statistical models, and since 
the weight gain guidelines for mothers of twins are considered provisional. Thus, the sample size for 
the analysis of GWG was N=116 (Figure S 1).   The recommended range of the Institute of Medicine 
(IOM) were used to define adequate GWG, which is based on pre-pregnancy BMI (Table S 1); weight 
gain less than the recommended range for the respective BMI group was considered “low” (N=12), 
within the range as “adequate” (N=41) and greater was con idered “excessive” (N=63).72  We also 
grouped low and adequate (N=41) GWG together due to the small number in the low group, and 
compared to excessive GWG.  WG was calculated using the pre-pregnancy weight and final weight 
from self-report in a questionnaire approximately one-month post-delivery.  When missing self-
reported final weight (9%), the final recorded weight preceding birth in the medical re ords of 
prenatal clinic visits was used.  Self-reported gestational weight gain has been validated in the full 
NOMIC cohort and showed a high degree of accuracy compared to measured weight gain 
(ICC=0.94).   
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Additional Data Sources 
Maternal questionnaires provided information on mode of delivery, education, parity
maternal smoking, ethnicity and use of antibiotics. Maternal age at delivery was calculated based on 
birth date from the Norwegian personal identification number. We obtained information on 
gestational age and preterm delivery from the Medical Birth Registry of Norway.     
Processing of Microbial Samples  
DNA was extracted using the standard Power Soil Kit protocol (MoBio). The extracted DNA 
was amplified using polymerase chain reaction (PCR) with barcoded primers targeting the V4 region 
of 16S ribosomal RNA (rRNA) as detailed in Eggesbo et al.50 Each PCR product was quantified using 
PicoGreen (Invitrogen) and equal amounts (ng) of DNA from each sample were pooled and cleaned 
using the UltraClean® PCR Clean-Up Kit (MoBio). Sequences were generated on a MiSeq personal 
sequencer (Illumina, San Diego, CA). Operational Taxonomic Units (OTUs) were assigned using 
UCLUST62 as implemented in QIIME73 via a closed reference-based system using the Greengenes 
13.861 database and a 97% threshold. A rarefied OTU table at 5000 sequences per sample served as 
input for the analyses.   
Statistical Analysis 
We compared maternal demographic and birth characteristics by pre-pregnancy weight group 
and excessive GWG status using chi-squared tests for categorical variables and Wilcoxon rank-sum 
tests for continuous variables.    
Alpha diversity 
Alpha diversity measures the microbial diversity of each sample.  There are many alpha 
diversity measures, and they differ in how they weight richness and evenness a d whether they 
incorporate phylogenetic distance. We chose to evaluate three measures of alpha diversity: Shannon 
diversity index (evenly weights richness and evenness), PD whole tree (emphasizes phylogenetic 
diversity), and observed species (number of OTUs observed at standardized sequ ncing depth; 
richness).  Rank-based regression was used to model alpha diversity measures with pre-pregnancy 
30 
 
weight status as the primary covariate of interest.  The following maternal characteristics were 
controlled for in the analysis: maternal age, education (<12 years, 12 years, >12 years), Norwegian 
ethnicity, parity (nulliparous, 1 prior child, >1 prior child), twins, and smoking during pregnancy 
(never, former, occasional, daily <=10, daily >10).  The same methods were utiliz d for comparing 
women by GWG group, except that twins were excluded from the list of covariates since all births 
were singleton. 
Microbiota composition 
We compared maternal gut microbiota samples by OW/OB and excessive GWG status using 
principal coordinate analysis plots of unweighted and weighted UniFrac distance.74  Random forests 
were used as a feature selection technique in order to evaluate which OTUs were most important to 
differentiate samples based on pre- gnancy weight group.75 This machine learning approach ranks 
factors in terms of their ability to discriminate exposure status, while taking into account the 
interrelationships in high dimensional complex data.  This method uses decision trees, and each tree is 
trained on a subset of the data and then tested on the remaining data; the error of these repeated tests 
is called the “out of bag” error rate.  Breiman’s random forest algorithm with down sampling75 was 
used to classify women’s pre-pregnancy weight group based on the percent abundance of the OTUs.  
All OTUs that were present in less than 10% of the samples and those with a maximum percent 
abundance less than 0.25% were excluded; 448 OTUs met these prevalence cutoffs.  The R function 
varselRF76 was used to select the most important features for classifying the exposure, which were 
then used in further analyses.  We evaluated the classification accuracy of these selected featur sby 
computing the ratio of the out of bag error from a random forest using these features to classify 
simulated random data to the error from a similar random forest classifying the true exposure status.56 
In order to quantify the direction of the relationships between these taxa and exposure status, 
the selected OTUs were then modeled individually as outcomes in beta-binomial generalized linear 
regressions, which account for overdispersion in the sequence counts, using the SAS procedure 
NLMIXED.  The models included the total number of sequences (5,000 for all tax ) as an offset in 
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order to allow for inference on the relative abundance. We also included covariates in the models, 
controlling for the same maternal characteristics as in the models of alpha diversity.    
These methods were repeated for different scenarios.  First, genus level taxonomies were 
used rather than OTUs to model pre-r gnancy weight group with the same prevalence cutoffs as for 
OTUs, leaving 169 genera.  We used these same methods to model excess GWG in the subset of 
women who were full term with singleton births, both at the OTU level and the genus level of 
taxonomy.  The random forest of OTUs included the 403 OTUs that met the prevalenc cutoffs; the 
random forest at the genus level included 80 genera.   
Association between maternal and ifant gut microbiota 
We used binary logistic regression to compare maternal gut microbiota taxa at the time of 
delivery with that of the infant at day 10.  OTU-level presence / absence of maternal samples was 
used as the exposure with infant presence / absence as the outcome for each of the OTUs selected to 
differentiate maternal OW/OB status in the 159 maternal-inf nt pairs with data, as well as for those 
selected to differentiate maternal excessive GWG among 123 maternal-infant pairs.  A hierarchical 
logistic model with a random aternal intercept was used to similarly evaluate presence / absence 
across all OTUs together, as well as across all of these selected OTUs together, in ord  to assess the 
overall maternal-infant taxonomic association.  
Sensitivity analyses 
In addition, several sensitivity analyses were performed.  In the models of alpha diversity, 
additional predictors were included as potential precision variables: maternal antibiotic use during 
pregnancy and gestational age. Maternal BMI was also considered for the models of GWG. 
In the analysis of gut microbial composition, continuous measures of the exposures were 
evaluated: BMI was used rather than pre- gnancy weight group and weight gain over the 
recommended limit (in kgs) as a measure of GWG.  These were used to d fine the exposures in the 
random forests and the beta binomial models at the OTU level, as described above.  The random 
forests used regression rather than classification since the exposures were continuous.  
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We used SAS v9.4 (SAS Institute Inc., Cary, North Carolina), R v3.2.0,77 and QIIME v1.9.073 
for analyses.  P-values less than 0.05 were considered statistically significant.   
Results 
Women with and without excess weight pre-pregnancy weight generally had similar 
characteristics (Table 4).  Excess weight women had slightly less education and were more likely to 
be smokers, as were women with excessive GWG (Table S 2).  There was a higher proportion of 
women who were overweight pre-pregnancy among those with excessive GWG relative to those with 
non-excessive GWG, and fewer underweight and obese.   
Alpha Diversity 
The median alpha diversity was significantly lower among OW/OB women for all three alpha 
diversity measures examined (Table 4).  In regression models controlling for maternal age, education, 
Norwegian ethnicity, parity, twins, and smoking during pregnancy (Table 5), Shannon diversity and 
PD whole tree remained significantly lower among OW/OB women, while the observed species was 
no longer significantly lower. Controlling for gestational age and maternl antibiotic use during 
pregnancy as potential precision variables did not substantially alter the rsults. 
In the subset of full term women, excessive GWG was not associated with significant 
differences in alpha diversity (Shannon: β=-0.1, 95% CI: -0.3, 0.1; p-value=0.53; PD: β=-0.1, 95% 
CI: -1.9, 1.8; p-value=0.96; Observed Species: β=-4.0, 95% CI: -28.3, 20.2; p-value=0.75).  
Controlling for maternal BMI, gestational age and maternal antibiotic usage did not alter the null 
results. 
Microbiota Composition 
The overall microbiota composition of the maternal samples resembled that typical of healthy 
European/US adults, with a dominance of Ruminococcaceae, Lachnospiraceae, and Bacteroidaceae 
(Figure S 2).78,79  Principal coordinate analysis plots of UniFrac distance did not show strong 
differentiation between gut microbiota samples by OW/OB or excessive GWG status (Figure S 3).  
Gut microbiota composition showed numerous differences by pre-pregnancy weight group.  Using the 
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most important OTUs from the random forest to classify pre-pregnancy weight status, the out f bag 
error rate was 18.9%; this classification accuracy was 2.4 times better than completely random 
guessing. 
The most important OTUs from the random forest included 2 members of the Actinobacteria, 
genus Bifidobacterium; 1 member of the Bacteroidetes, genus Parabacteroides; and 9 members of 
Firmicutes, all of order Clostridiales.  These taxa were modelled using beta-binomial regression 
models (Figure 3; Table S 3).  Eight of these OTUs were significantly different by maternal pre-
pregnancy weight group when adjusting for maternal characteristics: taxa that were lower among 
OW/OB included OTUs mapping to family Clostridiaceae with unclassified genus, Parabacteroides, 
Finegoldia, Ruminococcus, family Ruminococcaceae with unclassified genus, and Bifidobacterium, 
while OTUs from the order Clostridiales and family Lachnospiraceae were higher.   
The random forest using genus level taxa to predict pre-pregnancy weight status had n out of 
bag error rate of 28.4%; the predictive accuracy was 1.9 times as good as random guessing.  Figure 3 
shows the distributions of the genus-level taxa ranked as most important in the random forest and 
modelled using beta-binomial regressions (Table S 4), which were generally consistent with the 
OTU-level analysis.  
The random forest to classify GWG group based on OTUs had an out of bag error rate of 
24.1%; this classification accuracy was twice as accurate as random guessing.  The most important 
taxa included 1 member of the Archaea, genus Methanobrevibacter; 1 member of Actinobacteria, 
genus Bifidobacterium; 1 member of the Bacteroidetes, genus Bacteroides; and 7 members of 
Firmicutes, all of order Clostridiales.  In the beta-binomial regression models, there were three OTUs 
that were significantly higher among women with excess GWG when controlling f r maternal 
characteristics: one OTU from genus WAL 1855D (Family Tissierellaceae) and two from Blautia 
(Figure 4; Table S 5). The random forest using genus-level taxa as predictors had an out of bag error 
rate of 31.9%, which was 1.7 times as good as random guessing, and showed consistent patterns as 




In the sensitivity analyses, we used continuous measures of the exposures, rather than 
dichotomous. The results were generally comparable to the primary analysis and are reported in the 
supplement (Table S 7; Table S 8). 
Comparison of Maternal and Infant Gut Microbiota 
The presence of OTUs in maternal gut microbiota at the time of delivery significantly 
increased the odds of their presence in the infant gut microbiota at day 10; this was true when 
evaluating the average association across all OTUs and when specifically evaluating those associated 
with maternal OW/OB (Figure 5; OR=1.8, 95% CI: 1.4, 2.3; p-value<0.01).  Most of the individual 
OTUs associated with maternal OW/OB were not significantly associated between maternal-infant 
samples, and some were almost entirely absent from the infants.  There were a few exceptions.  
Bifidobacterium adolescentis was present in almost every maternal and infant sample; there was not 
enough variation in the data to model statistically.  The presence of lean-associated OTUs in the 
Parabacteroides and Finegoldia genera in maternal samples were associated with increased odds of 
presence in the infant (OR=4, 95% CI: 1, 15.4; p-value=0.04; OR=2.9, 95% CI: 1.3, 6.5 p-
value<0.01, respectively).  The group of OTUs highlighted as important to classify maternal 
excessive GWG were not significantly associated overall between maternal and infant samples 
(Figure 5; OR=1.0, 95% CI: 0.6, 1.6; p-value=0.9).  However, an OTU in the Bifidobacterium genus 
that was negatively associated with excessive GWG did show a positive association between presence 
in maternal and infant samples (OR=2.6, 95% CI: 1.3, 5.5; p-value<0.01). 
Discussion 
Both maternal OW/OB and excessive GWG have detrimental short and long-term health 
consequences for the infant, such as increased risk for fetal macrosomia, obesity, m tabolic 
syndrome, and even all-cause mortality.67  It is possible that the maternal gut microbiota may mediate 
some of the increased disease risk associated with these exposures, particularly with respect to 
obesity.  Our results showing numerous differences in maternal gut microbiota associated with pre-
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pregnancy OW/OB and GWG lend support to this notion.  We found that pre-pregnancy OW/OB is 
associated with both lower alpha diversity as well as differences in gut microbial composition, and 
that excess GWG is associated with compositional differences.   
Low alpha diversity has been associated with many diseases (including inflammatory bowel 
disease,80 autism,81 asthma / allergy,24 dyslipidemia 3  and obesity 3,82)  but may be a consequence of 
disease, as longitudinal studies are limited. Koren et al.33 showed a decrease in alpha diversity from 
the first to third trimester in pregnant women, which is consistent with the inverse association seen in 
some studies between more obese states and alpha diversity, although not replicated in a recent study 
of pregnant women by DiGuilo et al.70 
Numerous taxa that differentiated maternal OW/OB were higher among lean women, and 
many of these have shown consistent associations with leanness in prior studies, such as 
Parabacteroides,5,83 Lachnospira,84 Faecalibacterium prausnitzii,80 members of the family 
Christensenellacea,85 Ruminococcus,86 and Bifidobacterium8.  Furthermore, some of these taxa may 
be of particular importance in the early infant gut.  For example, in a prior study of the infants in this 
NOMIC cohort, low abundance in early infant gut microbiota of the OTU of Parabacteroides that we 
saw as decreased among OW/OB moms was associated with developmental delays.87 Intere tingly, 
maternal metabolic conditions (diabetes, hypertension, and obesity) during pregnancy have also been 
associated with developmental delays.88  Abundance of Lachnospira and Faecalibacterium in the first 
3 months of life have been associated with risk for developing asthma.89  Furthermore, members of 
Christensenellacea are among most heritable taxa and have shown a protective effect against weight 
gain in mouse studies involving fecal-transplants from obese humans,85 which could make it of key 
importance to explain the obesity associations across generations, as well as a key target for 
microbiota-based interventions.   
The taxa associated with excessive GWG in our results are generally distinct from those 
associated with pre-pregnancy OW/OB, and show less consistent patterns with prior studies of 
obesity.  One exception is the taxa Bl utia, which was enriched with excessive GWG and has been 
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associated with type 2 diabetes,90 and some species of this genus have been associated with obesity in 
a Japanese population.91   However, other studies have suggested that Blautia may also be beneficial 
to health in some contexts.92  The taxa that differentiated maternal excessive GWG also tended to be 
absent or at non-detectible levels in most of their infants at day 10; they tend to be later colonizers of 
the infant gut.  Some of these taxa are discussed further below.   
This study involves only one sample from each woman at the time of delivery, so conclusions 
about causality and direction of associations are limited.  However, the differences noted in the 
maternal microbiota could potentially influence the offspring through various means, including 
vertical transfer during and after birth which then shapes the gut colonization process of the infant.  
Work by Backhed et al.31 showed that the maternal gut microbiota is a major determinant of the infant 
gut microbiota; 72% of early colonizers in the infant gut matched species found in maternal samples 
for vaginally-born infants, and 41% in infants born via C-section.  Similarly, we see that the presence 
of taxa in the maternal gut microbiota at the time of delivery is highly predictive of presence in the 
infant at day 10 of life.  A recent study by Nayfach et al.93 performed a strain-level analysis to further 
explore the variation in maternal-infant vertical transmission across taxa and over the first year of life.   
They found evidence of extensive vertical transmission of gut microbiota shortly after birth, 
particularly for Bacteroides vulgatus, Parabacteroides distasonis, Bifidobacterium adolescentis, 
and Escherichia coli.  The vast majority of strains in the infants at 4 days that were transmitted from 
the mother persisted in the infants at 4 and 12 months. This is interesting in the context of our results 
because species in the Parabacteroides and Bifidobacterium genera were both associated with 
leanness in mothers, and presence of these taxa in the mother was predictive of presence in their 
infants at day 10.   
Some of the taxa associated with maternal pre-pregnancy OW/OB or excessive GWG tend to 
be later colonizing bacteria, such as Blautia, Ruminococcus, and Faecalibacterium, and they may 
originate from the environment rather than through vertical transmission.  However, Nayfach’s work 
also showed that while strain-level similarity between mothers and infants significantly decreased 
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over the first year of life, the maternal-infant species-level composition converged over time.93  Thus, 
while these taxa may not be vertically transmitted to the infants, their presence in the mother may still 
be predictive of species-level composition in their infants at later time points due to shared 
environmental exposures, and may still impact the infant risk for obesity.  
The differences in the maternal microbiota seen in our results could also have in utero 
impacts. The fetal programming hypothesis sets forth the notion that exposures in tero, at birth and 
in early life may have long-term effects on adult health.16  A recent study by Agüero et al.21 provides 
compelling evidence that in utero programming occurs, in part, through the maternal gut microbiota.  
Using a murine model, they found that transient maternal colonization during pregnancy had long-
term effects on the innate immune system of the offspring, as well as the expression of numerous 
genes in the newborn intestine, including genes involved in metabolism and oxidative stress.   
There is a growing body of research that provides compelling evidence that the gut 
microbiota play a role in obesity, as well as numerous mechanisms for these effects, as has been 
covered in numerous reviews.66,68  Furthermore, studies of diet-induced obesity in mice suggest that 
probiotics can protect against weight gain and metabolic abnormalities.94,95  Obesity is a complex 
condition with complex etiology, and there has been mixed results across human studies in term  of 
the associations with gut microbiota.40,80,82  There are numerous factors that influence the gut 
microbiota, particularly diet,96,97 and it has been proposed that the gut microbiota are a mediator of 
diet-induced obesity.69  As we begin to better understand these interrelationships, it may enable more 
targeted dietary-based interventions for obesity, both generally and during pregnancy.   
Exposure to maternal OW/OB and excessive GWG were associated with higher BMI in 
childhood in several studies.19,20  Genetics and lifestyle factors explain these associations to some 
extent, though not entirely.19,20  Furthermore, genetics offers little hope for intervention, and lifestyle 
interventions have proven challenging.98  If gut microbiota prove instrumental in the development of 
obesity in children, then interventions aimed at influencing the gut microbiota of both mothers and 
infants may prove to be a more effective avenue towards curbing the obesity epidemic.  Future studies 
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of maternal interventions may consider bacteria in the Parabacteroides and Bifidobacterium genera, 
shown in this study to associate with leanness in mothers and show evidence of transfer to the infant. 
In this study, many of the gut microbiota associated with OW/OB in pregnant women have 
been previously associated with obesity in non-pregnant adults.  Some of the taxonomic differences 
noted, while not previously associated with obesity, have been associated with childhood risk for 
other conditions, such as asthma and developmental delays.  Thus, pre/pro-biotics targeted towards 
obesity in the general population may be eneficial for pregnant women as well, however, there may 
be additional microbiota that are particularly advantageous for pregnant women around the time of 
delivery.  For example, bacteria from the genera of Parabacteroides or Bifidobacterium, or those 
from the family Christensenellacea, may play a protective role against excessive weight gain and be 
highly heritable.  These and other gut microbiota highlighted in this study offer insight into the 
etiology of childhood obesity, and may inform future studies related to obesity prevention efforts 





Table 4. Demographic and Birth Characteristics of Mothers by Pre-pregnancy Weight Group: Overweight / 






23.1 (21.1-25.5) 21.6 (20.2-23.1) 27.2 (25.7-31.7) <.001
Pre-pregnancy BMI category
Underweight 7 (4.1%) 7 (6.0%) 0 (0.0%) <.001
Normal 110 (65.1%) 110 (94.0%) 0 (0.0%)
Overweight 32 (18.9%) 0 (0.0%) 32 (61.5%)
Obese 20 (11.8%) 0 (0.0%) 20 (38.5%)
142 (87.1%) 95 (84.1%) 47 (94.0%) 0.13
<12yrs education 9 (5.6%) 4 (3.6%) 5 (10.4%) 0.01
12yrs education 28 (17.5%) 19 (17.0%) 9 (18.8%)
>12yrs education 123 (76.9%) 89 (79.5%) 34 (70.8%)
30.0 (27.0-34.0) 30.0 (27.0-33.0) 30.0 (27.5-34.0) 0.90
No prior pregnancies 83 (49.1%) 57 (48.7%) 26 (50.0%) 0.62
1 prior child 53 (31.4%) 39 (33.3%) 14 (26.9%)
>1 prior child. 33 (19.5%) 21 (17.9%) 12 (23.1%)
11 (6.5%) 8 (6.8%) 3 (5.8%) 0.99
Never smoker 111 (66.5%) 77 (67.0%) 34 (65.4%) 0.01
Past smoker 41 (24.6%) 28 (24.3%) 13 (25.0%)
Occasional 7 (4.2%) 5 (4.3%) 2 (3.8%)
Daily smoker <=10 4 (2.4%) 2 (1.7%) 2 (3.8%)
Daily smoker >10 4 (2.4%) 3 (2.6%) 1 (1.9%)
No Diabetes 167 (98.8%) 116 (99.1%) 51 (98.1%) 0.21
T1 1 (0.6%) 1 (0.9%) 0 (0.0%)
T2 1 (0.6%) 0 (0.0%) 1 (1.9%)
15 (8.9%) 8 (6.8%) 7 (13.5%) 0.16
8 (4.7%) 4 (3.4%) 4 (7.7%) 0.25
Gestational Weight Gain (kg) 14.0 (10.0-18.0) 15.0 (12.0-19.0) 11.0 (8.1-15.0) <.001
GWG relative to IOM recommendations
Low 12 (10.3%) 12 (14.6%) 0 (0.0%) 0.06
Adequate 41 (35.3%) 27 (32.9%) 14 (41.2%)
Excessive 63 (54.3%) 43 (52.4%) 20 (58.8%)
278 (254-285) 279 (256-285) 277 (253-287) 0.80
3.37 (2.46-3.75) 3.31 (2.47-3.69) 3.44 (2.46-3.84) 0.29
50 (29.6%) 31 (26.5%) 19 (36.5%) 0.19
52 (32.1%) 35 (31.0%) 17 (34.7%) 0.71
Day of Birth 9 (5.6%) 6 (5.3%) 3 (6.1%) 0.99
Day before Birth 2 (1.2%) 1 (0.9%) 1 (2.0%) 0.51
Week before Birth 6 (3.7%) 2 (1.8%) 4 (8.2%) 0.07
Month before Birth 9 (5.6%) 6 (5.3%) 3 (6.1%) 0.99
Month before Birth 26 (16.0%) 18 (15.9%) 8 (16.3%) 0.99
14 (8.6%) 7 (6.2%) 7 (14.3%) 0.13
Alpha Diversity
Shannon 5.7 (5.3-6.1) 5.7 (5.4-6.1) 5.5 (5.0-5.9) 0.05
N Observed Species 365 (307-400) 375 (315-400) 338 (292.5-385) 0.04
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Table 5. Results of rank-based regression models of alpha diversity of maternal gut microbiota samples at the 
time of delivery. * 
 
* β indicates the parameter estimate and 95% CI is the 95% confidence interval. 
 
  
Shannon PD Observed Species
β (95% CI) p-value β (95% CI) p-value β (95% CI) p-value
Intercept 5.82 (5.01, 6.62) <0.001 28.09 (21.03, 35.15) <0.001 353.41 (262.22, 444.6) <0.001
Maternal OW/OB -0.19 (-0.38, -0.01) 0.04 -1.74 (-3.36, -0.12) 0.04 -19.85 (-40.52, 0.83) 0.06
Maternal age 0.02 (-0.01, 0.04) 0.14 0.09 (-0.12, 0.29) 0.40 1.79 (-0.82, 4.41) 0.18
Norwegian -0.27 (-0.53, -0.01) 0.04 -1.45 (-3.73, 0.82) 0.21 -32.73 (-61.78, -3.69) 0.03
Education -0.11 (-0.27, 0.05) 0.20 -0.33 (-1.74, 1.07) 0.64 -1.22 (-19.16, 16.72) 0.89
Parity: >1 prior child -0.1 (-0.37, 0.17) 0.48 -0.38 (-2.78, 2.02) 0.76 -10.59 (-41.26, 20.08) 0.50
Parity: 1 prior child -0.15 (-0.34, 0.05) 0.14 -1.46 (-3.18, 0.26) 0.10 -24.25 (-46.19, -2.31) 0.03
Twins -0.18 (-0.53, 0.16) 0.31 -1.54 (-4.59, 1.5) 0.32 -16.01 (-54.94, 22.91) 0.42





Figure 3. Violin plots of important a) OTUs and b) genera from Random Forests for classifying 
maternal OW/OB status. Arrows indicate the direction of association with ma ernal OW/OB, 
with color corresponding to degree of significance of p-values in beta-binomial regression 
models controlling for the following maternal characteristics: matern l age, maternal education, 




Figure 4. Violin plots of important a) OTUs and b) genera from Random Forests for classifying maternal 
excessive GWG status. Arrows indicate the direction of association with maternal excessive GWG, with color 
corresponding to degree of significance of p-values in beta-binomial regression models controlling for the 






Figure 5. Plots of the presence of OTUs that differentiate a) pre-pregnancy maternal OW/OB status and b) 
excessive GWG in maternal gut microbiota samples.  The number of sample  with non-zero abundance from 
the mothers at the time of delivery are shown in red, from the infants at day10 of life are shown in green, and 
from both mother and child are shown in grey for each OTU, as well as the average across these OTUs.  The 
total number of mother-child samples is a) N=159 for the exposure of OW/OB and b) N=123 for excessive 
GWG.  The results of logistic regressions estimating the odds of presence in the infant based on presence in the 
mother are also shown.  OR indicates the odds ratio, and 95% CI is the 95% confidence interval.  In many 
cases, there was not enough data or enough variation in the presence of the OTUs across the samples to estimate 






THE ASSOCIATION BETW EEN INFANT GUT MICRO BIOTA, CHILDHOOD  BMI, AND 
THE ROLE OF MOTHER’S  PRE-PREGNANCY WEIGH T: A PROSPECTIVE 
LONGITUDINAL STUDY  
Abstract 
Background: Childhood obesity is a growing problem around the globe with serious 
consequences for health. Recent research suggests that the gut microbiota may play an import t and 
potentially causal role in the development of obesity, and that it may be one mechanism to explain the 
transgenerational transmission of obesity risk. Objective: To investigate he association between 
infant gut microbiota and later childhood BMI, and to examine the role of maternal weight in shaping 
the infant gut microbiota. Methods: We performed 16s rRNA sequencing on fecal samples from 165 
infants at 6 time points during the first two years of life. We calculated sex-specific BMI-for-age z-
scores throughout the first two years of life, as well as later in childhood (median age: 11.7 years, 
IQR: 11.4-12.3), and categorized the infants according to maternal pre-pregnancy body mass index 
[overweight/obese (OW/OB), BMI>25, N=69] or non-overweight/obese, BMI<25, N=96).  We 
examined whether 1) the infant gut microbiota over the first two years of life was predictive of BMI 
at age 12 using random forests, 2) whether infant gut microbiota characteristics predictive of later 
BMI were also associated with maternal OW/OB using permutational ANOVA and regression 
methods, and 3) the longitudinal trends of BMI z-scores in order to assess whether changes in gut 
microbiota preceded excessive weight gain.  Results:  Infant gut microbiota samples from days 4, 10, 
30 and 120 post-birth explained approximately 15% (range across sampling times: 14.6-15.9%) of the 
variation in later childhood BMI z-scores; samples from 1 year explained 35.5% (95% CI: 34.5-
36.5%) of the variation and samples from 2 years explained 53.0% (95% CI: 51.5-54.3%).  The gut 
microbiota features at 1 month post-birth that were highly predictive of ffspring childhood BMI 
were also significantly associated overall with exposure to maternal OW/OB (p=0.03), and some of 
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the individual taxa selected as predictive of BMI also showed consistent associations with maternal 
OW/OB.  Children who were OW/OB at age 12 showed no difference in BMI z-scores at age 2 years 
relative to non-OW/OB children.  Conclusions: Infant gut microbiota was predictive of BMI at age 
12.  Maternal OW/OB showed associations with gut microbiota features predictive of BMI.  Infant gut 
microbiota may offer potential as a biomarker for childhood obesity ri k. 
Introduction  
The prevalence of childhood obesity has been increasing in most nations across the globe in 
recent decades and has reached epidemic proportions.99,100  While we know that obesity has numerous 
health consequences, and we understand that genetics, poor diet, lack of exercises, and other aspects 
of the “Western lifestyle” contribute toward this epidemic, our understanding of the physiological 
etiology of obesity and effective ways to substantially curb the rising rates of obesity in children are 
lacking.99  
In recent decades, the idea that the gut microbiota may play an important, pote ially causal, 
role in obesity has gained traction and offers a possible mechanism to help explain the 
transgenerational transmission of obesity risk.  A recent review examines the evidence linking 
maternal obesity, maternal gut microbiota, fetal gut microbiota, and metabolic outcomes in children.67  
They present the idea that obesity alters the maternal pre-pregnancy gut microbiota, and that these 
differences may be maintained or amplified during pregnancy.34,101  These obesity-associated 
microbes may have in utero programming effects on the fetal immune and metabolic systems,21,102 
and they may also be passed from mother to child during birth and through breastmilk.30,31,93 Together 
these programming effects and transferred microbes may confer risk for adverse metabolic outcomes 
in the child.  Early infant microbiota has been associated with risk for childhood overweight and 
obesity.  For example, differences have been seen in the early infant gut microbiota among 
overweight compared to normal weight children,44,46 and exposures known to disrupt or alter the 
early infant gut microbiota, such as antibiotic use44,47 and delivery via cesarean section,48 have also 
been associated with risk for childhood obesity.  One of the promising aspects of this overall 
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hypothesis is that the gut microbiota is alterable – through diet, prebiotics and probiotics – and may 
offer a target for obesity prevention.103 
Maternal gut microbiota plays an important role in shaping the early infant gut microbiota for 
both vaginally and cesarean-born infants.31,93  Thus, we would expect that differences in maternal gut 
microbiota associated with overweight/obese (OW/OB) status would translate into differences in their 
infants’ gut microbiota.  However, studies have shown conflicting results.  Collado et al. found 
numerous differences according to maternal pre-pregnancy weight and gestational weight gain 
(GWG) in infant samples at 1 and 6 months;7 Mueller et al. found that microbiota from the first infant 
stool differed by maternal OW/OB only among vaginally-born infants;104 Galley et al. found 
differences at 18-27 months only among infants of high socioeconomic status.105 However, Laursen 
et al. found no impact of maternal obesity on microbial diversity or ax nomic composition at 9 or 18 
months.106 These inconsistencies across studies are not entirely surprising; infant gut microbiota 
changes drastically over the first few years of life, differs substantially across infants, and is affected 
strongly by other factors, including mode of deliv ry, breastfeeding, and antibiotic usage.31,107   
Although several studies have investigated the impact of maternal OW/OB status on infant 
gut microbiota composition, none of these studies examined the effects of maternal OW/OB in the 
context of the later development of OW/OB in the offspring. In this study, we examine maternal 
OW/OB and infant gut microbiota in relation to BMI at 12 years of age.  W use a longitudinal 
Norwegian birth cohort, NOMIC, to examine the associations between the infant gut microbiota over 
the first 2 years of life and later childhood BMI, whether the BMI-associated taxa are also associated 
with exposure to maternal OW/OB, and how similar these taxa are between the maternal gut 
microbiota at the time of delivery and the infant gut microbiota during the first 30 days of life.  
Additionally, we examine the longitudinal trends in BMI z-scores in order to assess whether changes 
in gut microbiota preceded excessive weight gain.  These lines of inquiry aim to assess the role of 
infant gut microbiota in the development of childhood obesity, whether maternal obesity contributes 
towards shaping these infant gut microbes, which of the BMI-associated taxa may be transferred 
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vertically from the mother to the infant, and whether the gut microbiota during early life can serve as 
a biomarker for the development of childhood obesity. This is an important area of research because 
targeting maternal or infant gut microbiota may offer potential to prevent the development of obesity 
in children, and an early biomarker for obesity could allow for more targeted prevention efforts.103 
Methods & Materials 
Study Cohort 
NOMIC is a Norwegian birth cohort of 552 children designed to study the establishment of 
gut microbiota during infancy and its consequences for child health. Participating mothers, recruited 
between 2002 and 2005, were asked to fill out periodic questionnaires and to collect and freeze fecal 
samples from themselves at 4 days post-par um, and from their infants at days 4, 10, 30, 120, 365, 
and 730 post-birth. Study personnel retrieved the fecal samples and kept them frozen during transport 
to the Biobank of the Norwegian Institute of Public Health, Oslo, where they were stored at -20° C 
upon arrival. 
The study was approved by the Regional Ethics Committee for Medical Research in Norway 
(approval ref 2002, S-02216) and the Norwegian Data Inspectorate (ref 2002/1934-2). The approvals, 
as well as informed consent from the mothers, were obtained prior to c llection of data and samples.  
The NOMIC study was funded by the FRIMEDBIO program at the Norwegian Research Council. 
Study Sample 
This study includes 781 infant gut microbiota samples from 165 infants in NOMIC for whom 
later childhood height and weight were available (median age: 11.7 years, IQR: 11.4-12.3), as well as 
maternal height and pre-pregnancy weight. The distribution of sampling times is listed in Table S 9. 
Additionally, we compared maternal and early infant gut microbiota (during the first month 
of life) in 166 mother-infant pairs in the NOMIC cohort who both had gut microbiota data, 
comprising 477 infant samples over the first month of life and the corresponding maternal sample; 




Height and weight were measured by a study nurse at follow up examinations when the 
children were approximately 12 years of age (Median=11.7; IQR: 11.4-12.3; Range: 10.8-13.4).  
Age- and sex-specific BMI z-scores and percentiles were calculated based on CDC growth charts.108  
Childhood overweight and obesity were defined using these BMI percentiles according to CDC 
standards (overweight: >85th percentile; obese: >95th percentile).109   
Mothers also provided information on infant height and weight from their “baby health visit” 
cards and reported this information in questionnaires, providing this information for numerous age
during childhood (range: 0-5 years; 99% of the measurements <2 years; median number of 
measurements per child: 7; IQR: 6-8).  As recommended by the CDC, age and sex-specific BMI z-
scores were calculated using WHO growth charts for ages under 2 years and CDC growth charts for 
ages over 2 years.108,110 
Pre-pregnancy BMI was based on maternal self-r port of weight at the first clinic visit of 
pregnancy; the median time of the first visit was at 9 weeks of gestation (IQR: 7.3-11.3 weeks). 
Height and weight were also measured at that visit. Pre-pregnancy BMI was initially categorized as: 
underweight, normal weight, overweight and obese according to standard definitions.71 We then 
further combined these groups into 1) non-OW/OB (55.8%): underweight (8.5%) and normal weight 
(47.3%); and 2) OW/OB (44.2%): overweight (30.9%) and obese (13.3%).   
Maternal questionnaires at 1, 6, 12 and 24 months provided information on mode of delivery, 
maternal age, education, parity, maternal smoking, ethnicity, infant sex, maternal and infant use of 
antibiotics, breastfeeding practices, and introduction of solid foods. We obtained informati n on 
gestational age at birth from the Medical Birth Registry of Norway.   
Processing of Microbial Samples 
DNA was extracted using the standard Power Soil Kit protocol (MoBio). The extracted DNA 
was amplified using polymerase chain reaction (PCR) with barcoded primers targeting the V4 region 
of 16S ribosomal RNA (rRNA) as detailed in Eggesbo et al.50 Each PCR product was quantified 
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using PicoGreen (Invitrogen) and equal amounts (ng) of DNA from each sample were pooled and 
cleaned using the UltraClean® PCR Clean-Up Kit (MoBio). Sequences were generated on a MiSeq 
personal sequencer (Illumina, San Diego, CA). Operational Taxonomic Units (OTUs) were assigned 
via a closed reference-based system62 using the Greengenes 13.8 database and a 97% threshold. OTUs 
are used when microorganisms are identified based on gene sequences. A rarefied OTU table at 5000 
sequences per sample (the optimal minimum rarefaction for all sampling time points) served as input 
for the analyses.   
Statistical Analysis 
We compared child demographic and birth characteristics by overweight / obese status at age 
12 using chi-squared tests for categorical variables and Wilcoxon rank-sum tests for continuous 
variables.  We used Principal Coordinate Analysis plots of unweighted UniFrac distance of the infant 
gut microbiota samples by sampling time, as well as the maternal gut microbiota samples near the 
time of delivery, to visualize the changes in the microbial communities in the samples with age.   
Random Forests to assess the association between infant gut microbiota and later childhood BMI z-
score 
In order to examine the association between infant gut microbiota during the firs  two years 
of life and BMI z-scores at age 12, we used the R package VSURF (Variable Selection using Random 
Forests)111 for feature selection at each sampling time on OTUs meeting the minimum threshold of 
presence in 10% of samples at that time and a minimum of 0.1% for the maximum relative abundance 
of each sample, in addition to four measures of alpha diversity: Phylogenetic Diversity (PD), Shannon 
Diversity Index, Chao1 and Observed Species.  The VSURF function is a multi-step algorithm that 
selects all highly important features for the prediction of the outcome. We then used repeated cross-
validation (3 folds, 100 repetitions) of random forests in the caret112 package in order to evaluate the 
R2 of the selected OTUs at each time to predict BMI z-score.  This method involves repeatedly using 
a subset of samples a  a training set and the remaining samples as the test set to pr dict the outcome.     
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Regressions to investigate the nature of the relationships between random forest selected gut 
microbes and later childhood BMI z-score 
Random forests are an ensemble technique that allow for complex interactions between the 
predictors.  While all of the selected microbiota features (taxa and alpha diversity) may be important 
together to predict BMI, we also wanted to understand whether these features individually had linear 
associations with BMI at age 12. Thus, we used linear regression models for each sampling time with 
BMI z-score as the outcome and each feature selected by the random forests (described above) as the 
predictor.  Since microbiota features are highly correlated, this method allowed us to assess the linear 
relationship with BMI for each feature, even those that were highly collinear with other features.  We 
repeated these models controlling for the following potential confounding variables: exclusive 
breastfeeding (yes/no for samples <120 days; duration of exclusive breastfeeding for samples at later 
times), delivery mode, antibiotics (lifetime exposure status at the time of the sample), gestational age 
at birth, and twin status. See supplemental directed acyclic graphs (DAGs; Figure S 4) for a full 
description of the choice of adjustment variables and the relationships between exposures and 
outcomes, which were determined based on prior research when available and on univariate 
relationships (p-values<0.1) otherwise.  The full list of covariates considered for inclusion across the 
regression models as confounders or mediators includes: maternal education, m ernal parity, 
maternal smoking during pregnancy, maternal ethnicity, infant sex, gestational age at birth, delivery 
mode, antibiotic use, twin status, and breastfeeding. 
Association between BMI-associated infant gut microbiota and maternal OW/OB  
In order to assess whether the gut microbiota characteristics identified as predictive of BMI at 
age 12 were also associated with exposure to maternal OW/OB, we first used permutational ANOVA 
of the bray-curtis distance matrix for the selected infant gut microbiota features at each time point.  
We then assessed the association of maternal OW/OB with each selected feature using regression 
models. Taxa were modeled individually as outcomes in longitudinal beta-binomial regression 
models with a random subject intercept, controlling for sampling time and includi g the total number 
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of sequences per sample (5,000 for all taxa).  Alpha diversity measures were modeled using 
longitudinal linear regression models with a random subject intercept, controlling for sampling time.  
Adjusted models included exclusive breastfeeding (yes/no at each time), delivery mode, antibiotics 
(yes/no at each time), and gestational age at birth (see Figure S 4 for DAGs). 
Association between BMI-associated infant gut microbiota taxa and maternal axa at the time of 
delivery 
Using data from 166 mother-infant pairs in the larger NOMIC cohort, we compared maternal 
gut microbiota at the time of delivery to infant gut microbiota over the first 30 days of life for the taxa 
we identified as predictive of BMI at age 12. Since the taxonomic profile of the gut microbiota of 
infants and adults is quite different, we compared the taxa primarily using presence / absence.  We 
used longitudinal hierarchical logistic regression with presence of each taxon in the infant at each 
sampling time during the first 30 days (days 4, 10, and 30) as the outcome, a random intercept for 
each infant, and presence of the taxon in the mother at the time of delivery as the predictor.  In cases 
when logistic regression could not be used (i.e., the taxon was present in all infant samples), 
longitudinal beta-binomial regression models were used, as described above, with presence of the 
taxon in the maternal sample as the exposure.  Adjusted models included gestational age and twin 
status (see Figure S 4 for DAGs).  Representative DNA sequences from the OTUs that were found to 
be significantly associated between maternal and infant samples as well as linearly associated with 
childhood BMI were retrieved from the greengenes FASTA file.61  We used a BLAST search 
(http://blast.ncbi.nlm.nih.gov) against the 16S rRNA database at NCBI to evaluate the taxonomic 
assignment for the OTUs.  We considered over 97% identity to be adequate to determine species level 
taxonomy. 
Longitudinal trends in BMI z-scores over infancy and childhood 
In order to assess whether BMI z-scores at age 12 were similar to those during infancy and 
early childhood, we plotted BMI z-scores by age using spaghetti plots and loess smoothing.  We 
additionally modeled the relationship using a mixed linear regression model with BMI z-scores as the 
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outcome and a random intercept by child.  The predictors included age, OW/OB status at ge 12 and 
an interaction between age and OW/OB status.  We used a t-test to examine whether there was a 
significant difference in BMI z-scores at age 2 (range 1.5-2.5 years) between children who were 
OW/OB at age 12 and those who were not for the subset of N=104 children with BMI data during 
that time frame.   
Supplemental Analyses: Association between maternal OW/OB and infant gut microbiota 
We also examined the overall association between maternal OW/OB and infant gut 
microbiota using random forests.  Our methods and results are detailed in the supplement. 
 We used SAS v9.4 (SAS Institute Inc., Cary, North Carolina), R v3.3.2,113 and QIIME 
v1.9.173 for analyses.  P-values less than 0.05 were considered statistically significant.   
Results 
The median age- and sex-specific BMI percentile at age 12 among the children in this cohort 
was 54.3% (IQR: 30.2-77.2); based on these percentiles, 20% of the children were overweight or 
obese (Table 6).  Mothers of OW/OB children tended to have less education and higher pre-
pregnancy BMI than mothers of non-OW/OB children; they also had higher rates of smoking during 
pregnancy and shorter duration of breastfeeding.     
Taxonomic Composition 
The phylum and genus level average relative abundance of infant gut microbiota ver the 
sampling times by OW/OB status at age 12 are shown in Figure 6.  The composition shifted over 
time, both at the phylum and genus levels.  The infant samples progressed towards a more adult-like 
community with age, as seen by comparing the infants to the maternal samples in the taxonomy plots 
(Figure 6), as well as the Principal Coordinate Analysis plots of UniFrac distance (Figure S 5). 
Association Between Infant Gut Microbiota and Later Childhood BMI  Z-Score 
We evaluated the predictive accuracy of the gut microbiota features identified by random 
forests as predictive of BMI at age 12 by the R2, which expresses the amount of variation in BMI 
explained by the features.  The R2 values with 95% confidence intervals are shown in Table 7.  As 
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can be seen, the gut microbiota of infants during the first 4 months explained a clinically significant 
portion of the variation in BMI z-score (R2 values range from 14.6-15.1%).  However, the association 
became much stronger at 1 and 2 years (R2=35.5 and 53.0%, respectively).   
The number of highly predictive features selected by the random forest VSURF function 
differed by sampling time (Figure 7).  Three alpha diversity measures were selected (Phylogenetic 
diversity at 10 days; Shannon and Observed Species at 4 months), as were 73 unique OTUs; 9 TUs 
were selected as predictive of child ood BMI at more than one sampling time, and these are included 
in Figure 7 at all selected time points.  For each feature, linear regressions were used to assess 
whether there was a linear relationship with BMI z-score.  Figure 7 shows features with a significant 
positive relationship to BMI in red - i.e. higher levels of these taxa or alpha diversity measures 
correspond to higher BMI; significant negative relationships are in green - i.e. higher levels of these 
taxa or alpha diversity measures correspond to lower BMI (Figure 7; Table S 10).  While a feature 
may have been selected as predictive of BMI only at a certain sampling time, we plotted the linear 
association with BMI at all times in order to assess the consistency of the association ver time. 
Results adjusted for covariates showed consistent patterns (Table S 10). 
Association Between BMI-Associated Infant Gut Microbiota and Maternal OW/OB  
We assessed the association between maternal OW/OB and the groups of infant gut 
microbiota taxa selected as predictive of childhood BMI using permutational ANOVA (Table 8).  
Maternal OW/OB was significantly associated with the selected infant gut microbiota taxa at day 30, 
explaining about 1.5% of the variation in these taxa (p-value=0.03); the features at day 4 and 730 
showed borderline significant associations (R2=1.2%, p-value=0.08; and R2=3.3%, p-value=0.06, 
respectively).  Some of the individual gut microbiota features were also significantly associated with 
exposure to maternal OW/OB; adjusted results were similar (Figure 7; Table S 11). The direction of 
association was generally consistent with the BMI associations, i.e. features that correlated positively 
with maternal OW/OB likewise correlated positively with c ildhood BMI.  One exception was an 
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OTU of Staphlyococcus, its abundance at 2 years correlated positively with childhood BMI but 
negatively with maternal OW/OB.   
Association Between BMI-Associated Infant Gut Microbiota Taxa and Maternal Taxa at the 
Time of Delivery  
We next investigated whether any of the infant OTUs selected as predictive of childhood 
BMI correlated with presence in the maternal microbiota at the time of delivery, as this may indicate 
exposure from the mother as a driving factor of presence in the infant.  Among the 73 unique taxa 
selected as predictive of childhood BMI, 11 (15%) showed a significant positive correlation between 
presence in the maternal gut microbiota at the time of delivery and in the infant gut microbiota 
longitudinally over the first 30 days (Figure 8; Table S 12).  Some of these OTUs also showed 
significant linear associations with childhood BMI.  Unfortunately, most of these OTUs were not 
classified down to the species level, so we used a BLAST search of t e representative sequences for 
these OTUs, which provided some additional information (Table S 13).  Among the lean-associated 
OTUs, one was classified as Bacteroides but showed a 97% identity match with B. dorei, and two 
were likely Enterrococcus that were initially classified only down to the Family and Order levels.  
Two obese-associated OTUs from Enterococcus were likely E. faceium and E. gallinarum. 
Longitudinal Trends in BMI Z -Scores Over Infancy and Childhood 
BMI z-scores showed a high degree of variation during the first years of life (Figure 9).  The 
pattern after that point differed among children who were OW/OB at age 12 and those who were not.  
Non-OW/OB children showed no significant change between early and later childhood (β=0.01; 95% 
CI: -0.01, 0.02; p-value=0.42), while OW/OB children showed an increase in BMI z-score (β=0.13; 
95% CI: 0.1, 0.15; p-value<0.001).  BMI z-scores at age 2 years did not differ by OW/OB status at 
age 12 (p-value=0.32).  For ages 2-18, overweight is defined as a BMI z-score >85%.109  Among 
children who were not OW/OB at age 12, 11.3% were in the top 15th percentile of BMI z-scores at 
age 2, whereas only 4.2% were in these top percentiles among those who would become OW/OB.  
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Thus, the overweight phenotype was l rgely absent at 2 years for the children who were OW/OB at 
age 12.   
Supplemental Analyses:  Association Between Maternal OW/OB and Infant Gut Microbiota 
Random forests trained to classify the infant gut microbiota according to maternal OW/OB 
had poor accuracy (Table S 14).  They were about 13% better than random guessing for classifying 
taxa by exposure status across all infants; a cutoff of twice and good as random guessing is often used 
to signify that the model identified clinically meaningful taxonomic differences.114 
Discussion 
In this study, we used a longitudinal Norwegian birth cohort in order to investigate the role of 
the infant gut microbiota in the devlopment of childhood obesity, as well as the potential role of 
maternal OW/OB in shaping the infant gut microbiota. We found that 1) the gut microbiota during the 
first two years of life, particularly at one and two years, is strongly associated with later childhood 
BMI; 2) some of the infant gut microbiota characteristics predictive of childhood BMI showed 
consistent associations with maternal OW/OB; and 3) the maternal gut microbiota at the time of 
delivery showed taxonomic similarities with the infant gu microbiota predictive of childhood BMI.  
Furthermore, the children who were OW/OB at age 12 did not show a significant difference in BMI 
z-scores at age 2 relative to children who were not.   
Infant gut microbiota samples from the first four months of life in this cohort explained about 
15% of the variation in childhood BMI z-scores, and samples at one and two years explained about 
36% and 53% of the variation, respectively.  These BMI-associated gut microbiota features may have 
directly influenced the BMI trajectory, or they may be a reflection of dietary and lifestyle patterns that 
influenced that trajectory.  The increasingly strong association between gut microbiota at one and two 
years and later childhood BMI could be due to dietary factors that are p cursors to obesity playing an 
increasing role in shaping the infant gut microbiota at those ages.  In a previous study from this cohort 
we observed that early gut microbiota was also associated with infant growth rates, however this 
study was performed on a limited number of 23 probes targeting specific species or microbial 
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groups.115 Numerous other studies have also examined the role of the gut microbiota in obesity, and 
results from human and animal studies support the idea that gut microbiota may play  causal role in 
the development of obesity and metabolic disease;5,35,36  the mechanisms for these effects have been 
covered in several reviews.66,68  There are numerous factors that influence the gut microbiota, 
particularly diet,96,97 and it has been proposed that the gut microbiota is a mediator of diet-induced 
obesity.69  Studies of diet-induced obesity in mice suggest that probiotics can protect against weight 
gain and metabolic abnormalities.94,95  Thus, even if the BMI-associated gut microbiota in this study 
are largely reflective of diet, it is possible that interventions would stil  be protective against 
excessive weight gain.   
Maternal OW/OB is a strong predictor of obesity in children, both in this cohort and many 
others.19,20  This association may extend beyond the influences of genetics and lifestyle fac ors,19,20 
and the gut microbiota may provide another possible mechanism to explain this association.67 As 
described in the supplement, we did find not a distinctive taxonomic signature associated with 
exposure to maternal OW/OB.  However, many of the taxa predictive of childhood BMI showed 
consistent associations with maternal OW/OB.  Thus, while maternal OW/OB may not strongly 
impact the overall composition of infant gut microbiota, it may impact a subset of specific taxa that 
also influence BMI trajectory.  However, as noted above, this relation may not be causal, rather the 
taxa predictive of childhood BMI in this cohort may be, at least in part, a reflection of dietary and 
other lifestyle influences, which are shared by mother and child, particully in early life. 
While other studies have conducted in-depth analyses of mother-infant similarities in gut 
microbiota and the dynamics of vertical transmission,31,107 we wanted to examine the similarity 
between mothers and infants for the gut microbiota taxa predictive of childhood BMI because 
targeting maternal gut microbiota near the time of delivery has been suggested as a potential target for 
obesity prevention efforts.  Intervening on maternal gut microbiota would likely be in the form of 
administered probiotics, thus, we were particularly interested in gut microbiota associated with lower 
childhood weight that may be vertically transferred from the mother.  Unfortunately, most of the lean-
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associated taxa showing similarity between mothers and infants were not classified at the species 
level; they included OTUs from Enterococcus and Lactobacillus genera, as well as Bacteroides dorei.   
Another avenue for the prevention of obesity would be through early biomarkers that could 
identify individuals at high risk for development of obesity.  Dietary or other interventions could be 
targeted to these individuals before they begin to gain weight.  Our results suggest that the gut 
microbiota during early childhood may have potential as such a biomarker.  Th  gut microbiota at age 
2 years was highly predictive of later OW/OB, yet these children did not show significantly elevated 
BMI z-scores at age 2. 
Some of the associations between gut microbiota and childhood BMI seen in this study 
support previous obesity-related research findings.  For example, Faecalibacterium prausnitzii 
abundance at two years was predictive of lower childhood BMI, as seen in studies of adults.80  Also at 
two years, OTUs of Blautia sp. were predictive of higher BMI, and this genus has been associated 
with obesity91 as well as type 2 diabetes.90  Some of our other findings are mixed or somewhat 
surprising.  Early abundance of OTUs of Bi idobacterium sp. and Bifidobacterium longum were 
associated with lower BMI, but Bifidobacterium bifidum showed the opposite association with BMI.  
Species of Bifidobacterium are generally thought to be very healthy, particularly in infants.  Other 
studies have shown protective associations between early abundance of Bifidobacterium and 
childhood overweight/obesity.44,46  While the positive association with childhood BMI seen in our 
results could be spurious, these findings are concerning because strains of B. bi idum are included in 
many prenatal and infant probiotics. There could be differences in the effects of different strains of B. 
bifidum, which would be important to understand.  We also found that alpha diversity at 10 days and 
at 4 months was associated with higher BMI and with exposure to maternal OW/OB.  Higher alpha 
diversity is often associated with leanness in adults, including among the mothers in this NOMIC 
cohort.82,101  However, the alpha diversity is a general summary measure, and the patterns seen i  
adults would not necessarily be the same in infants, particularly since low alpha diversity in infants is 
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characteristic of exclusive breastfeeding, which had a protective effect against obesity in this 
cohort.101   
This study has some important limitations.  The samples were weighted towards earlier 
timepoints, with fewer infants having samples at 1 and 2 years due to lossf llow up, and lower 
prevalence of childhood overweight / obesity among the infants sampled at these later time points, 
particularly at 2 years (14% versus 20% overall).  We did not have strain-level microbiota data, so our 
analysis of similarity between mother-infant pairs is not definitive of vertical transfer.  Furthermore, 
this cohort is almost entirely ethnically Norwegian, and the non-N rwegians were typically from 
other Nordic countries; thus, some of the taxonomic findings may not reflect patterns in other ethnic 
or racial groups, or in other geographic regions.  However, the results shouldbe internally consistent 
in terms of showing support for the notion that infant gut microbiota are associated with later BMI, 
and that maternal OW/OB may play a role in shaping this composition.  Obesity is a complex 
condition with complex etiology, and there has been notable inconsistencies across human studies in 
terms of the associations with gut microbiota.40,80,82  Some of these inconsistencies could be due to 
geographical, racial/ethnic and genetic variation across study populations.78,116  Thus, the 
homogeneity in our study may have allowed us to isolate a particularly consistent association between 
infant gut microbiota and later BMI.  A primary strength of this study is the larg  cohort of infants 
with repeated gut microbiota samples during the first two years of life and extensive data on maternal 
and infant characteristics and exposures, as well as maternal gut microbiota samples at the time of 
delivery.  
Overall, our findings show a strong association between infant gut microbiota and BMI at age 
12, and that the gut microbiota characteristics predictive of later BMI precede xcessive weight gain, 
suggesting that the gut microbiota could serve as an early biomarker to identify children at risk for 
obesity.  We also found that maternal OW/OB may result in compositional changes in infant gut 
microbiota that are associated with later BMI.  Further studies of the specific bacteria highlighted in 







Table 6. Characteristics and early life exposure of infants in the NOMIC cohort by overweight / obesity 
(OW/OB) status at age 12, as defined by age- and sex-specific BMI percentiles (overweight >85th percentile; 
obese >95th percentile). 
Non-OW/OB = 0 OW/OB
(N=132) (N=33)
Parental Characteristics
Maternal Age 30 (27-32) 30 (28-32) 29 (26-33) 0.45
Ethnic Norwegian 144 (87.3%) 116 (87.9%) 28 (84.8%) 0.26
Missing 5 (3.0%) 3 (2.3%) 2 (6.1%)
Maternal Education
<12yrs education 15 (9.1%) 10 (7.6%) 5 (15.2%) 0.002
12yrs education 29 (17.6%) 20 (15.2%) 9 (27.3%)
>12yrs education 118 (71.5%) 99 (75.0%) 19 (57.6%)
Missing 3 (1.8%) 3 (2.3%) 0 (0.0%)
Maternal pre-pregnancy BMI 24.5 (21.4-27.1) 23.1 (21.0-26.1) 26.3 (24.2-30.1) <0.001
Maternal pre-pregnancy OW/OB 73 (44.2%) 49 (37.1%) 24 (72.7%) <0.001
Paternal BMI 26.1 (23.7-28.2) 25.4 (23.7-27.7) 27.8 (25.9-29.2) 0.13
Exposures during pregnancy
Maternal smoking during pregnancy 20 (12.1%) 12 (9.1%) 8 (24.2%) 0.02
Diabetes
Type 1 1 (0.6%) 1 (0.8%) 0 (0.0%) 0.64
Gestational diabetes 1 (0.6%) 1 (0.8%) 0 (0.0%)
High BP 9 (5.5%) 7 (5.3%) 2 (6.1%) 0.99
Parity
No prior pregnancies 75 (45.5%) 61 (46.2%) 14 (42.4%) 0.17
1 prior child 54 (32.7%) 46 (34.8%) 8 (24.2%)
>1 prior child 36 (21.8%) 25 (18.9%) 11 (33.3%)
Infant and Birth
Female sex 75 (45.5%) 59 (44.7%) 16 (48.5%) 0.70
Twins 21 (12.7%) 20 (15.2%) 1 (3.0%) 0.08
Gestational age at birth (wks) 39.0 (36.0-40.0) 39.0 (36.5-40.0) 39.0 (36.0-40.0) 0.78
C-section delivery 51 (30.9%) 38 (28.8%) 13 (39.4%) 0.24
Birth Weight (g) 3,290 (2,560-3,750) 3,260 (2,540-3,740) 3,370 (2,878-3,990) 0.31
Infant feeding
Length of any breastfeeding (mths) 10 (5-13) 11 (5.5-14) 7 (3-13) 0.03
Length of exclusive breastfeeding (mths) 4 (2-6) 5 (2-6) 2 (0-5) 0.01
Childs age at receiving formula (wks) 3 (1-6) 3 (1-6) 3.5 (1-6) 0.80
Childs age when introduced to porridge (wks) 19 (16-22.5) 20 (16-23) 18 (16-20) 0.24
Childs age when introduced to solids (wks) 20 (16-26) 22 (17.5-26) 18 (16-26) 0.12
Antibiotic Exposures
Maternal antibiotics during pregnancy 56 (33.9%) 46 (34.8%) 10 (30.3%)
Missing 5 (3.0%) 3 (2.3%) 2 (6.1%) 0.83
Antibiotics given to newborn 24 (14.5%) 16 (12.1%) 8 (24.2%) 0.09
Missing 2 (1.2%) 1 (0.8%) 1 (3.0%)
Child antibiotics before 4 days 10 (6.1%) 6 (4.5%) 4 (12.1%) 0.11
Child antibiotics before 10 days 13 (7.9%) 9 (6.8%) 4 (12.1%) 0.30
Child antibiotics before 30 days 18 (10.9%) 13 (9.8%) 5 (15.2%) 0.38
Child antibiotics before 120 days 25 (15.2%) 20 (15.2%) 5 (15.2%) 0.99
Child antibiotics before 1 year 68 (41.2%) 52 (39.4%) 16 (48.5%) 0.34
Child antibiotics before 2 years 93 (56.4%) 74 (56.1%) 19 (57.6%) 0.88
Prepubertal BMI
BMI-for-age Z 0.1 (-0.5 to 0.7) -0.1 (-0.6 to 0.4) 1.7 (1.4-1.9) <0.001
BMI-for-age percentile 54.3 (30.2-77.2) 47.6 (26.9-64.4) 95.1 (92.0-97.1) <0.001
Total (N=165) P-Value 




Table 7.  The percent of variation in BMI z-score at age 12 explained by random forests of selected infant gut 
microbiota features at 6 times over the first two years of life.  Values repres nt the mean R2 and 95% 









Table 8. Association between exposure to maternal OW/OB and all of the infant gut microbiota features 
selected at each time as predictive of BMI z-score at age 12.  R2 indicates the amount of variation in these 
microbiota features explained bymaternal OW/OB and is the same for unadjusted and adjusted models.  
Adjusted models included the following covariates: exclusive breastfeeding, delivery mode at birth, infant 
exposure to anti-biotics and gestational age at birth.  







4 1.28% 0.086 0.049
10 0.60% 0.444 0.436
30 1.52% 0.018 0.022
120 0.73% 0.353 0.313
365 0.53% 0.827 0.827





4 14.6% (13.7, 15.4)
10 17.2% (16.3, 18.1)
30 15.9% (15.1, 16.7)
120 15.1% (14.1, 16)
365 35.5% (34.5, 36.5)





Figure 6. Mean relative abundance of the most prevalent phyla (top) and genera (bottom) in maternal gut 
microbiota samples at the time of delivery (labelled “Mother”) and infant gut microbiota samples over the first 






Figure 7. Infant gut microbiota features (OTUs listed with OTU, Phylum, and most specific level of known 
taxonomic classification) over the first two years of life selected by random forests at six time points (grouped 
vertically) to predict adolescent BMI z-score.  We used regressions in order to assess the direction of association 
between these features at each sampling time with BMI z-score at age 12, and longitudinally across sampling 
times with maternal OW/OB.  Since the assumptions underlying random forests and regressions are very 
different, we would not expect important features to necessarily be significant in regressions.  While a feature 
may have been selected as predictive of BMI only at a certain sampling time, we plotted the linear associations 
at all times (or longitudinally across time) in order to assess the t mporal consistency of the association 
(horizontal axis).  Regressions shown are unadjusted; adjusted results are in the supplement.  The colors 
represent the regression coefficients for each feature: red indicates a positive relationship between the fea ure 
and the outcome / exposure, e.g. higher abundance corresponds with higher BMI or probability of maternal 






Figure 8. Infant gut microbiota taxa (listed as OTU, Phylum, and most specific level of known taxonomic 
classification) selected by random forests to predict BMI z-score at age 12, grouped vertically by sampling time 
at which they were selected.  In order to assess whether presence of these taxa in maternal gut microbiota at the 
time of delivery was predictive of presence in the offspring microbiota in the first 30 days, longitudinal 
regressions were used.  The colors represent the regression coefficients for pre ence in the mothers: purple 
indicates a positive association between maternal and infant samples; grey indicates the regression model failed 
to converge. The direction of significant linear relationships with BMI are indicated by “+” for taxa that show a 





Figure 9. Spaghetti plots of BMI z-scores over time by OW/OB status at age 12.  Thetrends lines (denoted by 
thicker lines of darker color) show that BMI z-scores are fairly constant between age 2 and 12 for children who 
are not OW/OB at age 12 (β=0.01; 95% CI: -0.01, 0.02; p-value=0.42), but there is an increase in BMI z-scores 
during this time for children who become OW/OB (β=0.13; 95% CI: 0.1, 0.15; p-value<0.001).  At age 2, there 
is no difference between BMI z-scores of children who later become OW/OB and those who do not. 
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CHAPTER VI  
GUT MICROBIOTA IN ADOLESCENTS AS A B IOMARKER FOR NAFLD : 
THE EPOCH STUDY 
Abstract 
Recent evidence supports a biological basis for the role of the gut microbiota in the 
pathophysiology of non-alcoholic fatty liver disease (NAFLD).  Since many diagnostic techniques for 
NAFLD are expensive or highly invasive, the gut microbiota may offer potential as an early 
biomarker for NAFLD.  We investigated the association between gut microbiota and hepatic fat in 
107 adolescents (mean age 15.7 years, SD=0.99; 47.8% female; 50.4% Non-Hispanic White) enrolled 
in the EPOCH study in Colorado.  Height and weight were measured and used to calculate BMI z-
scores. Magnetic Resonance Imaging (MRI) was used to assess hepatic fat fraction. Habitual dietary 
intake was assessed using the 85 item Block Kid’s Food Questionnaire.  Fecal samples were collected 
and 16S rRNA sequencing was performed.  We examined the associations of alpha diversity and 
taxonomic composition of the gut microbiota samples with hepatic fat fraction and the predictive 
accuracy for hepatic fat fraction of 1) taxonomic composition, 2) dietary intake information, 3) 
demographic and comorbid conditions, and 4) the combination of all of the above.  We used linear 
regressions, controlling for important clinical factors, and random forests, for the analyses. Lower 
alpha diversity was associated with higher hepatic fat fraction in adjusted regr ssion models (β=-0.19, 
95% CI -0.36, -0.02). Seven taxa were selected as associated with hepatic fat fraction and together 
explained 17.7% (95% CI: 16.0-19.4%) of the variation. The combination of 2 of these taxa, 
Bilophila and Paraprevotella, with intake of dietary monounsaturated fatty acids and BMI z-scores 
explained 32.0% (95% CI: 30.3-33.6%) of the variation in hepatic fat fraction.  Our results suggest 
that gut microbiota taxa are associated with hepatic fat accumulation in adolescents and may offer 
potential as a non-invasive early biomarker for NAFLD, as well as insight into the pathogenesis of 





Non-alcoholic fatty liver disease (NAFLD) is a spectrum of conditions ranging from simple 
steatosis to progressive nonalcoholic steatohepatitis (NASH) and is the most common cause of 
chronic liver disease in the United States, as well as many other places in the world.117  Prevalence of 
NAFLD has been increasing rapidly in recent years, in conjunction with increases in obesity and 
metabolic disease,118 which are among the main risk factors for fatty liver, though it also occurs in 
lean individuals.119  Current prevalence estimates range from 10-30% among U.S. adults and 3–10% 
in children.118  These wide ranges in the estimates are due in part to sampling bias and variation in 
diagnostic methods, with the gold standard for diagnosis being liver biopsy, which is ig ly invasive 
and carries risk for complications.  NAFLD is usually asymptomatic, making early diagnosis 
particularly difficult.  Early interventions for NAFLD include dietary and lifestyle counseling, as well 
as vitamin supplementation, and may prevent the progression of NAFLD or reduce risk for common 
comorbid conditions, such as diabetes.120,121  In order to curb the long-term health effects of NAFLD, 
it is important to have better non-i vasive biomarkers of liver fat hat would provide the opportunity 
for early interventions, and to gain a deeper understanding of the biological processes underlying the 
condition, which may also inform more effective interventions.   
Both animal and observational studies in humans provide evidence that the pathogenesis of 
NAFLD may involve the gut microbiota.122,123  A recent review by Leung et al.124 summarizes the 
mechanisms by which the gut microbiota may impact the liver, such as through metabolism of bile 
acids, production of short-chain fatty acids (SCFAs), translocation of capsular components such as 
lipopolysaccharides, and production of non-dietary ethanol, which can affect intestinal permeability.  
These microbiota-derived effects can impact the metabolism of lipids and cholesterol, regulation of 
lipogenesis and gluconeogenesis, triglyceride storage, hepatic inflammation, the prevention of 
harmful bacterial products from reaching the portal system, and, ultimately, fibrosis and steatosis in 
the liver.  Furthermore, greater understanding of the role of gut microbiota in NAFLD may inform 




Diet may also play a role in NAFLD, either directly or through gut microbiota-mediated 
effects.  Fermentation of fiber produces SFCAs, which then effect energy metabolism, the immune 
system and adipose tissue expansion, and may play a role in gluconeogenesis in th  l ver.124,125,126 
Total carbohydrates, and specifically sugars and fructose, have been linked to increased risk for 
NAFLD; likewise for total fat, particularly saturated fat.124  However, at least two types of fat, 
monounsaturated and omega-3 fats may be protective.127   
In this study, we examined whether there is an association between gut microbiota and 
hepatic fat fraction (HFF) in an adolescent population from the Exploring Perinatal Outcomes among 
Children (EPOCH) cohort.  We assessed the accuracy of using the following information as potential 
biomarkers for HFF: 1) taxonomic composition, 2) dietary intake information, 3) demographic and 
comorbid conditions, and 4) the combination of all of the above.   
Population & Methods  
Study Cohort 
EPOCH is a historical prospective study of 604 mother / child pairs. Adolescents were 
identified through the Kaiser Permanente of Colorado Perinatal database based on exposure to 
gestational diabetes mellitus during singleton pregnancies. A research visit with data collection took 
place during 2012-2016, while the children were 12-19 years, and a fecal sample was requested from 
a randomly selected subsample of 240 participants. The subsample included 1 exposed participant for 
every 2 unexposed, matched on gender and race/ethnicity. Many participants chose to not provide a 
sample, or were unable to do so within the requested time frame.  Thus, fecal samples were 
successfully collected from 120 participants.  Of those, one sample failed to s quence, two had poor 
quality reads, four were missing dietary information, a d six were missing the outcome measure of 




The outcome variable in this study was the hepatic fat fraction (HFF) obtained by Magnetic 
Resonance Imaging (MRI). Hepatic imaging was performed using a modification of the Dixon 
method by Hussain involving multi-breath-hold double gradient echo sequences.128,129 HFF was 
calculated from the mean pixel signal intensity data, for each flip angle acquisition. An HFF of 5% or 
greater is commonly used as an indicator for mild fatty liver.130,131 
Data collection also involved completion of the Block Kid’s Food Questionnaire,58 a semi-
quantitative food frequency questionnaire (FFQ) developed for children aged 8 years and older, 
which assesses 85 food items consumed in the last week, frequency and average portion size.  Height 
was measured to the nearest 0.1 cm by SECA stadiometer, and weight was measured to the nearest 
0.1 kg using an electronic SECA scale, as described previously.63  Age- and sex-specific BMI z-
scores were calculated using CDC reference standards.132 Race / ethnicity was self-reported using 
2000 U.S. census definitions and categorized as Hispanic (any race), non-Hispa ic white, and non-
Hispanic African-American.  Maternal level of education and total household income at the time of 
birth were self-reported during the research office visit.  Maternal diabetes status was physician-
diagnosed using a standard two-step screening protocol (as described in prior studies63) and 
ascertained from the Kaiser Permanente of Colorado Perinatal database, an electronic database 
linking the neonatal and perinatal medical record. The database was also used to determine delivery 
mode at birth.  
DNA extraction and sequencing 
Before their study visit, a subsample (described above) of participants were asked for a 
microbiome stool sample.  If they agreed to provide a sample, they were sent instruc ions as well as a 
Fisher Scientific BBL™ CultureSwab™ kit, a dual swab system for the sterile collection and 
transport of fecal microbiological samples. Participants were asked to take the sample as close as 
possible to the time of the in-person visit.  The samples were frozen at the time of the interview and 
stored at -800 F.  DNA was extracted using the standard Power Soil Kit protocol (MoBio). Extracted 
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DNA was PCR amplified with barcoded primers targeting the V4 region of 16S rRNA as detailed in 
Yatsunenko et al.53 Control water samples that had undergone the same DNA extraction and PCR 
amplification procedures were also sequenced. Each PCR product was quantified using PicoGreen 
(Invitrogen), and equal amounts (ng) of DNA from each sample were pooled and cleed using the 
UltraClean PCR Clean-Up Kit (MoBio). Sequences were generated on a MiSeq personal sequencer 
(Illumina, San Diego, CA). 
Denoising and OTU picking 
Reads were first quality filtered and trimmed to a uniform length based on average position of 
first low quality base pair among all samples. DADA2133 was then run on default parameters to 
denoise the data and find exact sequence abundances across samples. These sequences were then used 
as input for open reference OTU picking using QIIME 1.973 with a 99% identity threshold to 
determine OTUs.  Greengenes 13.8 was used as a reference database of near-full length sequences,61 
and unassigned sequences were clustered into de novo OTUs using UCLUSTref.62 Analyses were 
standardized at the minimum sequence depth, 2537 sequences per sample, to avoid biases.  The OTUs 
were summarized at the most specific known level of taxonomy for all analyses of taxonomic 
composition. 
Statistical Methods 
We compared demographic characteristics by NAFLD status using chi-squared tests for 
categorical variables and Wilcoxon rank-sum tests for continuous variables.  We defined NAFLD 
using the same cutoff as typically used for adults to define mild steatosis: HFF>5%.130,131  Alpha 
diversity and UniFrac principal coordinates analyses (PCoA) were conducted using QIIME. 
Alpha diversity 
We used linear regression models to examine the association between alpha diversity of gut 
microbiota, using Shannon Diversity Index, and hepatic fat fraction (HFF).  We chose Shannon 
Diversity because it gives equal weight to evenness and richness.  We used a square root 
transformation in order to normalize HFF to meet the assumptions of linear regressions.  We 
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controlled for sex, age, race/ethnicity, parental education, exposure to gestational diabetes in utero 
and delivery method at birth. We also considered the inclusion of parental income, but it was highly 
collinear with parental education and showed a weaker ssociation with the outcome.   
Taxonomic composition 
In order to understand the interrelationships of the taxa, we used the graphical lasso 
technique134 as implemented in the R package qgraph,135 calculating the correlation using the 
Pearson’s correlation as input to the R function ccrepe,136 which was designed specifically for sparse 
compositional data such as these.  The minimum prevalence threshold for applying the ccrepe 
function was nonzero abundance in >10 samples, and we used this same cutoff for all analyses 
involving the gut microbiota taxa.  
Evaluation of association between HFF and taxonomic composition  
We used the R package VSURF (Variable Selection using Random Forests)111 for feature 
selection on 1) taxa meeting the minimum threshold of presence in >10 samples (N=76, pictured in ); 
2) dietary total daily kilocalories and the following macronutrients as percent of total intake: total fat, 
saturated fat, polyunsaturated fat, monounsaturated fat, total protein, total carbohydrates, sugars, 
soluble fiber, and insoluble fiber; 3) demographic and comorbid conditions: sex, age, race/ thnicity, 
parental income, parental education, exposure to gestational diabetes in utero, delivery mode at birth 
and current BMI z-score; and 4) the combination all of the these, in order to gain understanding of the 
role of gut microbiota and diet in the generation of hepatic fat, as well as to evaluate whether gut 
microbiota taxa offer an informative and useful biomarker of fatty liver disease in youth. The VSURF 
function is a multi-step algorithm that selects all highly important taxa for the prediction of HFF, 
called the “interpretation” subset, and then reduces that subset to only non-redundant features, the 
“prediction” subset.  We chose to retain all of the features from the “interpretation” subset since we 
were more interested in determining all relevant features than in building the most parsimonious 
model.  We performed a sensitivity analysis for the random forest of dietary nformation, additionally 
71 
 
including meat, fructose, vitamin D, vitamin A, and coffee / tea intake, which may be related to fatty 
liver.124,127   
We used a combination of partial plots, the plotmo137 R graphical package, the 
find.interactions function in the R package RandomForestSRC138 in order to interpret the findings of 
the variable selection process.  Since random forests do not provide regression coefficients, these 
tools are used to understand the direction of the relationships between the predictors and the outcome 
as well as inter- elationships between the predictors.  Whereas a linear regression would fit n y a 
linear relationship between the predictors and the outcome, random forests allow for any type of 
relationship, including complex interactions.  Marginal plots show the unadjusted relationship 
between the predictors and the features, ie all the other features are ignored, as in simple regression.  
Partial plots show the adjusted relationship between the predictors and HFF, ie all the other selected 
features are held constant, as in multiple regression.  We also used repeated cross-validation (3 folds, 
100 repetitions) in the caret112 package in order to evaluate the accuracy of the random forests.   
Sensitivity and specificity  
Predicted HFF was compared to actual HFF, and the specificity and sensitivity were 
calculated for two cutoffs: 1) >5% HFF, corresponding to NAFLD, and 2) >3%, to represent an 
informal cutoff for elevated risk of NAFLD; 25 individuals in the cohort (23%) met this lower cutoff.  
All statistical models were run using R v3.3.2.12 
Results 
Population Characteristics 
Individuals with NAFLD (defined as HFF>5%) were more likely to be Hispanic and were all 
either overweight or obese (Table 9).  Their parents tended to have a lower level of education and 
mothers had higher pre-pregnancy BMI.  Other demographic, comorbidity and dietary information 




In unadjusted models, there was a trend towards lower Shannon Diversity with increas g 
levels of liver fat (β=-0.15, 95% CI -0.33, 0.02; p-value=0.07; Figure 10). The effect became 
statistically significant when controlling for sex, age, race, parental education, exposure to diabetes in 
utero and delivery method at birth (β=-0.20, 95% CI -0.37, -0.03; p-value=0.03).   
Taxonomic Composition 
The fecal microbiota across our samples was dominated by the phyla Firmicutes and 
Bacteroidetes, particularly the genus of Bacteroides, those from the families of Lachnospiraceae and 
Ruminococcaceae, as is typically observed in Western populations (Figure S 6).78,79 Gut microbiota 
taxa of adolescents did not cluster strongly on UniFrac-based PCoA plots according to NAFLD, even 
when accounting for weight group (Figure S 7). 
In order to examine relationships between bacterial taxa, we formed a  n twork using the 
Graphical LASSO technique134 (Figure 11). This network has one large cluster of co- ccurring taxa 
(upper right) that included representatives ofa wide array of phyla, as well as many smaller clusters, 
although the majority of taxa were not in clusters. 
Evaluation of Association Between HFF and Taxonomic Composition, Diet and Comorbidities  
In order to identify features that were associated with hepatic fat, we used a random forest 
feature selection process, the results of which are shown in Figure 12.  The selected subset of gut 
microbiota included 7 taxa (R2: 17.7; 95% CI: 16.0, 19.4): Bilophila, Paraprevotella, Varibaculum, 
Sutterella, Oscillospira, Order RF32 with unclassified genus, and Bacteroides.  Varibaculum was 
highly correlated many other taxa, as indicated by the connected nodes in Figure 11;  Bacteroides 
showed a weak negative correlation with Prevotella copri; and Oscillospira and RF32 were positively 
correlated with each other. 
The selected dietary components explained substantially less of the variation in HFF 
compared with the taxa (R2: 5.2%, 95% CI: 4.4, 6.0) and included percent of monounsaturated fats, 
carbohydrates and total fats.  The sensitivity analysis including additional dietary components 
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performed even worse, and none of the additional dietary components were among the selec ed
features.   
The selected demographic and comorbid features included current BMI z-score and delivery 
mode at birth; these features explained more of the variation in HFFthan the taxa or dietary 
components alone (R2: 26.1%, 95% CI: 24.7, 27.4). The random forests using the combination of all 
of these groups of features had the best accuracy measures, and retained features from th  taxa, diet 
and comorbidities.  The selected subset of features included BMI z-score, percent monounsaturated 
fats, Bilophila and Paraprevotella (R2: 32.0%, 95% CI: 30.3, 33.6). 
In order to provide better interpretations of the findings from Random Forests that are more 
consistent with standard statistical approaches, w  used various plotting methods a  detailed in the 
methods section (Figure S 8-Figure S 12).  The most important features may be positively or 
negatively related to the outcome; or they may be related through complex interactions with each 
other, these findings are summarized in Table 10.   
Most of the taxa highlighted by the random forests correlated positively with HFF, including 
Bilophila, Paraprevotella, Suturella, and RF32.  Bacteroides showed a U-shaped pattern with hepatic 
fraction over levels of abundance; both low and high abundance corresponded to higher hepatic fat, 
while moderate levels corresponded with low hepatic fat. Oscillospira and Varibaculum were 
protective.  The accuracy measures for prediction of HFF based on dietary components alone were 
the worst among the groups of features examined. Furthermore, the selected features are highly 
correlated with each other, which makes it difficult to separate their effects.  With those caveats, the 
adjusted relationships showed protective effects of monounsaturated fats and carbohydrates, and 
positive correlation between percent total fat and HFF.  As would be expected, BMI z-scores 
positively correlated with HFF, but higher BMI was slightly more detrimental for risk for fatty liver 
among vaginal births than cesarean.  
When comparing the predictive accuracy of 1) gut microbiota taxa, 2) dietary components, 3) 
demographic and comorbid information, and 4) the combination of all of these, gut microbiota taxa 
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show important value in terms of the prediction of HFF (igure 12).  Dietary components alone were 
poor for prediction of HFF, but monounsaturated fats were selected for in the combined set of 
features.  The most accurate predictions of HFF included BMI z-scores, as might be expected since 
obesity is a major risk factor for NAFLD. 
Sensitivity and Specificity  
Figure 13 shows the actual versus predicted values of HFF for each random forest (excluding 
the one using only dietary information, since the predictive accuracy was poor), with the points 
colored by categories of HFF and overweight/obese status.   All of these random forests had very high 
specificity for NAFLD, defined as HFF>5% (98-100%).  The combined set of features had the best 
sensitivity (75%), whereas the random forests that included only taxa had the worst sensitivity for 
NAFLD (37.5%).  In contrast, for identifying those at-risk for NAFLD, which was defined using an 
informal cutoff of HFF>3%, the taxa alone actually had the best sensitivity (84.0%).     
We were further interested in the predictive potential of gut microbiota in the subset of 
individuals where BMI does not correspond with HFF – i.e. thin individuals with high HFF and 
overweight/obese individuals with low HFF.  These are colored orange and yellow, respectively, in 
the plots.  It is clear that the inclusion of BMI improves predictions for individuals whose BMI 
correlates with HFF, but it does lead to some overestimation of predicted HFF among 
overweight/obese individuals with HFF in the healthy range (i.e. false positives for being “at-risk”). 
In contrast, among normal weight individuals with HFF in the “at-risk” range, inclusion of BMI led to 
an underestimation of HFF (combined features among this subset of individuals: Sensitivity=14.2%, 
Specificity=85%), whereas the taxa only random forests are more accurate predictors (Sensitivity= 
85.7%, Specificity=90%). 
Discussion 
The gold standard for diagnosis of NAFLD is liver biopsy, which is highly invasive and 
carries some risk of complications.139  Other diagnostic measures include serologic markers, such as 
Cytokeratin-18, and imaging techniques, including MRI (used in this study) and other methods, such 
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as ultrasound and computed tomography (CT). These methods also have drawbacks, such as high 
cost, poor accuracy (particularly sensitivity), and exposure to radiation for CT.139   None of these 
measures are part of routine clinical care.  This is problematic since many people do not have any 
symptoms.  If gut microbiota samples become part of routine clinical care, like bloodwork, then a gut 
microbial biomarker for NAFLD would be very useful, particularly for early stages of liver fat 
accumulation.  In this study of adolescents, our results support the hypothesis that there is an 
association between gut microbiota and hepatic fat fraction, and that gut microbiota taxa have 
potential as a non-invasive biomarker for fatty liver, both alone and in conjunction with other 
information. 
A recent review of non-invasive biomarkers for NAFLD concluded that ultrasound is the best 
option in terms of cost and relative accuracy.139 Across studies, estimates ranged from 59-92% for 
sensitivity and 74-100% for specifi ity for detection of NAFLD.  Our results using gut microbiota 
taxa have comparable accuracy in this set of subjects.  As discussed further in the limitations, follow 
up studies would be necessary to validate our results, and the sensitivity and specificity would likely 
be lower in an independent sample of individuals.  However, our results still provide support that gut 
microbiota may offer potential as a non-invasive biomarker for fatty liver.  Using the combined set of 
features, including BMI z-score, monounsaturated fat, Bilophila and Paraprevotella, the sensitivity 
was 75% and specificity was 99%.  In contrast, for identifying individuals at ri k for NAFLD, the 
accuracy measures were better; the most accurate set of features were the taxa alone with 84% 
sensitivity and 95% specificity.  BMI is a non-invasive measure that correlates well with fatty liver, 
and the inclusion of it in our predictive models improved the accuracy measures for detecting 
NAFLD.  However, for people with higher BMI and low liver fat, as well as people who were normal 
weight with higher liver fat, gut microbiota taxa alone had better accuracy than models including 
BMI.  Clinically, the people with normal weight and higher liver fat may be the most i portant group 
to identify because overweight adolescents may be offered lifestyle interve ions or counseling that 
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aim to curb weight gain, with associated benefits in terms of liver fat, while these would unlikely for 
those who are normal weight. 
We observed lower adjusted alpha diversity with higher hepatic fat, as well as taxonomic 
differences associated with hepatic fat fraction.  Prior study of NAFLD and NASH in pediatric 
populations have shown similar trends of l wer alpha diversity with these conditions relative to 
healthy controls.140,141 While other studies have also hown lower alpha diversity with obesity,3,55 this 
has not been a consistent finding across all studies.80  However, a recent meta-analysis concluded that 
there is a small but significant association.82  Since liver fat and obesity are closely tied, our findings 
may reflect this relationship between obesity and lower alpha diversity.  The inconsistency across 
studies could reflect different physiologic phenotypes of obesity, such as varying degrees of 
metabolic syndrome, liver fat accumulation, etc.  NAFLD may also encompass a fair amount of 
physiological heterogeneity; it predominantly affects overweight and obese people, but not 
exclusively,119 and it encompasses conditions ranging from mild steatosis with no major health effects 
to progressive NASH requiring liver transplantation.142 
Among the microbiota predictive of fatty liver in this study are taxa that metabolize bile acids 
and associate with particular diets.  The gut microbiota play an important role in modulating bile acid 
homeostasis, and bile acids likewise play an important, but not fully understood, role in NAFLD.122  
Bilophila was positively correlated with HFF in our study and thrives in the presence of bil , 
specifically taurine conjugated bile.143  Interestingly, the bile acid pool shifts towards taurine 
conjugation in response to a diet high in taurine, which is predominantly in animal products.144 One 
species of Bilophila in particular, B. wadworthia, has been consistently seen across studies as 
enriched in response to Western diets or th se high in fat,145,146 and is also linked to Th1-mediated 
intestinal inflammation;145 it is thought that its by-products of hydrogen sulfide and secondary bile 
acids may degrade the gut mucosal barrier.145,147,148  Oscillospira and Bacteroides are also associated 
with diets high in animal products,96,97  and are likewise highly bile tolerant.  However, these 
microbes showed different patterns in their relationships with HFF in our study.    
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Oscillospira was negatively related to HFF.  This is not surprising since Oscillospira is 
generally associated with leanness and health,149 increases with fasting in animal models,150 and has 
previously been seen to be reduced with NAFLD and NASH in other pediatric populati ns.140,141  
However, its functions in the gut are not well understood.149  Interestingly, the positive association 
between HFF and Bilophila was only observed at low levels of Oscillospira (Figure S 9).  These 
microbes were not mutually exclusive; some individuals did have high levels of both Oscillospira and 
Bilophila. Since this is a cross-sectional epidemiologic study, we cannot offer conclusions about the 
biological underpinnings of this relationship, but it is possible that if Bilophila contributes toward 
fatty liver, Oscillospira counteracts its effects in some way. 
High levels of HFF were seen at both very low and very high abundance of Bacteroides, 
whereas moderate HFF corresponded with moderate abundance of Bacteroides.  Bacteroides is very 
common in the human gut, and has been associated with a “Western Diet”53 but certain species of 
Bacteroides have also been negatively associated with obesity.80 
Like Oscillospira, Varibaculum showed a protective association with HFF.  It was not 
detected in the majority of individuals in this cohort and was always in low abundance (<0.75%).  
According to data from the Human Microbiome Project, a study of the microbiomes f healthy 
individuals,151,152 this genus is more common in skin and vaginal samples than in the gut.    The 
network analysis (Figure 11) shows that Varibaculum is highly correlated with numerous other taxa, 
so our result may reflect the combined effects of co-o curring microbiota, such as Finegoldia, 
WAL_1855D and microbiota from the family Mogibacteriaceae.  
Dietary components were not highly predictive of hepatic fat without other information.  
Monounsaturated fat, total fat and carbohydrates wre highly correlated with each other; thus, it is 
difficult to disentangle their effects.  The protective effect of monounsaturated fat was the most 
consistent association, and agrees with prior research about the protective effects of this type of fat for 
cardiometabolic diseases.127 Given that many of the taxa that were associated with HFF in our results 
are also associated with diets high in animal products, it is somewhat surprising that dietary 
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components were not more predictive of fatty liver.  Total fat was selected as important, which might 
correlate with a diet high in animal products, but other indicators of a diet high in animal products, for 
example protein, saturated fats, or meat were not selected. 
This study has some important limitations.  Since it is cross-sectional, we cannot draw any 
conclusions about the direction of associations between gut microbiota and liver fat.  The highlighted 
taxa may contribute towards fatty liver or may be the result of obesity and fatty liver.  However, the 
use of gut microbiota taxa as a biomarker for disease leverages the associations between taxa and 
fatty liver independent of the direction of these relationships.  We identified numerous taxa that may 
prove to be important components of such biomarkers, but in order to derive an accurate biomarker, a 
study would need to have longitudinal data and be powered to examine differences in predictive 
accuracy by subgroups, such as race or sex.  It would also be useful to examine the differences in the 
predictive accuracy of the gut microbiota of samples taken with and without fasting.  The high 
prevalence of exposure to gestational diabetes in this cohort could also have biased the results.  One 
methodological limitation is that we did not explicitly separate the data into a training set and test set 
for the random forests due to a relatively small number of individuals with NAFLD.  However, we 
were able to estimate the error rates of the random forests using 3-fold repeated cross-validation, 
which repeatedly separates two-thirds of the data into a training set, using the remaining third as a test 
set.  
There are many strengths of this study as well.  We have a measure of hepatic fat from MRI 
scans on over 100 adolescents, dietary information from a questionnaire designed specifically for 
children, and a good distribution of weight groups across values of hepatic fat.  We used machine 
learning methods, which are particularly suited to the analysis of complex gut microbiota data.56   
Conclusions 
Our results show associations of the microbiota diversity and composition with fatty liver in 
adolescents.  The taxa highlighted in our results support the notion that gut microbiota taxa may play 
a role in the pathogenesis of NAFLD, possibly through interactions with bile acid metabolism.  
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Furthermore, our results suggest that the gut microbiota may offer potential as a non-invasive early 







Table 9. Demographic, comorbidity, and dietary information for adolescents in the EPOCH cohort, by NAFLD 
status (defined as HFF>5%) 
 
Variable NAFLD = 0 NAFLD = 1
(N=99) (N=8)
Male 55 (51.4%) 50 (50.5%) 5 (62.5%) 0.72
Race
Non-Hispanic White 52 (48.6%) 49 (49.5%) 3 (37.5%) 0.02
Hispanic 40 (37.4%) 35 (35.4%) 5 (62.5%)
Non-Hispanic Black 12 (11.2%) 12 (12.1%) 0 (0.0%)
Non-Hispanic Other 3 (2.8%) 3 (3.0%) 0 (0.0%)
Parental Education Level
High School 15 (14.0%) 11 (11.1%) 4 (50.0%) 0.001
Some college/Associate degree 33 (30.8%) 31 (31.3%) 2 (25.0%)
Bachelor's degree 31 (29.0%) 29 (29.3%) 2 (25.0%)
Graduate degree 28 (26.2%) 28 (28.3%) 0 (0.0%)
Household income
$16,000 through $34,999 4 (3.7%) 4 (4.0%) 0 (0.0%) 0.02
$35,000 through $74,999 40 (37.4%) 34 (34.3%) 6 (75.0%)
$75,000 or more 59 (55.1%) 57 (57.6%) 2 (25.0%)
Don't know/Missing 4 (3.7%) 4 (4.0%) 0 (0.0%)
Delivery Mode
C-section 25 (23.4%) 24 (24.2%) 1 (12.5%) 0.68
Vaginal 82 (76.6%) 75 (75.8%) 7 (87.5%)
Exposure to DM in utero 30 (28.0%) 28 (28.3%) 2 (25.0%) 0.99
Pre-pregnancy BMI 26.1 (22.8-30.3) 25.9 (22.5-30.3) 30.9 (25.8-38.4) 0.007
In person visit
Age (years) 15.6 (15.1-16.5) 15.7 (15.1-16.5) 15.6 (15.6-16.4) 0.16
BMI 22.5 (19.8-26.0) 21.9 (19.5-24.9) 32.2 (27.6-36.0) <.001
BMI-for-age Z 0.5 (-0.3 to 1.5) 0.4 (-0.3 to 1.2) 2.0 (1.7-2.5) <.001
Hepatic Fat Fraction 2.0 (1.4-2.8) 1.9 (1.3-2.5) 7.7 (6.0-8.5) <.001
Diet
Kilocalories 1,547 (1,217-2,078) 1,567 (1,217-2,091) 1,497 (1,085-1,899) 0.5
% Carbohydrates 48.6 (44.2-52.3) 48.6 (43.7-52.3) 48.1 (44.8-52.3) 0.22
% Added Sugars 24.6 (20.5-28.2) 24.5 (20.5-28.2) 25.1 (19.8-28.4) 0.43
% Fiber 3.0 (2.5-3.9) 3.0 (2.5-3.9) 2.6 (2.4-3.8) 0.72
% Insoluble Fiber 1.9 (1.5-2.5) 2.0 (1.5-2.5) 1.6 (1.5-2.4) 0.68
% Soluble Fiber 1.1 (0.9-1.4) 1.1 (0.9-1.4) 1.0 (0.9-1.3) 0.54
% Fat 38.0 (34.4-41.8) 38.0 (34.4-41.8) 37.1 (34.0-40.1) 0.16
% SFA 13.5 (11.9-15.3) 13.4 (11.9-15.0) 14.2 (12.4-15.4) 0.71
% PUFA 5.7 (4.8-6.7) 5.8 (4.8-6.8) 5.0 (4.5-5.7) 0.10
% MUFA 15.4 (13.7-16.8) 15.5 (13.7-16.8) 14.7 (13.6-15.8) 0.15
% Protein 34.2 (31.3-38.3) 34.2 (31.2-38.2) 35.9 (32.7-40.3) 0.53
Vitamin D (calciferol) mcg 3.3 (1.6-7.4) 2.9 (1.5-7.6) 4.7 (3.0-5.5) 0.67
Retinol mcg 394.4 (230.8-651.6) 394.4 (230.8-661.2) 370.2 (267.3-587.3) 0.47
Meat (servings/day) 1.0 (0.6-1.5) 1.0 (0.6-1.5) 1.0 (0.8-1.5) 0.60
Coffee & tea (servings/day) 0.0 (0.0-0.3) 0.0 (0.0-0.3) 0.1 (0.0-1.0) 0.34
Fructose (g) 20.8 (13.6-28.9) 21.1 (13.6-30.5) 16.8 (12.7-24.2) 0.28
Total (N=107) P-Value
N (%) or Median (IQR)
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Table 10. This table summarizes the general relationships between hepatic fat fraction (HFF) and the features 
selected in the random forests for the prediction of HFF.  Plots are used to understand the direction of he 
relationships between the predictors and the outcome, as well as the inter-r lationships between the predictors, 
since random forests do not provide regression coefficients; the partial and interaction plots showing these 
relationships in detail are in the supplemental figures.  Since random forests allow for complex interactions 
between the predictors, this table notes when there is no evidence of strong 2-way interactions and notes the 
interacting features when there is evidence of interactions.  In order to fully understand the nature of these 
interactions, please see the supplemental figures. 
 
Group Selected Features Adjusted association 
with HFF
Interactions?




g_Bilophila Positive Bacteroides, 
Oscillospira, 
g_Oscillospira Negative Bilophila
g_Bacteroides U-shaped: High HFF with 
low and high abundance, 
low HFF with moderate 
abundance
Bilophila
Diet % Carbohydrates Negative % MUFA
% Total fat Positive % MUFA
% MUFA Negative Carbohydrates, Total 
fat
BMI z-score Positive Delivery mode
Delivery mode Higher HFF with vaginal 
birth
BMI
Combined Features g_Bilophila Positive Paraprevotella
g_Paraprevotella Positive Bilophila,  % MUFA








Figure 10. The relationship between hepatic fat fraction (HFF) with square root transformation and Shannon 
Diversity Index of gut microbiota of adolescents in the EPOCH cohort.  Shannon diversity is significantly lower 
with higher HFF, when controlling for race/ethnicity, sex, age, parent l ducation, exposure to diabetes in utero 




Figure 11. This network depicts all the gut microbiota taxa present in at least 10 adolescents in the EPOCH 
cohort and their interrelationships.  Connected taxa are correlated; positive correlations are shown with green 
lines and negative correlations with red lines.  The width of the connectig lines represents the strength of 
association.  The taxa that were selected by random forests as most relevant to the outcome of hepatic fat 





Figure 12. This figure shows the results of feature selection procedures that choose the most important 
features for the prediction of hepatic fat fraction (HFF) in adolescents in the EPOCH cohort.  Four groups of 
variables were explored: gut microbiota taxa, dietary components, comorbidities & demographic variables, 
and the combination of all these.  For each group of variables, we indicate the select d features and amount of 
variation in HFF that is explained (R2 and the 95% confidence interval, CI). 
Figure 13. Plots of Hepatic Fat Fraction (HFF) versus predicted HFF from the random forest eature selection 
processes.  Illustrated here are predictions based on: 7 taxa: Bilophila, Paraprevotella, Varibaculum, Sutterella, 
Oscillospira, RF32, and Bacteroides (left); 2 demographic and comorbidities: BMI z-score and delivery mode at 
birth (middle); 4 features selected from the combined set of taxa, dietary compoenents and demographic/comorbid 
information: Bilophila, Paraprevotella, BMI z-score and dietary % monounsaturted fats (right).  Each plots 
shows the sensitivity and specificty of the predicted values at the cutpoint for NAFLD (>5% HFF), as well as at a 
lower cutoff to represent elevated risk for NAFLD (>3% HFF). 
84 
 
CHAPTER VII  
DISCUSSION 
The rapid increase in prevalence of obesity around the world in recent decades is a major 
public health concern.  Obesity increases risk for numerous diseases, including diabetes, 
cardiovascular disease, and cancers, and it is also a major risk factor for the development of non-
alcoholic fatty liver disease (NAFLD), which is among the most common causes of chronic liver 
disease.117  Together these diseases are a serious burden to the healthcare system and have vast 
economic consequences.  One recent study estimated that the combined annual medical costs of 
obesity-related illnesses are $190.2 billion, accounting for about 21% of all healthcare costs in the 
United States.153  Childhood obesity alone is responsible for about $14 billion in medical costs.153  
Unfortunately, there is a notable lack of success stories in the battle to significantly reduce obesity 
rates at the population level.154  Given the substantial consequences of obesity and cardiometabolic 
diseases, it is important to identify more effective ways to prevent the development of obesity and to 
curb the progression of cardiometabolic conditions, particularly in youth. 
Research about the role of the gut microbiome in obesity and related conditions has increased 
rapidly in recent years.  It has broadened our understanding of the etiology of obesity, and t may 
offer potential in terms of interventions to prevent or treat cardiometabolic conditions, or to provide 
early biomarkers that may help to attenuate their progression.  This work focused on the role of gut 
microbiota in cardiometabolic conditions in populations with particular potential in terms of 
prevention: pregnant women, infants, and teens.   
The first two aims of this dissertation used a single Norwegian birth cohort in order to 
investigate the gut microbiota as a mechanism to explain the association of obesity across 
generations.  In the first aim, we focused predominantly on the maternal gut microbiota and how it 
differs with pre-pregnancy overweight / obesity (OW/OB) and excessive gestational weight gain 
(GWG).  The second aim largely focused on the infant gut microbiota over the firs  two years of life, 
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examining how it relates to later childhood BMI, and whether maternal OW/OB plays a role in 
shaping the infant gut microbiota predictive of later BMI.   
Evidence from both animal and human studies suggest that the gut microbiota may play a 
causal role in obesity and related metabolic conditions.5,35,36 Differences in the gut microbiota have 
been associated with obesity in many studies,80 and these differences may be sustained or accentuated 
throughout pregnancy.8,34  Our results support that maternal gut microbiota at the time of delivery 
differs by pre-pregnancy OW/OB and excessive gestational weight gain (GWG) status.  Many of the 
taxonomic differences that we found were consistent with prior studies of obesity and were reflected 
in similar differences seen in the infant gut microbiota at 10 days of life, supporting that these taxa 
may be vertically transferred.  Prior research has also shown both substantial evidence of vertical 
transfer of maternal gut microbiota during birth and persistence of the maternal strains over the first 
year of life.93 Thus, the differences that we found in the maternal gut microbiota with these exposures 
may be passed on to the infant.  These differences may also have programming effects on th  fetus 
during pregnancy; animal models suggest that maternal gut microbiota may impact the innat  immune 
and metabolic systems of the fetus.21 
Despite the differences that we found in maternal gut microbiota at the time of delivery 
associated with maternal OW/OB, we did not find a distinctive taxonomic signature in the early infant 
gut microbiota associated with this exposure.  This is not altogether surprising; infant gut microbiota 
changes drastically over the first few years of life, differs substantially across infants, and is affected 
strongly by other factors, including mode of delivery, breastfeeding, and antibiotic usage.31,107  
However, the infant gut microbiota over the first two years of life was highly predictive of BMI at age 
12, and the subset of taxa associated with later BMI showed some consistent associations with 
maternal OW/OB status.  The maternal gut microbiota at the time of delivery also showed taxonomic 
similarities with the infant gut microbiota predictive of childhood BMI.   These results support that 
the gut microbiota may be a mechanism to explain the transgenerational transmission of obesity risk.  
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We also examined the longitudinal trends in BMI z-scores throughout infancy and childhood.  
This analysis showed that the children who were OW/OB at age 12 did not have higher BMI z-scores 
at age 2 than the children who were not OW/OB at 12.  Thus, the gut microbiota taxa at age 2 that 
were predictive of later childhood BMI preceded excessive weight gain in the children.  This is an 
important finding because it suggests that the gut microbiota may have potential as a biomarker that 
could identify children who are at risk for development of childhood obesity, which could allow for 
more targeted obesity prevention efforts. 
In the third aim of this dissertation, we examined an outcome that is closely related to 
obesity: non-alcoholic fatty liver disease (NAFLD).  While not all people with fatty liver are 
overweight or obese, obesity is among the strongest risk factors for NAFLD.119 NAFLD is a growing 
problem among pediatric populations, in large part due to the prevalence of obsity.118 However, this 
condition is typically asymptomatic, and many of the diagnostic tools for NAFLD are highly 
invasive, expensive, or carry risks for complications.139 Since recent evidence suggests that the gut 
microbiota may be involved in the accumulation of liver fat,122,123 we examined whether the gut 
microbiota would have potential as an early biomarker for NAFLD.  We found that he gut microbiota 
was strongly associated with epatic fat fraction, particularly in conjunction with BMI and dietary 
information.  If the collection of fecal samples becomes part of routine clinical care, the gut 
microbiota may offer potential as part of a biomarker for the preliminary diagnosis of NAFLD.  Since 
obesity is such a strong predictor for NAFLD, and since NAFLD tends to be asymptomatic, one of 
the most challenging groups of people to identify early as at-ri k for NAFLD is those who are normal 
weight.  We saw that the gut microbiota had very good sensitivity and specificity for this group of 
people, suggesting a clear advantage to this type of biomarker.   
This part of our study was entirely cross-sectional, so we could not draw any causal 
conclusions, and the taxa ssociated with fatty liver may actually be the result of fatty liver.  
However, the use of gut microbiota taxa as a non-invasive biomarker for NAFLD is not dependent on 
the direction of these relationships.  Furthermore, some of the taxa highlighted in our results may 
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provide candidates for fut re studies aiming to understand the role of gut microbiota in the etiology of 
NAFLD, such as Oscillospira.  This genus was negatively related to hepatic fat in our study.  
Bilophila showed the opposite relationship with hepatic fat but, interestingly, only at low levels of 
Oscillospira.  Other research has also shown lower levels of Oscillospira among people with 
NAFLD.141  While the functions of this genus are not fully understood, it is generally associ ted with 
leanness and health149  Thus, further functional studies of this genus, as well as its potential for 
protecting against NAFLD, may be warranted. 
In the coming era of personalized medicine in which healthcare decisions and tre tment are 
guided by personal data, the work in this dissertation supports that the gut microbiota will likely offer 
potential for prevention, treatment and diagnosis of cardiometabolic conditions.  However, there are 
still many important questions that need to be answered. Before probiotic interventions can be 
effectively and safely applied during pregnancy, further longitudinal studies of the gut microbiota 
during pregnancy are necessary.  Prior research has disagreed about whether the maternal gut 
microbiota is stable over the course of pregnancy or highly dynamic.33,70  This is important to 
understand because the maternal gut microbiota may have fetal programming effects,21 and variation 
in the maternal gut microbiota may reflect temporal dynamics in these effects. 
Many women currently take probiotics during pregnancy; they are added to some brands of 
prenatal vitamins.  Typically, these supplements are predominantly Lactobacillus and 
Bifidobacterium.  Evidence suggests that these bacteria are gen rally safe during this time, and 
numerous studies have also shown that maternal probiotics may reduce risk for atopic dermatitis in 
the infant.155  Our work suggests that some types of Bifidobacterium may also be protective against 
obesity, however, we also found that one OTU of Bifidobacterium bifidum was associated with igher 
childhood BMI.  Strains of B. bifidum are often included in prenatal and infant probiotic supplements.  
Thus, it is important to further investigate the effects of B. bifidum to assess whether our results were 
spurious or if some strains could have detrimental effects.  
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Similarly, more research is necessary before it is prudent, safe and effective to significantly 
intervene on the gut microbiota of infants in early life for the goal of obesity prevention.  The gut 
microbiota of infants play an important role in programming the immune and metabolic systems.6,156  
As is the case for pregnant women, many babies are currently given probiotics, typically strains of 
Lactobacillus and Bifidobacterium.  Bifidobacterium is a major component of the early infant gut, 
while Lactobacillus tends to be much lower in relative abundance.  However, neither of these taxa are 
constant in relative abundance over the first few years of life; the taxonomic composition of infants is 
extremely dynamic.31,107 Consistently administering the same probiotics over the first years of life 
may alter or stabilize those dynamics, which may have unintended consequences for immune and 
metabolic programming.  These effects would likely be difficult to isolate in human observational 
studies, but experimental studies in animal models could help to elucidate the consequences of 
different methods of interventions on the gut microbiota in early life, and whether probiotic cocktails 
could help to prevent excessive weight gain. 
Diet plays a large role in shaping the gut microbiome.96,97  There may be interactions between 
the diet and the microbiota in their effects on obesity,5 which begets the question: would interventions 
to prevent obesity and related conditions be effective in the context of a poordiet?  Current research 
suggests that certain interventions would likely still be effective.  For example, probiotics have shown 
benefits in terms of counteracting the pro-inflammatory effects of a poor diet in mice,38 as well as 
protection against weight gain and metabolic abnormalities in studies of diet-induced obesity.94,95  
Prebiotics may also be advantageous, independent of diet.  Prebiotics shift the gut microbiota 
composition and have shown positive effects on gut permeability, inflammation, body weight, fat 
mass accumulation, glucose homeostasis, lipid metabolism and leptin sensitivity in he context of 
obesity and type 2 diabetes.157  Furthermore, studies of the gut microbiota and diet may help to 
improve the effectiveness of dietary interventions.  Dietary changes tend to have inconsistent and 
highly individualized effects on metabolism, but a recent study of microbial biomarkers for dietary 
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responsiveness in obese individuals concluded that the gut microbiota may have potential to guide 
more effective personalized dietary recommendations.158 
The long-term public health goal of the lines of research in this dissertation re two-fold: to 
prevent obesity and cardiometabolic conditions in youth and to reduce associated morbidities.  At this 
point in time, the primary avenues towards these goals would be through gut microbiota-based 
interventions or early clinical biomarkers.  As described above, there are still many unanswered 
research questions about how to safely and effectively intervene on maternal gut microbiota during 
pregnancy or on infant gut microbiota in early life.  However, the maternal gut microbiota near the 
time of delivery may offer a relatively safe window to intervene.  The gut microbiota may also be an 
important aspect of early clinical biomarkers for cardiometabolic conditions in the future.  In order 
for interventions or biomarkers to be broadly applied in diverse populations, it is important to 
understand the variation in the relationships between the gut microbiota and these conditions across 
heterogeneous populations.  Race / ethnicity associates strongly with the gut microbiota in healthy 
individuals,78 as does geography.53,116  Understanding these types of population-level patterns is an 
important role for epidemiologists, who are trained to investigate these kinds of complex 
relationships.  Despite these challenges and the need for further studies, I b lieve that both gut 
microbiota-based interventions and clinical biomarkers for cardiometabolic conditions are in the 
foreseeable future as the result of the work of the many scientists across diverse disciplines working 
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APPENDIX A  
SUPPLEMENTARY MATERI AL FOR CHAPTER IV: MATERNAL GUT MICROBIOTA 








Weight Gain (lbs / kg)
Underweight <18.5 28–40 lbs / 13-18 kg
Normal weight 18.5-24.9 25–35 / 11.5-16 kg
Overweight 25.0-29.9 15–25 lbs / 7-11.5 kg
Obese ≥30.0 11–20 / 5-9 kg
Table S 1. Institute of Medicine's recommended range of adequate gestational weight gain based on 
pre-pregnancy BMI; weight gain less than the recommended range was considered “low” and greater 










22.9 (21.2-25.3) 22.5 (21.1-25.1) 23.1 (21.2-25.4) 0.84
Pre-pregnancy BMI category
Underweight 5 (4.3%) 4 (7.5%) 1 (1.6%) <.001
Normal 77 (66.4%) 35 (66.0%) 42 (66.7%)
Overweight 25 (21.6%) 8 (15.1%) 17 (27.0%)
Obese 9 (7.8%) 6 (11.3%) 3 (4.8%)
Overweight / Obese 34 (29.3%) 14 (26.4%) 20 (31.7%) 0.53
96 (84.2%) 47 (88.7%) 49 (80.3%) 0.30
<12yrs education 4 (3.6%) 2 (3.9%) 2 (3.3%) 0.06
12yrs education 16 (14.4%) 6 (11.8%) 10 (16.7%)
>12yrs education 91 (82.0%) 43 (84.3%) 48 (80.0%)
31.0 (28.0-34.0) 31.0 (28.0-35.0) 30.0 (27.0-33.0) 0.28
No prior pregnancies 53 (45.7%) 19 (35.8%) 34 (54.0%) 0.12
1 prior child 41 (35.3%) 21 (39.6%) 20 (31.7%)
>1 prior child. 22 (19.0%) 13 (24.5%) 9 (14.3%)
11 (6.5%) 8 (6.8%) 3 (5.8%) 1
Never smoker 82 (71.3%) 38 (71.7%) 44 (71.0%) 0.02
Past smoker 25 (21.7%) 12 (22.6%) 13 (21.0%)
Occasional 5 (4.3%) 2 (3.8%) 3 (4.8%)
Daily smoker <=10 3 (2.6%) 1 (1.9%) 2 (3.2%)
No Diabetes 115 (99.1%) 53 (100.0%) 62 (98.4%) 1
T1 1 (0.9%) 0 (0.0%) 1 (1.6%)
15 (8.9%) 8 (6.8%) 7 (13.5%) 0.16
9 (7.8%) 3 (5.7%) 6 (9.5%) 0.51
Gestational Weight Gain (kg) 15.0 (12.0-18.9) 11.7 (8.0-14.0) 18.0 (17.0-22.0) <.001
284.0 (277.0-287.5) 282.0 (275.0-286.0) 284.0 (277.0-288.0) 0.21
3.58 (3.31-3.87) 3.44 (3.23-3.69) 3.74 (3.38-4.0) 0.003
24 (20.7%) 9 (17.0%) 15 (23.8%) 0.37
31 (27.2%) 14 (26.4%) 17 (27.9%) 1
Day of Birth 3 (2.6%) 1 (1.9%) 2 (3.3%) 1
Day before Birth 1 (0.9%) 0 (0.0%) 1 (1.6%) 1
Week before Birth 3 (2.6%) 1 (1.9%) 2 (3.3%) 1.00
Month before Birth 7 (6.1%) 1 (1.9%) 6 (9.8%) 0.12
>Month before Birth 18 (15.8%) 11 (20.8%) 7 (11.5%) 0.2
5 (4.4%) 0 (0.0%) 5 (8.2%) 0.06
Alpha Diversity
Shannon 5.8 (5.3-6.1) 5.8 (5.2-6.2) 5.7 (5.3-6.1) 0.54
N Observed Species 371.0 (311.5-403.0) 373.0 (309.0-412.0) 369.0 (312.0-393.0) 0.82
PD Whole Tree 28.0 (23.8-30.8) 28.2 (23.8-31.0) 27.6 (23.6-30.6) 0.99
Variable













Maternal Smoking at Beginning of Pregnancy
Diabetes
Glucose in urine




Table S 3. Results of Beta-Binomial Models for the most important OTUs from random forests (RF) to classify 
women based on pre-pregnancy weight group.  Taxonomy indicates the green genes taxonomy. Adjusted p-
values account for the following maternal characteristics: maternal age, maternal education, Norwegian 











p_Firmicutes;c_Clostridia;o_Clostridiales;f_Lachnospiraceae;g_Lachnospira ↓ -0.625 0.001 0.001 1
p_Firmicutes;c_Clostridia;o_Clostridiales;f_Christensenellaceae;g_ ↓ -0.630 0.002 0.003 4
p_Firmicutes;c_Clostridia;o_Clostridiales;f_[Tissierellaceae];g_Finegoldia ↓ -1.206 0.013 0.004 5
p_Actinobacteria;c_Actinobacteria;o_Bifidobacteriales;f_Bifidobacteriaceae;g_Bifidobacterium ↓ -0.226 0.124 0.056 2
p_Firmicutes;c_Clostridia;o_Clostridiales;f_Ruminococcaceae;g_Faecalibacterium ↓ -0.223 0.150 0.158 3
p_Bacteroidetes;c_Bacteroidia;o_Bacteroidales;f_Porphyromonadaceae;g_Parabacteroides ↓ -0.233 0.255 0.167 7
p_Firmicutes;c_Clostridia;o_Clostridiales;f_Ruminococcaceae;g_ ↓ -0.088 0.487 0.382 8
p_Firmicutes;c_Clostridia;o_Clostridiales;f_Clostridiaceae;g_02d06 ↑ 0.069 0.720 0.471 6
Table S 4. Results of Beta-Binomial Models for most important genera from random forests (RF) to classify 
women based on pre-pregnancy weight group.  Adjusted p-values account for the following maternal 









198636 p_Firmicutes; c_Clostridia; o_Clostridiales; f_Lachnospiraceae; g_Blautia; s_ ↑ 0.366 0.012 0.007 10
505670 p_Firmicutes; c_Clostridia; o_Clostridiales; f_[Tissierellaceae]; g_WAL_1855D; s_ ↑ 1.880 0.014 0.007 5
199575 p_Firmicutes; c_Clostridia; o_Clostridiales; f_Lachnospiraceae; g_Blautia; s_ ↑ 0.429 0.040 0.019 6
152450 k_Archaea;p_Euryarchaeota;c_Methanobacteria;o_Methanobacteriales;f_Methanobacteriaceae;g_Methanobrevibacter ↑ 0.555 0.058 0.072 7
185420 p_Bacteroidetes; c_Bacteroidia; o_Bacteroidales; f_Bacteroidaceae; g_Bacteroides; s_ ↓ -0.467 0.090 0.056 4
359314 p_Firmicutes; c_Clostridia; o_Clostridiales; f_Ruminococcaceae; g_Faecalibacterium; s_prausnitzii ↑ 0.317 0.106 0.086 3
354334 p_Firmicutes; c_Clostridia; o_Clostridiales; f_Ruminococcaceae; g_; s_ ↑ 0.198 0.230 0.128 1
316496 p_Firmicutes; c_Clostridia; o_Clostridiales; f_Clostridiaceae; g_SMB53; s_ ↑ 0.094 0.601 0.346 9
352347 p_Firmicutes; c_Clostridia; o_Clostridiales; f_Ruminococcaceae; g_; s_ ↑ 0.072 0.657 0.545 2
365385 p_Actinobacteria; c_Actinobacteria; o_Bifidobacteriales; f_Bifidobacteriaceae; g_Bifidobacterium; s_b ↑ 0.041 0.872 0.788 8
OTU Taxonomy
OW/OB 





4434334 p_Firmicutes; c_Clostridia; o_Clostridiales; f_Clostridiaceae; g_; s_ ↓ -0.464 0.006 0.007 1
847228 p_Bacteroidetes; c_Bacteroidia; o_Bacteroidales; f_Porphyromonadaceae; g_Parabacteroides; s_ ↓ -0.720 0.011 0.009 12
192015 p_Firmicutes; c_Clostridia; o_Clostridiales; f_; g_; s_ ↑ 0.388 0.013 0.003 7
1096610 p_Firmicutes; c_Clostridia; o_Clostridiales; f_[Tissierellaceae]; g_Finegoldia; s_ ↓ -1.170 0.016 0.005 9
2979308 p_Firmicutes; c_Clostridia; o_Clostridiales; f_Ruminococcaceae; g_Ruminococcus; s_ ↓ -0.600 0.022 0.015 3
194443 p_Firmicutes; c_Clostridia; o_Clostridiales; f_Ruminococcaceae; g_; s_ ↓ -0.493 0.027 0.037 10
813479 p_Actinobacteria; c_Actinobacteria; o_Bifidobacteriales; f_Bifidobacteriaceae; g_Bifidobacterium; s_ ↓ -0.468 0.030 0.023 11
195759 p_Firmicutes; c_Clostridia; o_Clostridiales; f_Lachnospiraceae; g_; s_ ↑ 0.319 0.060 0.022 5
173876 p_Firmicutes; c_Clostridia; o_Clostridiales; f_; g_; s_ ↓ -0.347 0.140 0.086 2
194686 p_Firmicutes; c_Clostridia; o_Clostridiales; f_Ruminococcaceae; g_; s_ ↓ -0.219 0.171 0.312 6
194258 p_Firmicutes; c_Clostridia; o_Clostridiales; f_Ruminococcaceae; g_Faecalibacterium; s_prausnitzii ↓ -0.219 0.192 0.228 8
4347159 p_Actinobacteria; c_Actinobacteria; o_Bifidobacteriales; f_Bifidobacteriaceae; g_Bifidobacterium; s_adolescentis ↓ -0.174 0.238 0.211 4
Table S 5. Results of Beta-Binomial Models for the most important OTUs from random forests (RF) to classify 
women based on GWG group.  Taxonomy indicates the green genes taxonomy. Adjusted p-values account for 
the following maternal characteristics: maternal age, matern l education, Norwegian ethnicity, maternal 










vs Non Estimate P-value
Adjusted 
P-value RF Rank
p_Firmicutes;c_Clostridia;o_Clostridiales;f_[Tissierellaceae];g_WAL_1855D ↑ 1.999 0.009 0.004 3
k_Archaea;p_Euryarchaeota;c_Methanobacteria;o_Methanobacteriales;f_Methanobacteriaceae;g_Methanobrevibacter ↑ 0.556 0.058 0.071 2
p_Bacteroidetes;c_Bacteroidia;o_Bacteroidales;f_[Barnesiellaceae];g_ ↓ -0.358 0.185 0.126 4
p_Firmicutes;c_Clostridia;o_Clostridiales;f_Clostridiaceae;g_SMB53 ↑ 0.133 0.450 0.264 5
p_Firmicutes;c_Clostridia;o_Clostridiales;f_Ruminococcaceae;g_ ↓ -0.008 0.948 0.927 1
OTUID Taxonomy
Relationship 





505670 p_Firmicutes;c_Clostridia;o_Clostridiales;f_[Tissierellaceae];g_WAL_1855D ↑ 0.107 0.002 0.002 5
185420 p_Bacteroidetes; c_Bacteroidia; o_Bacteroidales; f_Bacteroidaceae; g_Bacteroides; s_ ↓ -0.061 0.021 0.022 4
359314 p_Firmicutes; c_Clostridia; o_Clostridiales; f_Ruminococcaceae; g_Faecalibacterium; s_prausnitzii ↑ 0.024 0.132 0.098 3
354334 p_Firmicutes; c_Clostridia; o_Clostridiales; f_Ruminococcaceae; g_; s_ ↑ 0.018 0.189 0.106 1
352347 p_Firmicutes; c_Clostridia; o_Clostridiales; f_Ruminococcaceae; g_; s_ ↑ 0.014 0.326 0.238 2
Table S 6. Results of Beta-Binomial Models for the most important genera from random forests (RF) to classify 
women based on GWG group.  Adjusted p-values account for the following maternal characteristics: maternal 
age, maternal education, Norwegian ethnicity, maternal smoking, and parity.
OTUID Taxonomy
Relationship 





196100 p_Firmicutes; c_Clostridia; o_Clostridiales; f_Lachnospiraceae; g_; s_ ↑ 0.069 0.002 0.001 6
360995 p_Firmicutes; c_Clostridia; o_Clostridiales; f_Ruminococcaceae; g_; s_ ↑ 0.042 0.009 0.004 4
847228 p_Bacteroidetes; c_Bacteroidia; o_Bacteroidales; f_Porphyromonadaceae; g_Parabacteroides; s_ ↓ -0.090 0.005 0.005 8
359493 p_Firmicutes; c_Clostridia; o_Clostridiales; f_Lachnospiraceae; g_Blautia; s_ ↑ 0.028 0.086 0.023 1
195759 p_Firmicutes; c_Clostridia; o_Clostridiales; f_Lachnospiraceae; g_; s_ ↑ 0.032 0.093 0.034 2
194443 p_Firmicutes; c_Clostridia; o_Clostridiales; f_Ruminococcaceae; g_; s_ ↓ -0.049 0.044 0.074 5
195674 p_Firmicutes; c_Clostridia; o_Clostridiales; f_Lachnospiraceae; g_; s_ ↑ 0.015 0.356 0.103 3
730906 p_Firmicutes; c_Clostridia; o_Clostridiales; f_Ruminococcaceae; g_; s_ ↓ -0.029 0.176 0.215 7
197080 p_Firmicutes; c_Clostridia; o_Clostridiales; f_Ruminococcaceae; g_; s_ ↑ 0.013 0.474 0.301 11
178478 p_Bacteroidetes; c_Bacteroidia; o_Bacteroidales; f_Bacteroidaceae; g_Bacteroides; s_ ↓ -0.027 0.309 0.397 10
197204 p_Firmicutes; c_Clostridia; o_Clostridiales; f_Ruminococcaceae; g_; s_ ↓ -0.015 0.4903 0.7041 9
Table S 7. Results of Beta-Binomial Models for the most important OTUs from random forests (RF) to predict 
BMI.  Taxonomy indicates the green genes taxonomy. Adjusted p-values account for the following maternal 
characteristics: maternal age, maternal education, Norwegian ethnicity, twins, maternal smoking, and parity. 
Table S 8. Results of Beta-Binomial Models for the most important OTUs from random forests (RF) to predict 
weight gain over the recommended limit (WG).  Taxonomy indicates the green gen s taxonomy. Adjusted p-
values account for the following maternal characteristics: maternal age, maternal education, Norwegian 









Figure S 2. Most abundant a) phylum, b) family and c) genus level taxa in maternal samp es by pre-pregnancy 




Figure S 3. Principal coordinate analysis plots of i) unweighted and ii) weighted UniFrac distance of maternal 
gut microbiota samples 4 days post-partum by a) OW/OB status, b) excessive GWG status, and c) OW/OB and 





SUPPLEMENTARY MATERI AL FOR CHAPTER V: THE ASSOCIATION BETWEEN 
INFANT GUT MICROBIOTA, CHILDHOOD  BMI, AND THE ROLE O F MOTHER’S PRE-
PREGNANCY WEIGHT: A PROSPECTIVE LONGITUD INAL STUDY  
Supplemental methods 
Study Sample 
The study for these analyses includes the 2300 infant gut microbiota samples from 510 
infants (including 31 sets of twins) of 478 mothers in NOMIC for whom maternal height and pre-
pregnancy weight were available.  205 (40.5%) of these infants had mothers who were overweight 
(N=134) or obese (N=71); 305 (59.8%) had mothers who were undrweight (N=25) or normal weight 
(N=280).    
 
Statistical Methods  
Random forests were used for feature selection to identify which OTUs were most important 
to differentiate samples based on exposure status.75 This machine learning approach ranks factors in 
terms of their ability to discriminate exposure status, while taking into account the complex 
interrelationships in high dimensional data.  All OTUs that were present in less than 5% of the 
samples and those with a maximum percent abundance less than 0.1% were grouped into one 
category of “other.”  Breiman’s random forest algorithm75 in the R package randomForest was used 
for classification based on percent abundance of the OTUs, with varselRF76 to choose the subset of 
OTUs important to differentiate exposures status.  We evaluated the classification accuracy of the 
random forest by computing the ratio of the out of bag error from a random forest using these 
important OTUs to classify simulated random data to the error from a similar random forest 
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Table S 10. Association between infant gut microbiota features selected as predictive of BMI z-score at age 12 
and BMI z-score based on linear regressions.  Adjusted models included the following: exclusive breastfeeding, 
delivery mode, antibiotics, gestational age at birth and twin status.  
 
Time Feature Taxonomy Estimate Lower CI Upper CI p-value Estimate Lower CI Upper CI p-value





-0.0797 -0.1488 -0.0106 0.024 -0.0612 -0.1309 0.0084 0.084





0.0006 0.0000 0.0012 0.038 0.0005 -0.00004 0.0011 0.066
OTU198788 k_Bacteria; p_Bacteroidetes; 
c_Bacteroidia; o_Bacteroidales; 
f_Bacteroidaceae; g_Bacteroides; s_
-0.0352 -0.0840 0.0136 0.156 -0.0430 -0.0916 0.0056 0.082
OTU465079 k_Bacteria; p_Firmicutes; c_Bacilli; 
o_Bacillales; f_Planococcaceae; g_; 
s_
-0.0010 -0.0122 0.0102 0.861 0.0005 -0.0107 0.0117 0.934
OTU403068 k_Bacteria; p_Firmicutes; c_Bacilli; 
o_Bacillales; f_Staphylococcaceae; 
g_Staphylococcus; s_
-0.0034 -0.0292 0.0225 0.797 0.0048 -0.0219 0.0315 0.723
OTU439908 k_Bacteria; p_Firmicutes; c_Bacilli; 
o_Bacillales; f_Staphylococcaceae; 
g_Staphylococcus; s_
0.0000 -0.0003 0.0004 0.758 0.0001 -0.0002 0.0004 0.567
OTU898871 k_Bacteria; p_Firmicutes; c_Bacilli; 
o_Bacillales; f_Staphylococcaceae; 
g_Staphylococcus; s_
0.0193 -0.0832 0.1217 0.711 0.0256 -0.0751 0.1263 0.616
OTU944063 k_Bacteria; p_Firmicutes; c_Bacilli; 
o_Bacillales; f_Staphylococcaceae; 
g_Staphylococcus; s_epidermidis
0.1700 -0.0402 0.3802 0.112 0.1997 -0.0095 0.4089 0.061
OTU289933 k_Bacteria; p_Firmicutes; c_Bacilli; 
o_Lactobacillales; f_; g_; s_
-0.1297 -0.2403 -0.0191 0.022 -0.1191 -0.2295 -0.0086 0.035




-0.0344 -0.0939 0.0251 0.255 -0.0437 -0.1041 0.0168 0.156
OTU109478 k_Bacteria; p_Firmicutes; c_Bacilli; 
o_Lactobacillales; 
f_Enterococcaceae; g_; s_
-0.0845 -0.1752 0.0063 0.068 -0.0883 -0.1833 0.0068 0.068
OTU767863 k_Bacteria; p_Firmicutes; c_Bacilli; 
o_Lactobacillales; 
f_Enterococcaceae; g_; s_
-0.0452 -0.0914 0.0011 0.055 -0.0441 -0.0905 0.0022 0.062
OTU183089 k_Bacteria; p_Firmicutes; 
c_Clostridia; o_Clostridiales; 
f_Clostridiaceae; g_; s_
0.0002 -0.0007 0.0011 0.672 0.0000 -0.0008 0.0009 0.968




0.0632 -0.0095 0.1358 0.088 0.0493 -0.0232 0.1217 0.181




0.0631 -0.0109 0.1371 0.094 0.0591 -0.0164 0.1345 0.124




-0.0001 -0.0002 0.0001 0.396 0.0000 -0.0002 0.0002 0.937





-0.0019 -0.0035 -0.0003 0.022 -0.0020 -0.0036 -0.0004 0.016





0.0006 0.0001 0.0011 0.023 0.0006 0.0001 0.0011 0.025
OTU439908 k_Bacteria; p_Firmicutes; c_Bacilli; 
o_Bacillales; f_Staphylococcaceae; 
g_Staphylococcus; s_
-0.0003 -0.0006 0.0000 0.061 -0.0004 -0.0007 -0.0001 0.021
PD_whole_tr
ee
0.0574 -0.0150 0.1298 0.119 0.0360 -0.0408 0.1128 0.355





-0.0680 -0.1185 -0.0175 0.009 -0.0573 -0.1089 -0.0057 0.03




0.0026 0.0002 0.0050 0.032 0.0022 -0.0002 0.0046 0.069
OTU36125 k_Bacteria; p_Firmicutes; c_Bacilli; 
o_Bacillales; f_Bacillaceae; 
g_Bacillus; s_
-0.0334 -0.1233 0.0565 0.464 -0.0553 -0.1461 0.0355 0.231
OTU496787 k_Bacteria; p_Firmicutes; c_Bacilli; 
o_Bacillales; f_Staphylococcaceae; 
g_Staphylococcus; s_
-0.0044 -0.0085 -0.0003 0.038 -0.0045 -0.0086 -0.0004 0.031




0.3222 0.0583 0.5861 0.017 0.2580 -0.0345 0.5506 0.083




0.0893 0.0244 0.1542 0.007 0.0746 0.0065 0.1426 0.032




0.2291 0.0033 0.4549 0.047 0.2149 -0.0170 0.4468 0.069




-0.0487 -0.0977 0.0003 0.051 -0.0400 -0.0893 0.0094 0.111




0.0000 -0.0016 0.0016 0.978 -0.0004 -0.0020 0.0012 0.589




0.0169 -0.0133 0.0472 0.27 0.0142 -0.0164 0.0448 0.359








Table S 10 (continued). Association between infant gut microbiota features selected as predictive of BMI z-
score at age 12 and BMI z-score based on linear regressions.  Adjusted models included the following: 
exclusive breastfeeding, delivery mode, antibiotics, gestational age at birth and twin status. 
 
  
Time Feature Taxonomy Estimate Lower CI Upper CI p-value Estimate Lower CI Upper CI p-value
30 OTU403068 k_Bacteria; p_Firmicutes; c_Bacilli; 
o_Bacillales; f_Staphylococcaceae; 
g_Staphylococcus; s_
-0.0296 -0.0712 0.0120 0.161 -0.0248 -0.0661 0.0164 0.236




0.0019 0.0006 0.0031 0.004 0.0016 0.0003 0.0030 0.014




0.0013 0.0004 0.0023 0.005 0.0011 0.0001 0.0021 0.026





0.0093 -0.0064 0.0251 0.244 0.0086 -0.0070 0.0242 0.277
OTU441155 k_Bacteria; p_Firmicutes; c_Bacilli; 
o_Bacillales; f_Bacillaceae; 
g_Bacillus; s_
-0.2315 -0.5624 0.0993 0.169 -0.1932 -0.5214 0.1350 0.247




0.0013 -0.0003 0.0030 0.109 0.0012 -0.0005 0.0028 0.156
OTU4458959 k_Bacteria; p_Firmicutes; 
c_Clostridia; o_Clostridiales; 
f_Veillonellaceae; g_Veillonella; s_
0.0216 -0.0010 0.0442 0.061 0.0168 -0.0063 0.0398 0.152




0.5320 0.1709 0.8931 0.004 0.4392 0.0768 0.8016 0.018




-0.2813 -0.5382 -0.0243 0.032 -0.2561 -0.5095 -0.0027 0.048
120 OTU289933 k_Bacteria; p_Firmicutes; c_Bacilli; 
o_Lactobacillales; f_; g_; s_
-0.2344 -0.4003 -0.0685 0.006 -0.2213 -0.3846 -0.0579 0.008





0.0367 -0.0218 0.0952 0.217 0.0451 -0.0127 0.1029 0.125
observed_sp
ecies
0.0017 -0.0034 0.0067 0.51 0.0021 -0.0033 0.0074 0.447
shannon 0.2408 -0.0236 0.5051 0.074 0.2650 -0.0168 0.5468 0.065





-0.0311 -0.0532 -0.0089 0.006 -0.0326 -0.0547 -0.0105 0.004





0.0006 -0.0006 0.0018 0.323 0.0005 -0.0006 0.0017 0.369
OTU225919 k_Bacteria; p_Firmicutes; c_Bacilli; 
o_Lactobacillales; f_; g_; s_
-0.0033 -0.0061 -0.0005 0.02 -0.0035 -0.0063 -0.0007 0.016




-0.0011 -0.0017 -0.0004 0.002 -0.0010 -0.0017 -0.0003 0.003
OTU4434334 k_Bacteria; p_Firmicutes; 
c_Clostridia; o_Clostridiales; 
f_Clostridiaceae; g_; s_
0.0006 -0.0008 0.0019 0.396 0.0007 -0.0007 0.0021 0.342




0.0083 -0.0031 0.0197 0.154 0.0064 -0.0048 0.0176 0.258





0.0690 -0.0517 0.1897 0.261 0.0693 -0.0490 0.1875 0.249
OTU560685 k_Bacteria; p_Tenericutes; 
c_Mollicutes; o_; f_; g_; s_
-0.2158 -0.4077 -0.0239 0.028 -0.1758 -0.3647 0.0131 0.068




-0.0047 -0.0091 -0.0003 0.037 -0.0047 -0.0091 -0.0004 0.034
OTU225919 k_Bacteria; p_Firmicutes; c_Bacilli; 
o_Lactobacillales; f_; g_; s_
-0.0206 -0.0362 -0.0050 0.01 -0.0151 -0.0319 0.0018 0.079




-0.0005 -0.0025 0.0015 0.637 -0.0007 -0.0027 0.0013 0.473




-0.0108 -0.0287 0.0070 0.231 -0.0087 -0.0268 0.0093 0.34
OTU195828 k_Bacteria; p_Firmicutes; 
c_Clostridia; o_Clostridiales; f_; g_; 
s_
-0.0169 -0.0528 0.0190 0.353 -0.0177 -0.0528 0.0174 0.32
OTU306368 k_Bacteria; p_Firmicutes; 
c_Clostridia; o_Clostridiales; f_; g_; 
s_
0.6774 0.2289 1.1260 0.003 0.5211 0.0467 0.9956 0.032
OTU3931537 k_Bacteria; p_Firmicutes; 
c_Clostridia; o_Clostridiales; 
f_Clostridiaceae; g_Clostridium; s_
0.0036 -0.0045 0.0117 0.378 0.0054 -0.0026 0.0134 0.186
OTU194870 k_Bacteria; p_Firmicutes; 
c_Clostridia; o_Clostridiales; 
f_Lachnospiraceae; g_; s_




Table S 10 (continued). Association between infant gut microbiota features selected as predictive of BMI z-
score at age 12 and BMI z-score based on linear regressions.  Adjusted models included the following: 
exclusive breastfeeding, delivery mode, antibiotics, gestational age at birth and twin status. 
   
Time Feature Taxonomy Estimate Lower CI Upper CI p-value Estimate Lower CI Upper CI p-value
365 OTU3301187 k_Bacteria; p_Firmicutes; 
c_Clostridia; o_Clostridiales; 
f_Lachnospiraceae; g_; s_
0.3227 0.0355 0.6099 0.028 0.3442 0.0647 0.6237 0.016
OTU531582 k_Bacteria; p_Firmicutes; 
c_Clostridia; o_Clostridiales; 
f_Lachnospiraceae; g_Blautia; s_
-0.5561 -1.0289 -0.0833 0.022 -0.6479 -1.1115 -0.1843 0.007




0.4107 0.0449 0.7766 0.028 0.2757 -0.0992 0.6507 0.148
OTU4470603 k_Bacteria; p_Firmicutes; 
c_Clostridia; o_Clostridiales; 
f_Lachnospiraceae; g_Dorea; s_
0.0098 -0.0136 0.0332 0.407 0.0090 -0.0147 0.0328 0.452




0.0320 -0.0436 0.1075 0.403 0.0183 -0.0559 0.0925 0.626
OTU180285 k_Bacteria; p_Firmicutes; 
c_Clostridia; o_Clostridiales; 
f_Ruminococcaceae; g_; s_
0.0001 -0.0002 0.0004 0.542 0.0002 -0.0001 0.0005 0.196
OTU183048 k_Bacteria; p_Firmicutes; 
c_Clostridia; o_Clostridiales; 
f_Ruminococcaceae; g_; s_
0.0026 -0.0018 0.0069 0.242 0.0036 -0.0008 0.0079 0.109
OTU185021 k_Bacteria; p_Firmicutes; 
c_Clostridia; o_Clostridiales; 
f_Ruminococcaceae; g_; s_
-0.1332 -0.3220 0.0555 0.165 -0.1213 -0.3076 0.0649 0.199
OTU185542 k_Bacteria; p_Firmicutes; 
c_Clostridia; o_Clostridiales; 
f_Ruminococcaceae; g_; s_
-0.0390 -0.1604 0.0825 0.526 -0.0320 -0.1514 0.0874 0.596
OTU265871 k_Bacteria; p_Firmicutes; 
c_Clostridia; o_Clostridiales; 
f_Ruminococcaceae; g_; s_
0.0174 -0.0027 0.0376 0.089 0.0242 0.0043 0.0442 0.018
OTU352347 k_Bacteria; p_Firmicutes; 
c_Clostridia; o_Clostridiales; 
f_Ruminococcaceae; g_; s_
0.0000 -0.0004 0.0005 0.947 0.0001 -0.0004 0.0005 0.746
OTU4439469 k_Bacteria; p_Firmicutes; 
c_Clostridia; o_Clostridiales; 
f_Ruminococcaceae; g_; s_
0.0120 0.0029 0.0211 0.01 0.0100 0.0009 0.0191 0.031




0.0024 -0.0145 0.0194 0.777 0.0055 -0.0111 0.0221 0.513




0.0055 -0.0007 0.0116 0.079 0.0075 0.0015 0.0135 0.015




-0.1570 -0.3282 0.0142 0.072 -0.1228 -0.2957 0.0501 0.162




-0.1498 -0.3131 0.0135 0.072 -0.1585 -0.3178 0.0007 0.051





-0.1616 -0.2623 -0.0609 0.002 -0.1590 -0.2611 -0.0568 0.003




-0.0037 -0.0091 0.0018 0.185 -0.0034 -0.0088 0.0021 0.221
730 OTU4449054 k_Bacteria; p_Bacteroidetes; 
c_Bacteroidia; o_Bacteroidales; 
f_Bacteroidaceae; g_Bacteroides; s_
0.0037 -0.0075 0.0150 0.509 0.0043 -0.0073 0.0159 0.46
OTU183249 k_Bacteria; p_Firmicutes; 
c_Clostridia; o_Clostridiales; f_; g_; 
s_
0.0306 -0.0178 0.0790 0.211 0.0269 -0.0231 0.0769 0.285
OTU193863 k_Bacteria; p_Firmicutes; 
c_Clostridia; o_Clostridiales; 
f_Lachnospiraceae; g_; s_
0.5686 0.3106 0.8267 <.001 0.5337 0.2636 0.8038 <.001
OTU194353 k_Bacteria; p_Firmicutes; 
c_Clostridia; o_Clostridiales; 
f_Lachnospiraceae; g_Blautia; s_
0.0091 0.0023 0.0160 0.01 0.0079 0.0006 0.0152 0.036
OTU198636 k_Bacteria; p_Firmicutes; 
c_Clostridia; o_Clostridiales; 
f_Lachnospiraceae; g_Blautia; s_
0.0040 0.0005 0.0075 0.027 0.0038 0.0001 0.0074 0.043
OTU178447 k_Bacteria; p_Firmicutes; 
c_Clostridia; o_Clostridiales; 
f_Ruminococcaceae; g_; s_
0.8658 0.4296 1.3019 <.001 0.8327 0.3716 1.2938 <.001








Table S 11. Results of unadjusted and adjusted r gressions to assess the association between exposure to 
maternal OW/OB and infant gut microbiota features selected as predictive of BMI z-score at age 12.  Adjusted 
models included the following: exclusive breastfeeding (yes/no at each time), anti-biotic exposure (yes/no at 
each time), and delivery mode at birth. 
 
  
Feature Taxonomy Estimate 95% CI Pr > |t| Estimate 95% CI Pr > |t|
OTU109478 k_Bacteria;p_Firmicutes;c_Bacilli;o_Lactobacillales;f_Enterococcaceae;g_;s_ -0.23 (-0.61, 0.16) 0.254 -0.31 (-0.69, 0.06) 0.099
OTU132041 k_Bacteria;p_Actinobacteria;c_Actinobacteria;o_Bifidobacteriales;f_Bifidobacteriaceae;g_Bifidobacterium;s_ -0.15 (-0.38, 0.07) 0.178 -0.14 (-0.37, 0.09) 0.228
OTU147860 k_Bacteria;p_Proteobacteria;c_Gammaproteobacteria;o_Enterobacteriales;f_Enterobacteriaceae;g_Plesiomonas;s_ 0.24 (-0.15, 0.63) 0.233 0.23 (-0.15, 0.62) 0.235
OTU1546671 k_Bacteria;p_Firmicutes;c_Bacilli;o_Lactobacillales;f_Lactobacillaceae;g_Lactobacillus;s_zeae 0.15 (-0.17, 0.47) 0.348 0.19 (-0.12, 0.5) 0.236
OTU1696853 k_Bacteria;p_Firmicutes;c_Bacilli;o_Lactobacillales;f_Carnobacteriaceae;g_Granulicatella;s_ 0.08 (-0.15, 0.3) 0.508 0.05 (-0.18, 0.27) 0.677
OTU178447 k_Bacteria;p_Firmicutes;c_Clostridia;o_Clostridiales;f_Ruminococcaceae;g_;s_ 0.23 (-0.71, 1.17) 0.633 0.23 (-0.71, 1.17) 0.623
OTU180285 k_Bacteria;p_Firmicutes;c_Clostridia;o_Clostridiales;f_Ruminococcaceae;g_;s_ 0.18 (-0.17, 0.52) 0.318 0.16 (-0.2, 0.52) 0.385
OTU181422 k_Bacteria;p_Firmicutes;c_Clostridia;o_Clostridiales;f_Ruminococcaceae;g_Faecalibacterium;s_prausnitzii 0.10 (-0.32, 0.53) 0.632 0.04 (-0.4, 0.48) 0.858
OTU183048 k_Bacteria;p_Firmicutes;c_Clostridia;o_Clostridiales;f_Ruminococcaceae;g_;s_ -0.08 (-0.5, 0.34) 0.706 -0.14 (-0.6, 0.32) 0.541
OTU183089 k_Bacteria;p_Firmicutes;c_Clostridia;o_Clostridiales;f_Clostridiaceae;g_;s_ -0.08 (-0.36, 0.2) 0.575 -0.12 (-0.39, 0.15) 0.390
OTU183249 k_Bacteria;p_Firmicutes;c_Clostridia;o_Clostridiales;f_;g_;s_ 0.59 (0.09, 1.08) 0.021 0.54 (0.03, 1.04) 0.037
OTU185542 k_Bacteria;p_Firmicutes;c_Clostridia;o_Clostridiales;f_Ruminococcaceae;g_;s_ 0.13 (-0.3, 0.56) 0.557 0.09 (-0.33, 0.52) 0.664
OTU186819 k_Bacteria;p_Firmicutes;c_Clostridia;o_Clostridiales;f_Lachnospiraceae;g_Coprococcus;s_ 0.60 (-0.34, 1.54) 0.210 0.48 (-0.42, 1.37) 0.294
OTU194353 k_Bacteria;p_Firmicutes;c_Clostridia;o_Clostridiales;f_Lachnospiraceae;g_Blautia;s_ 0.20 (-0.35, 0.75) 0.470 0.19 (-0.34, 0.72) 0.487
OTU194870 k_Bacteria;p_Firmicutes;c_Clostridia;o_Clostridiales;f_Lachnospiraceae;g_;s_ 0.27 (-0.15, 0.69) 0.207 0.25 (-0.15, 0.65) 0.224
OTU195828 k_Bacteria;p_Firmicutes;c_Clostridia;o_Clostridiales;f_;g_;s_ 0.15 (-0.2, 0.51) 0.392 0.13 (-0.24, 0.5) 0.497
OTU197435 k_Bacteria;p_Firmicutes;c_Clostridia;o_Clostridiales;f_Lachnospiraceae;g_[Ruminococcus];s_gnavus 0.22 (-0.31, 0.74) 0.414 0.17 (-0.35, 0.69) 0.518
OTU198636 k_Bacteria;p_Firmicutes;c_Clostridia;o_Clostridiales;f_Lachnospiraceae;g_Blautia;s_ 0.26 (-0.19, 0.71) 0.257 0.25 (-0.22, 0.71) 0.297
OTU198788 k_Bacteria;p_Bacteroidetes;c_Bacteroidia;o_Bacteroidales;f_Bacteroidaceae;g_Bacteroides;s_ -0.18 (-0.76, 0.4) 0.541 -0.14 (-0.72, 0.43) 0.618
OTU224813 k_Bacteria;p_Firmicutes;c_Bacilli;o_Lactobacillales;f_Enterococcaceae;g_Enterococcus;s_ -0.03 (-0.28, 0.22) 0.815 -0.06 (-0.27, 0.16) 0.585
OTU225919 k_Bacteria;p_Firmicutes;c_Bacilli;o_Lactobacillales;f_;g_;s_ -0.13 (-0.39, 0.13) 0.330 -0.16 (-0.38, 0.07) 0.168
OTU236142 k_Bacteria;p_Proteobacteria;c_Gammaproteobacteria;o_Enterobacteriales;f_Enterobacteriaceae;g_;s_ 0.33 (-0.07, 0.74) 0.104 0.35 (-0.05, 0.75) 0.085
OTU2497305 k_Bacteria;p_Firmicutes;c_Bacilli;o_Lactobacillales;f_Enterococcaceae;g_Enterococcus;s_ -0.31 (-0.71, 0.1) 0.135 -0.34 (-0.71, 0.02) 0.067
OTU265871 k_Bacteria;p_Firmicutes;c_Clostridia;o_Clostridiales;f_Ruminococcaceae;g_;s_ 0.24 (-0.33, 0.81) 0.413 0.16 (-0.4, 0.72) 0.577
OTU289918 k_Bacteria;p_Firmicutes;c_Bacilli;o_Lactobacillales;f_Lactobacillaceae;g_Lactobacillus;s_ 0.34 (-0.16, 0.84) 0.187 0.35 (-0.15, 0.85) 0.174
OTU289933 k_Bacteria;p_Firmicutes;c_Bacilli;o_Lactobacillales;f_;g_;s_ -0.45 (-0.89, -0.01) 0.044 -0.51 (-0.91, -0.1) 0.015
OTU295146 k_Bacteria;p_Firmicutes;c_Bacilli;o_Lactobacillales;f_Enterococcaceae;g_Enterococcus;s_ -0.26 (-0.63, 0.1) 0.158 -0.33 (-0.66, 0) 0.052
OTU306368 k_Bacteria;p_Firmicutes;c_Clostridia;o_Clostridiales;f_;g_;s_ 0.60 (-0.34, 1.54) 0.211 0.41 (-0.54, 1.36) 0.395
OTU315982 k_Bacteria;p_Firmicutes;c_Clostridia;o_Clostridiales;f_Clostridiaceae;g_Clostridium;s_perfringens 0.51 (-0.13, 1.16) 0.119 0.43 (-0.2, 1.06) 0.175
OTU319275 k_Bacteria;p_Firmicutes;c_Clostridia;o_Clostridiales;f_Ruminococcaceae;g_Faecalibacterium;s_prausnitzii 0.28 (-0.16, 0.72) 0.205 0.24 (-0.2, 0.68) 0.290
OTU3301187 k_Bacteria;p_Firmicutes;c_Clostridia;o_Clostridiales;f_Lachnospiraceae;g_;s_ 1.27 (0.37, 2.18) 0.006 1.17 (0.06, 2.29) 0.039
OTU352347 k_Bacteria;p_Firmicutes;c_Clostridia;o_Clostridiales;f_Ruminococcaceae;g_;s_ 0.18 (-0.18, 0.55) 0.323 0.16 (-0.21, 0.53) 0.403
OTU3569942 k_Bacteria;p_Firmicutes;c_Clostridia;o_Clostridiales;f_Veillonellaceae;g_Veillonella;s_dispar 0.03 (-0.6, 0.66) 0.927 0.01 (-0.61, 0.64) 0.964
OTU36125 k_Bacteria;p_Firmicutes;c_Bacilli;o_Bacillales;f_Bacillaceae;g_Bacillus;s_ -0.64 (-1.13, -0.14) 0.012 -0.71 (-1.18, -0.24) 0.003
OTU365385 k_Bacteria;p_Actinobacteria;c_Actinobacteria;o_Bifidobacteriales;f_Bifidobacteriaceae;g_Bifidobacterium;s_bifidum 0.02 (-0.43, 0.47) 0.940 0.03 (-0.41, 0.48) 0.881
OTU3931537 k_Bacteria;p_Firmicutes;c_Clostridia;o_Clostridiales;f_Clostridiaceae;g_Clostridium;s_ -0.02 (-0.38, 0.34) 0.916 -0.05 (-0.41, 0.31) 0.797
OTU403068 k_Bacteria;p_Firmicutes;c_Bacilli;o_Bacillales;f_Staphylococcaceae;g_Staphylococcus;s_ -0.22 (-0.46, 0.03) 0.084 -0.20 (-0.44, 0.04) 0.104
OTU4297420 k_Bacteria;p_Firmicutes;c_Clostridia;o_Clostridiales;f_Veillonellaceae;g_Veillonella;s_dispar 0.44 (0.01, 0.87) 0.047 0.44 (0.01, 0.86) 0.047
OTU4328910 k_Bacteria;p_Firmicutes;c_Clostridia;o_Clostridiales;f_Veillonellaceae;g_Veillonella;s_parvula 0.21 (-0.11, 0.52) 0.203 0.18 (-0.13, 0.49) 0.260
OTU4335781 k_Bacteria;p_Actinobacteria;c_Actinobacteria;o_Bifidobacteriales;f_Bifidobacteriaceae;g_Bifidobacterium;s_ -0.03 (-0.19, 0.14) 0.765 -0.02 (-0.19, 0.15) 0.785
OTU4375080 k_Bacteria;p_Proteobacteria;c_Gammaproteobacteria;o_Pasteurellales;f_Pasteurellaceae;g_Haemophilus;s_parainfluenzae 0.02 (-0.24, 0.28) 0.879 0.05 (-0.2, 0.31) 0.688
OTU4380886 k_Bacteria;p_Proteobacteria;c_Gammaproteobacteria;o_Enterobacteriales;f_Enterobacteriaceae;g_;s_ 0.39 (-0.04, 0.82) 0.073 0.38 (-0.04, 0.8) 0.076
OTU439908 k_Bacteria;p_Firmicutes;c_Bacilli;o_Bacillales;f_Staphylococcaceae;g_Staphylococcus;s_ -0.16 (-0.32, 0) 0.045 -0.14 (-0.29, 0.02) 0.081
OTU4432891 k_Bacteria;p_Proteobacteria;c_Gammaproteobacteria;o_Enterobacteriales;f_Enterobacteriaceae;g_Enterobacter;s_hormaechei 0.23 (-0.03, 0.48) 0.084 0.23 (-0.03, 0.49) 0.078
OTU4433823 k_Bacteria;p_Bacteroidetes;c_Bacteroidia;o_Bacteroidales;f_Bacteroidaceae;g_Bacteroides;s_fragilis 0.03 (-0.37, 0.43) 0.887 0.05 (-0.35, 0.44) 0.820
OTU4434334 k_Bacteria;p_Firmicutes;c_Clostridia;o_Clostridiales;f_Clostridiaceae;g_;s_ 0.14 (-0.07, 0.35) 0.189 0.13 (-0.08, 0.33) 0.231
OTU4439469 k_Bacteria;p_Firmicutes;c_Clostridia;o_Clostridiales;f_Ruminococcaceae;g_;s_ 0.12 (-0.35, 0.59) 0.612 0.09 (-0.36, 0.54) 0.705
OTU4449054 k_Bacteria;p_Bacteroidetes;c_Bacteroidia;o_Bacteroidales;f_Bacteroidaceae;g_Bacteroides;s_ 0.43 (-0.06, 0.91) 0.087 0.46 (-0.02, 0.93) 0.058
OTU4458306 k_Bacteria;p_Firmicutes;c_Clostridia;o_Clostridiales;f_Veillonellaceae;g_Veillonella;s_dispar 0.14 (-0.08, 0.37) 0.201 0.14 (-0.08, 0.36) 0.212
OTU4458959 k_Bacteria;p_Firmicutes;c_Clostridia;o_Clostridiales;f_Veillonellaceae;g_Veillonella;s_ 0.33 (0.02, 0.64) 0.040 0.31 (0, 0.62) 0.049
OTU4470603 k_Bacteria;p_Firmicutes;c_Clostridia;o_Clostridiales;f_Lachnospiraceae;g_Dorea;s_ 0.35 (-0.05, 0.75) 0.085 0.31 (-0.09, 0.71) 0.130
OTU4476950 k_Bacteria;p_Firmicutes;c_Clostridia;o_Clostridiales;f_[Tissierellaceae];g_Anaerococcus;s_ 0.32 (-0.14, 0.79) 0.172 0.30 (-0.17, 0.76) 0.207
OTU4481613 k_Bacteria;p_Actinobacteria;c_Coriobacteriia;o_Coriobacteriales;f_Coriobacteriaceae;g_Collinsella;s_aerofaciens 0.19 (-0.38, 0.77) 0.505 0.19 (-0.36, 0.74) 0.488
OTU465079 k_Bacteria;p_Firmicutes;c_Bacilli;o_Bacillales;f_Planococcaceae;g_;s_ -0.14 (-0.35, 0.08) 0.220 -0.13 (-0.34, 0.09) 0.247
OTU496787 k_Bacteria;p_Firmicutes;c_Bacilli;o_Bacillales;f_Staphylococcaceae;g_Staphylococcus;s_ -0.29 (-0.51, -0.07) 0.010 -0.27 (-0.49, -0.06) 0.014
OTU510870 k_Bacteria;p_Proteobacteria;c_Gammaproteobacteria;o_Enterobacteriales;f_Enterobacteriaceae;g_;s_ 0.08 (-0.21, 0.36) 0.596 0.06 (-0.21, 0.33) 0.660
OTU511908 k_Bacteria;p_Proteobacteria;c_Gammaproteobacteria;o_Enterobacteriales;f_Enterobacteriaceae;g_Klebsiella;s_ 0.05 (-0.36, 0.46) 0.811 0.02 (-0.37, 0.42) 0.906
OTU523025 k_Bacteria;p_Firmicutes;c_Bacilli;o_Lactobacillales;f_Streptococcaceae;g_Streptococcus;s_ -0.08 (-0.29, 0.14) 0.488 -0.07 (-0.28, 0.15) 0.550
OTU526682 k_Bacteria;p_Actinobacteria;c_Actinobacteria;o_Actinomycetales;f_Actinomycetaceae;g_Actinomyces;s_ 0.02 (-0.38, 0.42) 0.932 -0.004 (-0.41, 0.4) 0.983
OTU528421 k_Bacteria;p_Proteobacteria;c_Gammaproteobacteria;o_Enterobacteriales;f_Enterobacteriaceae;g_;s_ 0.04 (-0.39, 0.47) 0.852 0.003 (-0.41, 0.42) 0.989
OTU531582 k_Bacteria;p_Firmicutes;c_Clostridia;o_Clostridiales;f_Lachnospiraceae;g_Blautia;s_ -0.45 (-1.28, 0.37) 0.278 -0.51 (-1.33, 0.32) 0.227
OTU560685 k_Bacteria;p_Tenericutes;c_Mollicutes;o_;f_;g_;s_ 0.19 (-0.26, 0.64) 0.399 0.21 (-0.24, 0.66) 0.364
OTU566976 k_Bacteria;p_Proteobacteria;c_Gammaproteobacteria;o_Enterobacteriales;f_Enterobacteriaceae;g_;s_ 0.05 (-0.48, 0.59) 0.842 0.04 (-0.49, 0.57) 0.881
OTU591285 k_Bacteria;p_Actinobacteria;c_Actinobacteria;o_Bifidobacteriales;f_Bifidobacteriaceae;g_Bifidobacterium;s_longum -0.15 (-0.36, 0.06) 0.151 -0.14 (-0.35, 0.07) 0.186
OTU593781 k_Bacteria;p_Firmicutes;c_Bacilli;o_Lactobacillales;f_Enterococcaceae;g_Enterococcus;s_haemoperoxidus -0.23 (-0.67, 0.21) 0.302 -0.30 (-0.71, 0.12) 0.162
OTU767863 k_Bacteria;p_Firmicutes;c_Bacilli;o_Lactobacillales;f_Enterococcaceae;g_;s_ -0.61 (-0.99, -0.23) 0.002 -0.66 (-1.01, -0.31) 0.000
PD Phylogenetic Diversity 0.46 (0.01, 0.92) 0.047 0.42 (0.01, 0.84) 0.046
Shannon Shannon Diversity Index 0.17 (0.05, 0.29) 0.007 0.16 (0.05, 0.27) 0.005




Table S 12. Results of regressions to assess the association between presence of maternal taxa at the time of 
delivery and presence in the infant for all taxa selected as predictive of BMI z-score at age 12. For the taxa 
marked with *, the models of presence failed to run due to lack of variation acr ss infants; beta-binomial 
regression models of abundance were used instead.  Missing results indicates that both types of models failed to 
run.  Adjusted models included the following covariates: gestational age and twin status. 
 
  
Feature Taxonomy 95% CI p-value 95% CI p-value
OTU526682 k_Bacteria;p_Actinobacteria;c_Actinobacteria;o_Actinomycetales;f_Actinomycetaceae;g_Actinomyces;s_ 0.12 (-1.01, 1.24) 0.83 * 0.1 (-0.98, 1.17) 0.86
OTU941632 k_Bacteria;p_Actinobacteria;c_Actinobacteria;o_Actinomycetales;f_Corynebacteriaceae;g_Corynebacterium;s_
OTU132041 k_Bacteria;p_Actinobacteria;c_Actinobacteria;o_Bifidobacteriales;f_Bifidobacteriaceae;g_Bifidobacterium;s_ 0.18 (-0.47, 0.84) 0.58 0.16 (-0.5, 0.82) 0.63
OTU4335781 k_Bacteria;p_Actinobacteria;c_Actinobacteria;o_Bifidobacteriales;f_Bifidobacteriaceae;g_Bifidobacterium;s_ -0.21 (-0.74, 0.31) 0.43 -0.24 (-0.77, 0.29) 0.37
OTU365385 k_Bacteria;p_Actinobacteria;c_Actinobacteria;o_Bifidobacteriales;f_Bifidobacteriaceae;g_Bifidobacterium;s_bifidum 0.71 (0.13, 1.28) 0.02 0.64 (0.06, 1.23) 0.03
OTU591285 k_Bacteria;p_Actinobacteria;c_Actinobacteria;o_Bifidobacteriales;f_Bifidobacteriaceae;g_Bifidobacterium;s_longum 0.1 (-0.59, 0.78) 0.78 0.13 (-0.56, 0.82) 0.71
OTU4481613 k_Bacteria;p_Actinobacteria;c_Coriobacteriia;o_Coriobacteriales;f_Coriobacteriaceae;g_Collinsella;s_aerofaciens 1.2 (0.15, 2.25) 0.03 1.07 (0, 2.15) 0.05
OTU198788 k_Bacteria;p_Bacteroidetes;c_Bacteroidia;o_Bacteroidales;f_Bacteroidaceae;g_Bacteroides;s_ 0.96 (0.11, 1.8) 0.03 1.03 (0.16, 1.89) 0.02
OTU4449054 k_Bacteria;p_Bacteroidetes;c_Bacteroidia;o_Bacteroidales;f_Bacteroidaceae;g_Bacteroides;s_ 0.24 (-0.47, 0.96) 0.5 * 0.27 (-0.63, 1.16) 0.55
OTU4433823 k_Bacteria;p_Bacteroidetes;c_Bacteroidia;o_Bacteroidales;f_Bacteroidaceae;g_Bacteroides;s_fragilis 0.63 (0.01, 1.25) 0.05 0.63 (0, 1.25) 0.05
OTU36125 k_Bacteria;p_Firmicutes;c_Bacilli;o_Bacillales;f_Bacillaceae;g_Bacillus;s_ 0.13 (-2.42, 2.68) 0.92 -0.92 (-3.74, 1.9) 0.52
OTU441155 k_Bacteria;p_Firmicutes;c_Bacilli;o_Bacillales;f_Bacillaceae;g_Bacillus;s_ -0.09 (-2.07, 1.9) 0.93 -0.34 (-2.38, 1.69) 0.74
OTU465079 k_Bacteria;p_Firmicutes;c_Bacilli;o_Bacillales;f_Planococcaceae;g_;s_ 0.58 (-0.68, 1.83) 0.37 0.55 (-0.76, 1.85) 0.41
OTU403068 k_Bacteria;p_Firmicutes;c_Bacilli;o_Bacillales;f_Staphylococcaceae;g_Staphylococcus;s_ 0.97 (-0.91, 2.85) 0.31 0.88 (-1.06, 2.82) 0.37
OTU439908 k_Bacteria;p_Firmicutes;c_Bacilli;o_Bacillales;f_Staphylococcaceae;g_Staphylococcus;s_ 0.56 (-1.01, 2.14) 0.48 0.68 (-0.94, 2.31) 0.41
OTU496787 k_Bacteria;p_Firmicutes;c_Bacilli;o_Bacillales;f_Staphylococcaceae;g_Staphylococcus;s_ 1 (-0.61, 2.6) 0.22 0.92 (-0.7, 2.54) 0.27
OTU898871 k_Bacteria;p_Firmicutes;c_Bacilli;o_Bacillales;f_Staphylococcaceae;g_Staphylococcus;s_ -0.67 (-2.45, 1.11) 0.46 -0.74 (-2.55, 1.07) 0.42
OTU944063 k_Bacteria;p_Firmicutes;c_Bacilli;o_Bacillales;f_Staphylococcaceae;g_Staphylococcus;s_epidermidis 1.39 (-0.87, 3.66) 0.23 1.11 (-1.36, 3.58) 0.38
OTU225919 k_Bacteria;p_Firmicutes;c_Bacilli;o_Lactobacillales;f_;g_;s_ 0.1 (-0.71, 0.91) 0.81 -0.25 (-1.09, 0.59) 0.56
OTU289933 k_Bacteria;p_Firmicutes;c_Bacilli;o_Lactobacillales;f_;g_;s_ * 3.02 (0.99, 5.04) <.01 * 3.02 (0.99, 5.04) <.01
OTU1696853 k_Bacteria;p_Firmicutes;c_Bacilli;o_Lactobacillales;f_Carnobacteriaceae;g_Granulicatella;s_ -0.09 (-0.6, 0.41) 0.71 -0.14 (-0.65, 0.36) 0.58
OTU109478 k_Bacteria;p_Firmicutes;c_Bacilli;o_Lactobacillales;f_Enterococcaceae;g_;s_ 2.82 (0.18, 5.45) 0.04 1.93 (-0.91, 4.77) 0.18
OTU767863 k_Bacteria;p_Firmicutes;c_Bacilli;o_Lactobacillales;f_Enterococcaceae;g_;s_ 0.39 (-1.44, 2.21) 0.68 -0.5 (-2.53, 1.52) 0.63
OTU224813 k_Bacteria;p_Firmicutes;c_Bacilli;o_Lactobacillales;f_Enterococcaceae;g_Enterococcus;s_ 0.59 (-0.39, 1.56) 0.24 0.49 (-0.51, 1.5) 0.33
OTU2497305 k_Bacteria;p_Firmicutes;c_Bacilli;o_Lactobacillales;f_Enterococcaceae;g_Enterococcus;s_ * 3.35 (1.77, 4.93) <.01 * 3.35 (1.77, 4.93) <.01
OTU295146 k_Bacteria;p_Firmicutes;c_Bacilli;o_Lactobacillales;f_Enterococcaceae;g_Enterococcus;s_ * 2.04 (0.53, 3.55) <.01 * 2.04 (0.53, 3.55) <.01
OTU593781 k_Bacteria;p_Firmicutes;c_Bacilli;o_Lactobacillales;f_Enterococcaceae;g_Enterococcus;s_haemoperoxidus 2.31 (-0.04, 4.66) 0.05 2.15 (-0.53, 4.83) 0.12
OTU289918 k_Bacteria;p_Firmicutes;c_Bacilli;o_Lactobacillales;f_Lactobacillaceae;g_Lactobacillus;s_ 1.18 (0.41, 1.94) <.01 1.18 (0.4, 1.95) <.01
OTU1546671 k_Bacteria;p_Firmicutes;c_Bacilli;o_Lactobacillales;f_Lactobacillaceae;g_Lactobacillus;s_zeae 0.94 (0.07, 1.81) 0.04 0.93 (0.03, 1.83) 0.04
OTU523025 k_Bacteria;p_Firmicutes;c_Bacilli;o_Lactobacillales;f_Streptococcaceae;g_Streptococcus;s_ -0.28 (-0.9, 0.33) 0.36 -0.27 (-0.89, 0.36) 0.41
OTU183249 k_Bacteria;p_Firmicutes;c_Clostridia;o_Clostridiales;f_;g_;s_ -0.27 (-1.96, 1.42) 0.76 -0.26 (-1.97, 1.44) 0.76
OTU195828 k_Bacteria;p_Firmicutes;c_Clostridia;o_Clostridiales;f_;g_;s_ -0.39 (-1.69, 0.92) 0.56 * -0.4 (-1.75, 0.95) 0.56
OTU306368 k_Bacteria;p_Firmicutes;c_Clostridia;o_Clostridiales;f_;g_;s_
OTU4476950 k_Bacteria;p_Firmicutes;c_Clostridia;o_Clostridiales;f_[Tissierellaceae];g_Anaerococcus;s_ -0.53 (-1.54, 0.49) 0.31 -0.49 (-1.52, 0.53) 0.35
OTU183089 k_Bacteria;p_Firmicutes;c_Clostridia;o_Clostridiales;f_Clostridiaceae;g_;s_ 0.27 (-0.41, 0.95) 0.43 0.24 (-0.44, 0.92) 0.49
OTU4434334 k_Bacteria;p_Firmicutes;c_Clostridia;o_Clostridiales;f_Clostridiaceae;g_;s_ 0.15 (-0.68, 0.98) 0.72 0.16 (-0.68, 1.01) 0.71












OTU180285 k_Bacteria;p_Firmicutes;c_Clostridia;o_Clostridiales;f_Ruminococcaceae;g_;s_ 0.7 (-0.43, 1.84) 0.22 0.89 (-0.27, 2.06) 0.13
OTU183048 k_Bacteria;p_Firmicutes;c_Clostridia;o_Clostridiales;f_Ruminococcaceae;g_;s_ 0.99 (-0.58, 2.57) 0.21 * 0.98 (-0.58, 2.55) 0.21
OTU185021 k_Bacteria;p_Firmicutes;c_Clostridia;o_Clostridiales;f_Ruminococcaceae;g_;s_
OTU185542 k_Bacteria;p_Firmicutes;c_Clostridia;o_Clostridiales;f_Ruminococcaceae;g_;s_
OTU265871 k_Bacteria;p_Firmicutes;c_Clostridia;o_Clostridiales;f_Ruminococcaceae;g_;s_ -0.36 (-2.02, 1.31) 0.67 -0.36 (-2.03, 1.31) 0.67
OTU352347 k_Bacteria;p_Firmicutes;c_Clostridia;o_Clostridiales;f_Ruminococcaceae;g_;s_ -1.08 (-2.63, 0.48) 0.17 -1.02 (-2.69, 0.65) 0.23
OTU4439469 k_Bacteria;p_Firmicutes;c_Clostridia;o_Clostridiales;f_Ruminococcaceae;g_;s_ 0.73 (-0.65, 2.11) 0.3 * 0.77 (-0.65, 2.18) 0.29
OTU181422 k_Bacteria;p_Firmicutes;c_Clostridia;o_Clostridiales;f_Ruminococcaceae;g_Faecalibacterium;s_prausnitzii -0.25 (-1.59, 1.09) 0.72 * -0.26 (-3.17, 2.65) 0.86
OTU319275 k_Bacteria;p_Firmicutes;c_Clostridia;o_Clostridiales;f_Ruminococcaceae;g_Faecalibacterium;s_prausnitzii 0.64 (-0.76, 2.03) 0.37 * 0.63 (-0.77, 2.03) 0.38
OTU529940 k_Bacteria;p_Firmicutes;c_Clostridia;o_Clostridiales;f_Ruminococcaceae;g_Faecalibacterium;s_prausnitzii
OTU4458959 k_Bacteria;p_Firmicutes;c_Clostridia;o_Clostridiales;f_Veillonellaceae;g_Veillonella;s_ -0.57 (-2.91, 1.77) 0.63 -0.59 (-2.94, 1.76) 0.62
OTU3569942 k_Bacteria;p_Firmicutes;c_Clostridia;o_Clostridiales;f_Veillonellaceae;g_Veillonella;s_dispar
OTU4297420 k_Bacteria;p_Firmicutes;c_Clostridia;o_Clostridiales;f_Veillonellaceae;g_Veillonella;s_dispar
OTU4458306 k_Bacteria;p_Firmicutes;c_Clostridia;o_Clostridiales;f_Veillonellaceae;g_Veillonella;s_dispar 0.61 (-0.03, 1.25) 0.06 0.52 (-0.12, 1.16) 0.11
OTU4328910 k_Bacteria;p_Firmicutes;c_Clostridia;o_Clostridiales;f_Veillonellaceae;g_Veillonella;s_parvula 0.57 (-0.75, 1.9) 0.39 0.53 (-0.81, 1.87) 0.44
OTU236142 k_Bacteria;p_Proteobacteria;c_Gammaproteobacteria;o_Enterobacteriales;f_Enterobacteriaceae;g_;s_
OTU4380886 k_Bacteria;p_Proteobacteria;c_Gammaproteobacteria;o_Enterobacteriales;f_Enterobacteriaceae;g_;s_ 0.28 (-1.42, 1.99) 0.74 0.23 (-1.57, 2.02) 0.8
OTU510870 k_Bacteria;p_Proteobacteria;c_Gammaproteobacteria;o_Enterobacteriales;f_Enterobacteriaceae;g_;s_ -0.3 (-0.83, 0.23) 0.27 -0.34 (-0.88, 0.2) 0.21
OTU528421 k_Bacteria;p_Proteobacteria;c_Gammaproteobacteria;o_Enterobacteriales;f_Enterobacteriaceae;g_;s_ -0.22 (-1.22, 0.78) 0.67 -0.33 (-1.37, 0.71) 0.53
OTU566976 k_Bacteria;p_Proteobacteria;c_Gammaproteobacteria;o_Enterobacteriales;f_Enterobacteriaceae;g_;s_
OTU4432891 k_Bacteria;p_Proteobacteria;c_Gammaproteobacteria;o_Enterobacteriales;f_Enterobacteriaceae;g_Enterobacter;s_hormaechei -0.5 (-1.69, 0.69) 0.41 -0.48 (-1.68, 0.72) 0.43
OTU511908 k_Bacteria;p_Proteobacteria;c_Gammaproteobacteria;o_Enterobacteriales;f_Enterobacteriaceae;g_Klebsiella;s_ 0.78 (-0.88, 2.43) 0.36 0.37 (-1.41, 2.15) 0.69
OTU147860 k_Bacteria;p_Proteobacteria;c_Gammaproteobacteria;o_Enterobacteriales;f_Enterobacteriaceae;g_Plesiomonas;s_ 1.02 (-0.81, 2.86) 0.27 0.94 (-0.94, 2.82) 0.33
OTU4375080 k_Bacteria;p_Proteobacteria;c_Gammaproteobacteria;o_Pasteurellales;f_Pasteurellaceae;g_Haemophilus;s_parainfluenzae 0.91 (0.12, 1.7) 0.02 0.81 (0.01, 1.61) 0.05





Table S 13. Results of BLAST search of representative sequences for the OTUs found to be linearly associated 
with BMI and associated in maternal-infant samples. 
  
Association with 







Positive Bifidobacterium bifidum  Bifidobacterium bifidum strain NBRC 100015 16S rRNA gene, partial sequence 2429 2429 0.98 99% NR_113873.1
Enterococcus sp.  Enterococcus gallinarum strain LMG 13129 16S rRNA gene, complete sequence 2370 2370 100% 97% NR_104559.2
Enterococcus casseliflavus strain NBRC 100478 16S rRNA gene, partial sequence 2355 2355 92% 99% NR_104560.1
Enterococcus sp.  Enterococcus faecium strain DSM 20477 16S rRNA gene, complete sequence 2427 2427 100% 97% NR_114742.1
Enterococcus faecium strain NBRC 100486 16S rRNA gene, partial sequence 2405 2405 99% 97% NR_113904.1
Collinsella aerofaciens Collinsella aerofaciens strain JCM 10188 16S rRNA gene, partial sequence 2471 2471 100% 98% NR_113316.1
Collinsella aerofaciens strain ATCC 25986 16S rRNA gene, partial sequence 2396 2396 100% 97% NR_028604.1
Negative Order Lactobacillales Enterococcus faecalis strain LMG 7937 16S rRNA gene, complete sequence 2296 2296 100% 96% NR_114782.1
Lactobacillus sp. Lactobacillus taiwanensis strain BCRC 17755 16S rRNA gene, partial sequence 2327 2327 99% 96% NR_044507.1
Lactobacillus gasseri strain ATCC 33323 16S rRNA gene, complete sequence 2314 2314 100% 96% NR_075051.1
Bacteroides sp. Bacteroides dorei strain 175 16S rRNA gene, partial sequence 2361 2361 100% 97% NR_041351.1
Family Enterococcaceae Enterococcus canis strain NBRC 100695 16S rRNA gene, partial sequence 2412 2412 100% 97% NR_113931.1
Enterococcus termitis strain LMG 8895 16S rRNA gene, complete sequence 2405 2405 100% 97% NR_042406.1
Enterococcus faecium strain DSM 20477 16S rRNA gene, complete sequence 2405 2405 100% 97% NR_114742.1
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Table S 14. Results of random forest selection process to identify infant gut microbiota taxa associated with 
exposure to maternal OW/OB.  The out of bag error was 35.5%.  For a similar random forest classifying 
randomly assigned exposure status the out of bag error was comparable, indicating that the model failed to 









OTU4347159 k_Bacteria; p_Actinobacteria; c_Actinobacteria; o_Bifidobacteriales; f_Bifidobacteriaceae; g_Bifidobacterium; s_adolescentis 0.40% 39.76
OTU3723096 k_Bacteria; p_Firmicutes; c_Bacilli; o_Lactobacillales; f_Streptococcaceae; g_Streptococcus; s_ 0.35% 32.56
OTU591285 k_Bacteria; p_Actinobacteria; c_Actinobacteria; o_Bifidobacteriales; f_Bifidobacteriaceae; g_Bifidobacterium; s_longum 0.25% 18.02
OTU182517 k_Bacteria; p_Firmicutes; c_Clostridia; o_Clostridiales; f_Lachnospiraceae; g_[Ruminococcus]; s_gnavus 0.25% 22.41
OTU1142029 k_Bacteria; p_Actinobacteria; c_Actinobacteria; o_Bifidobacteriales; f_Bifidobacteriaceae; g_Bifidobacterium; s_ 0.22% 30.38
OTUother NA 0.21% 41.78
OTU4294457 k_Bacteria; p_Actinobacteria; c_Actinobacteria; o_Actinomycetales; f_Micrococcaceae; g_Rothia; s_mucilaginosa 0.20% 19.52
OTU439908 k_Bacteria; p_Firmicutes; c_Bacilli; o_Bacillales; f_Staphylococcaceae; g_Staphylococcus; s_ 0.19% 27.78
OTU109382 k_Bacteria; p_Proteobacteria; c_Betaproteobacteria; o_Burkholderiales; f_; g_; s_ 0.18% 22.10
OTU3166216 k_Bacteria; p_Firmicutes; c_Bacilli; o_Lactobacillales; f_Streptococcaceae; g_Streptococcus; s_ 0.16% 20.10
OTU180509 k_Bacteria; p_Firmicutes; c_Clostridia; o_Clostridiales; f_Ruminococcaceae; g_Ruminococcus; s_ 0.16% 11.53
OTU510870 k_Bacteria; p_Proteobacteria; c_Gammaproteobacteria; o_Enterobacteriales; f_Enterobacteriaceae; g_; s_ 0.16% 26.44
OTU182882 k_Bacteria; p_Firmicutes; c_Clostridia; o_Clostridiales; f_Lachnospiraceae; g_[Ruminococcus]; s_gnavus 0.14% 15.22
OTU289709 k_Bacteria; p_Proteobacteria; c_Gammaproteobacteria; o_Enterobacteriales; f_Enterobacteriaceae; g_; s_ 0.13% 21.60
OTU681370 k_Bacteria; p_Actinobacteria; c_Actinobacteria; o_Bifidobacteriales; f_Bifidobacteriaceae; g_Bifidobacterium; s_pseudolongum 0.12% 22.97
OTU284014 k_Bacteria; p_Proteobacteria; c_Gammaproteobacteria; o_Enterobacteriales; f_Enterobacteriaceae; g_; s_ 0.12% 28.43
OTU4375080 k_Bacteria; p_Proteobacteria; c_Gammaproteobacteria; o_Pasteurellales; f_Pasteurellaceae; g_Haemophilus; s_parainfluenzae 0.12% 20.59
OTU496787 k_Bacteria; p_Firmicutes; c_Bacilli; o_Bacillales; f_Staphylococcaceae; g_Staphylococcus; s_ 0.11% 19.99
OTU3449122 k_Bacteria; p_Firmicutes; c_Bacilli; o_Lactobacillales; f_Streptococcaceae; g_Streptococcus; s_ 0.11% 15.60
OTU292289 k_Bacteria; p_Proteobacteria; c_Gammaproteobacteria; o_Enterobacteriales; f_Enterobacteriaceae; g_; s_ 0.10% 16.58
OTU511908 k_Bacteria; p_Proteobacteria; c_Gammaproteobacteria; o_Enterobacteriales; f_Enterobacteriaceae; g_Klebsiella; s_ 0.10% 18.33
OTU224813 k_Bacteria; p_Firmicutes; c_Bacilli; o_Lactobacillales; f_Enterococcaceae; g_Enterococcus; s_ 0.10% 26.98
OTU1063810 k_Bacteria; p_Firmicutes; c_Bacilli; o_Bacillales; f_Staphylococcaceae; g_Staphylococcus; s_aureus 0.10% 18.47
OTU4425214 k_Bacteria; p_Firmicutes; c_Bacilli; o_Lactobacillales; f_Streptococcaceae; g_Streptococcus; s_ 0.09% 37.75
OTU813564 k_Bacteria; p_Proteobacteria; c_Gammaproteobacteria; o_Enterobacteriales; f_Enterobacteriaceae; g_Erwinia; s_ 0.09% 7.32
OTU4439469 k_Bacteria; p_Firmicutes; c_Clostridia; o_Clostridiales; f_Ruminococcaceae; g_; s_ 0.09% 9.40
OTU225919 k_Bacteria; p_Firmicutes; c_Bacilli; o_Lactobacillales; f_; g_; s_ 0.08% 22.77
OTU4481613 k_Bacteria; p_Actinobacteria; c_Coriobacteriia; o_Coriobacteriales; f_Coriobacteriaceae; g_Collinsella; s_aerofaciens 0.08% 15.52
OTU272150 k_Bacteria; p_Firmicutes; c_Bacilli; o_Lactobacillales; f_Streptococcaceae; g_Streptococcus; s_ 0.08% 32.55
OTU905211 k_Bacteria; p_Actinobacteria; c_Actinobacteria; o_Actinomycetales; f_Micrococcaceae; g_Rothia; s_ 0.08% 9.07
OTU813479 k_Bacteria; p_Actinobacteria; c_Actinobacteria; o_Bifidobacteriales; f_Bifidobacteriaceae; g_Bifidobacterium; s_ 0.08% 21.06
OTU4354477 k_Bacteria; p_Proteobacteria; c_Gammaproteobacteria; o_Enterobacteriales; f_Enterobacteriaceae; g_; s_ 0.07% 9.92
OTU4344883 k_Bacteria; p_Firmicutes; c_Clostridia; o_Clostridiales; f_Clostridiaceae; g_; s_ 0.07% 13.23
OTU4335781 k_Bacteria; p_Actinobacteria; c_Actinobacteria; o_Bifidobacteriales; f_Bifidobacteriaceae; g_Bifidobacterium; s_ 0.07% 22.55
OTU197367 k_Bacteria; p_Bacteroidetes; c_Bacteroidia; o_Bacteroidales; f_Bacteroidaceae; g_Bacteroides; s_ 0.07% 20.89
OTU1100972 k_Bacteria; p_Firmicutes; c_Bacilli; o_Lactobacillales; f_Streptococcaceae; g_Lactococcus; s_ 0.07% 10.60
OTU365385 k_Bacteria; p_Actinobacteria; c_Actinobacteria; o_Bifidobacteriales; f_Bifidobacteriaceae; g_Bifidobacterium; s_bifidum 0.06% 20.98
OTU4449054 k_Bacteria; p_Bacteroidetes; c_Bacteroidia; o_Bacteroidales; f_Bacteroidaceae; g_Bacteroides; s_ 0.06% 10.92
OTU352347 k_Bacteria; p_Firmicutes; c_Clostridia; o_Clostridiales; f_Ruminococcaceae; g_; s_ 0.05% 13.11
OTU637546 k_Bacteria; p_Proteobacteria; c_Gammaproteobacteria; o_Enterobacteriales; f_Enterobacteriaceae; g_; s_ 0.05% 6.94
OTU403068 k_Bacteria; p_Firmicutes; c_Bacilli; o_Bacillales; f_Staphylococcaceae; g_Staphylococcus; s_ 0.05% 14.82
OTU296358 k_Bacteria; p_Proteobacteria; c_Gammaproteobacteria; o_Enterobacteriales; f_Enterobacteriaceae; g_; s_ 0.05% 7.74
OTU193235 k_Bacteria; p_Firmicutes; c_Clostridia; o_Clostridiales; f_Lachnospiraceae; g_Dorea; s_ 0.05% 6.34
OTU4451899 k_Bacteria; p_Firmicutes; c_Clostridia; o_Clostridiales; f_Lachnospiraceae; g_; s_ 0.05% 6.78
OTU1733364 k_Bacteria; p_Bacteroidetes; c_Bacteroidia; o_Bacteroidales; f_Bacteroidaceae; g_Bacteroides; s_uniformis 0.04% 13.24
OTU744941 k_Bacteria; p_Proteobacteria; c_Gammaproteobacteria; o_Thiohalorhabdales; f_; g_; s_ 0.04% 10.60
OTU9727 k_Bacteria; p_Proteobacteria; c_Gammaproteobacteria; o_Enterobacteriales; f_Enterobacteriaceae; g_Pantoea; s_agglomerans 0.04% 11.23
OTU919490 k_Bacteria; p_Firmicutes; c_Bacilli; o_Bacillales; f_Staphylococcaceae; g_Staphylococcus; s_aureus 0.04% 4.45
OTU191913 k_Bacteria; p_Firmicutes; c_Clostridia; o_Clostridiales; f_Lachnospiraceae; g_; s_ 0.03% 5.65





Figure S 4. The diagram at the top shows the overall conceptual model of the relationships examined in this 
study between maternal weight, maternal and infant gut microbiota and childhood BMI.  Below this are directed 
acyclic graphs (DAGs) of the relationships between exposures, outcomes, and other factors in the analysis of i) 
infant gut microbiota and BMI z-score at age 12, ii) maternal OW/OB and infant gut microbiota and iii) 
maternal gut microbiota and infant gut microbiota.  DAGs show the conceptual relationships between 
exposures, outcomes, confounders, and mediators and inform decisions about what to include in regression 
models.  Relationships were determined based on prior research when available and on univariate analyses for 











Figure S 5. Principal Coordinate Analysis plots of unweighted UniFrac distance of infant and 
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Figure S 6. Percent abundance of the most abundant a) phylum-level and b) genus-level taxa of 






Figure S 7. Principal Coordinate Analysis plots of a) unweighted UniFrac distance, and b) weighted UniFrac 




Figure S 8. These plots show the relationship between the taxa selected by the random forests as important to 
predict HFF against the predicted values of HFF (�).  Since random forests do not provide regression coefficients, 
these plots are used to understand the direction of the relationships between the predictors and the outcome.  A 
linear regression would fit only a linear relationship between the predictors and the outcome, but random forests 
allow for any type of relationship, including complex interactions.  The general trends shown in these pictures are 
summarized in Table 10. Marginal plots (a) show the unadjusted relationship between the taxa and HFF, ie all the 
other features are ignored, as in simple regression.  Partial plots (b) show the adjusted relationship between the taxa 









Figure S 9. These heat plots show the 2-way inter-relationships between the taxa selected by the random forests as 
important to predict HFF, with the predicted values of HFF represented in color: red indicates high values off HFF, 
yellow corresponds with low values. Since random forests do not provide regression coefficients and may include 
complex interactions between the features, these plots are used to understand these interactions. For example, the 
plot of Oscillospira and Bilophila suggests an interaction: the previous figure shows that Bilophila has a positive 
relationship with HFF (higher abundance generally corresponds to higher HFF), but this plot shows that high 
abundance of Bilophila corresponds with high HFF only when Oscillospira abundance is <20%.  The presence of 







Figure S 10. These plots show the a) marginal and b) partial relationships between the dietary components selected 
by the random forests as important to predict HFF against the predicted valu s of HFF (�), as well as c) the 
interactions between these dietary components with red corresponding to high predicted values off HFF and yellow 
corresponding to low values.  See previous supplemental figures for a general description of these types of plots.  
The following abbreviations are used: pmufa_ii corresponds to % monounsaturated fats, ptotfat_ii s % total fat, 




Figure S 11. These plots show the a) marginal and b) partial relationships between the comorbidities selected by the 
random forests as important to predict HFF against the predicted values of HFF (�), as well as c) the interactions 
between these comorbidities with red corresponding to high predicted values off HFF and yellow corresponding to low 
values.  See previous supplemental figures for a general description of thes  types of plots.  The following abbreviations 














Figure S 12. These plots show the a) partial relationship  between the combined set of features selected by the 
random forests as important to predict HFF against the predicted values of HFF (�), as well as b) the interactions 
between these features with red corresponding to high predicted valuesoff HFF and yellow corresponding to low 
values.  See previous supplemental figures for a general description of these types of plots.  The following 
abbreviations are used: pmufa_ii corresponds to % monounsaturated fats, and bmiz is BMI z-score. 
